var title_f24_39_25200="Dependent airspace disease CT";
var content_f24_39_25200=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F60461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F60461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 602px\">",
"   <div class=\"ttl\">",
"    Dependent airspace disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 582px; height: 212px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical supine chest CT scans in a patient with the acute respiratory distress syndrome (ARDS) reveal areas of dependent airspace disease in a patient with left lower lobe pneumonia. In the scan on the left, airway pressure (P",
"    <sub>",
"     aw",
"    </sub>",
"    ) = 0 cmH",
"    <sub>",
"     2",
"    </sub>",
"    0; in the scan on the right, (P",
"    <sub>",
"     aw",
"    </sub>",
"    ) = 40 cmH",
"    <sub>",
"     2",
"    </sub>",
"    0.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David Schwartz, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25200=[""].join("\n");
var outline_f24_39_25200=null;
var title_f24_39_25201="Gram stain sputum 6";
var content_f24_39_25201=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F65288&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F65288&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain sputum 6",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25201=[""].join("\n");
var outline_f24_39_25201=null;
var title_f24_39_25202="Occiput posterior and occiput transverse positions";
var content_f24_39_25202=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57241&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57241&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 529px\">",
"   <div class=\"ttl\">",
"    Occiput posterior and occiput transverse positions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 509px; height: 554px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Right occiput posterior (ROP).",
"    <br>",
"     (B) Right occiput transverse (ROT).",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25202=[""].join("\n");
var outline_f24_39_25202=null;
var title_f24_39_25203="Saccharomyces boulardii: Drug information";
var content_f24_39_25203=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Saccharomyces boulardii: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?7/40/7812?source=see_link\">",
"    see \"Saccharomyces boulardii: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F3870517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Florastor&reg; Kids [OTC];",
"     </li>",
"     <li>",
"      Florastor&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F3870521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Dietary Supplement;",
"     </li>",
"     <li>",
"      Probiotic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F3871284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral: Dosing varies by manufacturer; consult product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Florastor&reg;: 250 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F3871283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral: Dosing varies by manufacturer; consult product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Florastor&reg; Kids: 250 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3871285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. Use caution in debilitated patients.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F3871288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Florastor&reg;: S. boulardii lyo 250 mg [contains lactose 32.5 mg/capsule, magnesium 2.85 mg/capsule; provides 5 billion live cells]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Florastor&reg; Kids: S. boulardii lyo 250 mg/packet (10s) [contains lactose 32.5 mg/packet, magnesium 2.85 mg/packet; tutti frutti flavor; provides 5 billion live cells]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F3870519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F3871287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Florastor&reg;: Swallow capsule whole or capsules may be opened and emptied on tongue (wash down with water or juice) or sprinkled on semisolid food (eg, applesauce, sour cream, yogurt) or added to a drink (eg, water, apple or orange juice, milk or formula); may be administered with or without food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Florastor&reg; Kids: Add powder to a drink or sprinkle on semisolid food; may be administered with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F3871262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Promote maintenance of normal microflora in the gastrointestinal tract; used in management of bloating, gas, and diarrhea, particularly to decrease the incidence of diarrhea associated with antibiotic use",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F10535315\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Codex: Brand name for",
"       <i>",
"        saccharomyces boulardii",
"       </i>",
"       [Italy], but also the brand name for acetaminophen/codeine [Brazil]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Codex [Italy] may be confused with Cedax brand name for ceftibuten [U.S. and multiple international markets]; Clobex brand name for clobetasol [U.S., Canada, and multiple international markets]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Precosa [Finland, Norway, Sweden] may be confused with Precose brand name for acarbose [U.S.]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F3871268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Constipation, flatulence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Thirst",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Postmarketing and/or case reports: Fungemias",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F3871263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to",
"     <i>",
"      Saccharomyces boulardii",
"     </i>",
"     or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F3871264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull;	Yeast allergy: Use with caution in patients allergic to yeast;",
"     <i>",
"      S. boulardii",
"     </i>",
"     is a live yeast preparation and a subtype of the species,",
"     <i>",
"      S. cervasiae",
"     </i>",
"     , which is also referred to as &ldquo;baker&rsquo;s yeast&rdquo; or &ldquo;brewer&rsquo;s yeast.&rdquo;",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Antifungals: Avoid use in patients with concurrent systemic antifungals;",
"     <i>",
"      S. boulardii",
"     </i>",
"     may be susceptible.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull;	Immunocompromised patients: Use with caution or avoid use in immunocompromised, debilitated, or critically ill patients, particularly those with a central venous catheter and/or previous or current antibiotic therapy;",
"     <i>",
"      S. boulardii",
"     </i>",
"     , although a nonpathogenic yeast, use has been associated with case reports of fungemia in this population.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Lactose: Some products may contain lactose; use with caution in patients with lactose intolerance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull;	Various preparations: Significant differences may exist from one preparation of",
"     <i>",
"      S. boulardii",
"     </i>",
"     compared to another with respect to biologic activity and composition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull;	Dietary supplement: Probiotics are classified as dietary supplements; therefore, there are no safety reviews or approved therapeutic indications by the FDA. There is no conclusive evidence to support widespread use in the treatment of diarrhea.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F3871272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents: May diminish the therapeutic effect of Saccharomyces boulardii.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Butenafine; Butoconazole; Ciclopirox; Clotrimazole (Topical); Econazole; Gentian Violet; Iodoquinol; Ketoconazole (Topical); Miconazole (Topical); Naftifine; Natamycin; Nystatin (Topical); Oxiconazole; Povidone-Iodine (Topical); Sertaconazole; Sulconazole; Sulfanilamide; Terbinafine (Topical); Terconazole; Tioconazole; Tolnaftate; Undecylenic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F3871286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be given with or without food. Some products may contain lactose.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16570480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (ReZyst SB Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (60): $45.00",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Codex (IT);",
"     </li>",
"     <li>",
"      Econorm (IN);",
"     </li>",
"     <li>",
"      Enflor (PK);",
"     </li>",
"     <li>",
"      Enterol (BE, BG, CZ, EE);",
"     </li>",
"     <li>",
"      Floratil (AR, CO, EC, MX, PE);",
"     </li>",
"     <li>",
"      Florestor (VE);",
"     </li>",
"     <li>",
"      Inteflora (ZA);",
"     </li>",
"     <li>",
"      Pediarol (DO, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Perenterol (CH, CR, GT, PY);",
"     </li>",
"     <li>",
"      Perenteryl (CN);",
"     </li>",
"     <li>",
"      Perocur (CN);",
"     </li>",
"     <li>",
"      Precosa (FI, NO, SE);",
"     </li>",
"     <li>",
"      UL-250 (PT);",
"     </li>",
"     <li>",
"      Ultra-Levora (ES)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F3871276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <i>",
"      S. boulardii",
"     </i>",
"     , a nonpathogenic live yeast probiotic, acts as temporary flora to help re-establish the normal gastrointestinal microflora. May also modulate the immune system by inducing cytokines and suppress pathogenic bacteria growth.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F3871278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Yeast cell release from capsules/powder: 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: Yeast cells cleared in 5-7 days",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Enache-Angoulvant A and Hennequin C, &ldquo;Invasive Saccharomyces Infection: A Comprehensive Review,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(11):1559-68.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/39/25203/abstract-text/16267727/pubmed\" id=\"16267727\" target=\"_blank\">",
"        16267727",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9481 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-3C09538E6E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25203=[""].join("\n");
var outline_f24_39_25203=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3870517\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3870521\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871284\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871283\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871285\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871288\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3870519\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871287\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871262\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10535315\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871268\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871263\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871264\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300018\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871272\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871286\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570480\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539983\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871276\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3871278\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9481\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9481|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?7/40/7812?source=related_link\">",
"      Saccharomyces boulardii: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_39_25204="Hepatic hydrothorax nuclear";
var content_f24_39_25204=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F64287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F64287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hepatic hydrothorax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intraperitoneal injection of 500 MBq 99mTc-tagged nannocolloids, followed by scintigrams taken between 5 minutes and 24 hours post injection, demonstrated a transdiaphragmatic tracer flow into the right pleural cavity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Truninger K, Frey LD. Hepatic hydrothorax without ascites. Schweiz Med Wochenschr 2000; 130:1706.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25204=[""].join("\n");
var outline_f24_39_25204=null;
var title_f24_39_25205="APL hypergranular variant";
var content_f24_39_25205=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F76618%7EHEME%2F66640&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F76618%7EHEME%2F66640&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypergranular variant of acute promyelocytic leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The malignant promyelocytes in the more common \"hypergranular\" variant of acute promyelocytic leukemia (APL) have characteristic large reddish-blue or dark purple granules in the cytoplasm. The nucleus is often folded, indented, or dumb-bell shaped.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard A Larson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute promyelocytic leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 252px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD8AYADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDjvF+gTWqW0sLrLlQSY+evr71zM1xcQw/ZbmFgRyrE84r2l7WOfTo7e9DxyyrjpkBsdK5Cfwnc3TldVnUW8WRE6EZ+lehSxCtaQubm1ZwVpF57KkYXeeTu6V674DSGOe0gkYK2d3y8Bj9K868RaDc6K4DBngzlZQMfrVPStYuNOuFkSRioOSuf5VrVgq8LJg1pY+w4dscI+4RjO4ivmT4uaVLZ+LJ544gUlO4HHFd9oniu71GwjW2vlhcrkZ+YN7VjeJvEVgsUsGo4acjiVUD498V5uDoTw9R9SaaaZ5AIJHfLDJPTFadroF/NjyYbgbumxSc10Nn4q0e1lQrp7yleDI4UbvfbXVN410xrMyW11CrgcRsdv6V6Mp1E/diW3bZXPMNR0m+s2KTShCP4GbB/Ko9Omhim2yJ+93YLE8VPql2+oag105WbeTwHxiq/2Q4aZCrBRl1U8it1fqa26o3TLBaz/aLsGQbdqIQB+QrLj+yzzuwZ41znG3v6VVkdyFWRjNGeQScMK2dJi8OFY1u7q+WRj864AH50NqIc1mSyXZSGOJhGigjBX+ZqeW4iXDTMXb+FlHSunXwdod3bLLp9zLMh4IVssKfb6Da2dyIoY2LRjJMpzxXP9Yp9BqcTmF04XTwrZSrukOSGByK6mHw4YnhkuLnz9vGxOB9M1poLVoFms7f5U/iVcIfXJ71OI4G8sRuPm54JINYyryltoZzqSYkMbIrRrGiPjBbPao5itwWRpQeMAk8L9PU+9S28BR2eIFA2U3HkE+uDU0WnyovnPsDAZc7ck1hdLUyvZ3uZk9zNYJHHplubtl5kcnOPwq01wf7PaedGtp3z8sz5yPatCK5ly7BUOOFBXjPrxV1wz6bJHciGUsMFgmNv0pqVmm0Epp6WPnrXpzPqkzcgFqckJljQLI2wjkVd8SadFZzSmSQ+cZDtT2rFWRkkzExC9uK9S51JqL12ZYmsnjJK4K+ueaiSZBA8ZTDHofSiWWUZbn0PHFMhj899oHzGgJNXtFHSeGo3GlXrbgygZA9DWRLg75HfIz2OPyrsvCVg8UEloIzNLOMBAe3rmuW8R6c9jevG6AAE9+lC3YoVFrFFO1i3DfyVB47GrxkSIATLhR+dZ2nZ+0AM21O9XNR2TFBGWOOAMc07XN4TtG6IL547t447dCWziuu0iU6FbrLnbkAOpPB9qz9C0s2ML6hdRfLEN3J6Vz+q6jLfXUk0sjMSeF/u0rLY5ZtVHdnqVl8VZLZDBFYxGIE5aSU5z7e1Vrj4matqN1LbRxW4tHQhkVcnHs3WvKA2F4GW9Samt52iJdV+bsfSsPqlG9+VXCKh2O3upPtbKkCxwDGHweW96z7xHiO5gjrF0PIz/jVDR9SiASNg3nEnJxwwrd1K9ja1jjTYgIwOOtaJWOlPaxX+1yyGKS3lnWId4uFzWlaeIbyBHV55m5xnIKVzssTQSAwx5LD5lDZ/H0FTSS20FoTIIkbOMZJP1pOMXuhyhFrU9C0rW4b+YeYrpIox8v3W/Ci6mkMhSWUH5shQMcVyXh0288yfY7rBjXnBKlz6YNbN/FcrGsziNWj4A3ZrmlCMJWRjGmubQ1nlR0WCAv5xPQ+nqKqyxOsiRKG83P3jwahsX+0KZm3tIDjb3PvWnvMbNPvZc/dBIz+FZbFP3XZDo1l8tPNjUz87sDkCte30OG4jgDF0XvkcmuesDJK0kirM8jthdh4H1rvNOMiWoiucbguBkcVlVbjqjCq3H3blyytLWziMdvF82OWPVqxPFca2emz3DYRgpG1T1z61tWrFY1RnQsTxznNUPGarPodzAAPNZc5HPSuanJqojBLXU+cb1vNvJH3FjuPNLAIycyfqKntZ4ILyT7RFuwxxUVzJHLOzAbV7AV7h3xtuMMaySbFAB7ZNPaybBI5x1AqKYon+rOfUipLMyPcIFY/OduBSG+W9me2TXsv2hWaILGn3V3HLCkikkmLps2K4IwwBJ/Guf0Lxba6xMYWQxTrzknhhXTxMHUEEFexFeFiK7oS5XE4o07mNqtobrRbtb9HiRVwN7ZzjuBXityP3jgdFOBn0r2nxtqU2naEWjjSQOdhLdQPavGL9g8rSAFdx5Ga9TAVPa03PzHJWRc0jVpbNWijbCt3J6H1FWDFDcWzC4uJTOQW4Ocn6VhHIwRVu3cyMhU/vAfzFdq1HCXQS2jkilV1jDnoARkGpri3dpA0saRs56YwBWhfu8M0Toq4Veo/rVFxNdhsfMR0FUXZLQglhcTJGArE9AnOa6nQdBuRG9xPFLFBwrEDfnPsK5602WExkIErr0XoK0W17UrhcR3DomMbI+APYVElJ6IcVbbc2/GfgqTRY4bm0nW6s5B8m0/MvsR2rko1iDf6UhRRxwe/vVu31i9tpDsuZgwOeeeffNF9qKajlp4VWY4DFeN3v9aUFJK0nfzGtNzT0LVLnT5Y3025VWxjDd/wrSl8SXdtdSrfzvFLKPmaPGDXDu81pcKVBRh90+1Nu3kaTfKW8xh826m4Rk7tCc11R3OneKriwkIF+ZIyfuHBH5V1eheIrK9wkVysV0DwrRjB+h7V5D9lAtEuI3XHfJ5BrW8N3Nqmqq8wdViQuWQ9SKidCElcU7W2ser6jrMWlq07zpK3eNMHJ9/SuG1/x9ftIFsRHCB7ZrkdU1aa8vpJUcohPyqPSqaMZXJkPA5zShQhDdXZMYR+Z1Vj451ZJVLSRse5K9a7TQvFMeq38UVxL9mbgMe2a8lDhZg0Yww59Kntrx7bUUlYjg5IHSrdOMuhTpRt5ntHjbwNDr0ZubYC3nXkOGyH/AArxrVtC1LS5mW4gZkBx5ijKmvoLw3qL6ho9pPh1UjAC9z71oyQQ3S+VcQxlDyVK5rzoYmdF8stbGSk0fMcs09xGiJF8o44XvWzoWjXbXAaSJgw6Jjk/Wveh4Z0KHeWs13jkBV5NN/syxtBvihG5h0bk1usfHpEcqjkctoenvpsS3dw5jlIAwi5IHpU2rWljqsG6aMvLk7X2evY4rckhjZJEiU/aQBuTdgD2qpBp8sKgqCuTlvnGBUe1UnzN6mOqeh5vL4TK3TMbS7CA4VkGAT/Sul0LwVNJIXeDYijOGYZrpo5JJL8bHcwAcgcj8a1Xf5cFwoHUk4qqmJnayKnN2scN8QbKKy8LNBAeQ+XIFeNhljY4O7HPNfROuRQajYS2jeXscEM/evB9c0O40y8kikX92Dw/YitcLK8bPc0pP3bLcywQ8uSBjNaV1LbpbKkK4P8AFWaRsBwO/WkjfbICea6UaKVtC7YSn7ZAxUN8wHAxmupv5I4xIkSwMxO1iFz5dc74asmvdaghVGkO7ccdAPevYNRhtYrOWWaG38+GIkBlAOcccd6yqVOVpWGqvItTyzUb0WSRLEoMxU7i3p61gGdnk3SMWye9LfyPLdSvI2WZiSarjtzV3sKdRtmtZtiRZFl27OQa7HRNTBidL9S+8/LNj+lef28gjkVjzjqK0Yb19iqGLRqenf6USgpqzNITTVj0uBFgIYF0yOADU8aqVLYlLA5Y9hWVo0TR6ZFNOkkgkf5U3Z4/pWkBJdqTbIIwvJyOcVxS0drlNdTqNCt0WEOJQwJ+RAcY+taX9oWsZK3EhQIcMSDgGsnQnNvpDyFACmSd3ANcpqniSO5eY3LonO1Y2Pf1rKNB1JM45e9K+56JJeWkl1boLlRH1wqjDexNa5MTHkoysPqK8Tt/EKRR7ftG09sLgV0Wk6q0371JjMyDOA/T8KdTBNLcmV1utDO8dfD28+2y3+lwhoHO5kj5K/hXmlzZXFvIySxMjg9xX0LpHi5ZJhDcJtPQtnpWtrNnpt5EHuLSKVn7lAc/jUrE1aHu1V8y41ejR81WlpcTfIiElvQV6D4O8Dyb0u7ttirztYcj8K7SLRbEPKiWEVtGOI3U5JPqa1NPg+zQ+WZWmA6M/GK5sVmiUWqW5u23ofNVlcG3lDgncO4r1DwrrKRWaG5kO1umTnaK8nRSW+WvXvAcUCaSzfK7HAIYV2Y9RdF8yMk2a3iiwh1nw9Om4kAeahXqSK8LkBLY3dDjmvomFlZQMD3WvK/GXhO4sbyW5trYzWMjbw8Yy0Z7gj0rgynExg3Rk7X2LlHmRwp9ORmlBwcg85606ddr4UN17rgmpUs5mVSEwD0Br6Axs27IuLqx+xiFoVZv7xrU0azvdQhYkrDaryWC4Le2av8AhbwPc3zC4v0aOzUg7scH8+teoajbx2+hPY2iRmIRnY20Dbx645Nc9SulLljqzRTcdDwu8XFxIF55x+FW4gsFruRwxI6DqDVC6MiXcileQ3zHFSyn90rjKN3roZ0Qdm2DhjzKh5/DNVJCGJZF2fQ1Yhfziqsc89+tXNQtVihV4wijGevWgTXMroqSxyXWmCZjk2/Deu0mqbEzSKfYDAyTXV+D7BLu3vfOA2yJs49e1c9LBLpl3JDdW7jGVGRj8aL3djBauxG9pJFB5jEbRzjNa/h7ThPb3l0cJCsZXLHkn2o0Xwxr2qbmsbFzE4x5kp2Lj8eter6P4Rj0/wAMS2s6h7iRcEqMhT7VlVxEIaX1CUopaHhMiBSRkE1dsbVZ4Sd4DDt0NSa9pc2mXskNxGyPk4z0IzWfFJ5bAg4PetWuxpFqMrtaF6azaMgvkZ61CyRsw8sEEdWJpXut6gPuOPQ0lshlmjRQcscY7VSRcnH7J6v4c8R2mi+Blmv5GDFsRwo/zOf8K4/VPiPrdy5FnMLGEdFi5J+pNc74lm8y/wDKVgY4FEa4PSswIWXIBrFUoJuVrtnMdJB428QxPvXVLgknOGORXaeF/iSLidbfxBHGxPCzqMc+9eWCMCHdnLHt6VASRnHBqp0oSVmgaXU+ll0u21AJcGcSIP3mEPUe9JdTsImEG5QRt5Xgf4VneGZZ4dDsizAu0ALEH2qst87XRj3NtcnCrx+ZrzKcueTV72JaY6G4kXUPJinARQGYBcg/U9qmvLx4/lM0ck5+6g5OPpUazxwyy7EaJhwWf7rmuf8AEOo+RODF5cN0RhpV6qPQVvFOcrJDUeZlvUNdWBmiO9ZtuHaIZK/h0rItvENo8EkepI1ymeGZQTj0rB82Itva4LSSNk+496sysnlFokSNjwuBz+NdSoxSsdKoqxrRaDoOqSMUin2sPvRjaF+tVl8BWD3Sql3dbCeV2DP51n2j3AjZ1Ztw9G6musstcnstPUDbLO65AAzge9ZzVSHwu5Mqcr6G/wCGtC0/SIgtrb+Wc4Zz8zN9TVm/01LmKZJSrB1Kh9uSoNUtH1OK4eMgSE7fmI4wa2vM3q/3jjr7fWuOfMpXuccuZPXc+efEmmvperTWr5wpyp9RWWAM8nAr1/4h+G31K2F7axF54zh8c8etcVZ+CNVu0EnlfZ4j0ef5VP0Nd0KsZR5mzZPmVzm08sA8MxxWlo+mXN/qNpa7SgnPy9zirTeFdRjuDETD/v78Ae9dp4I0y00G7N5eXbS3S8L5a/KBjpk1cp8sbx1ZXMkjc8QaY1m9s1lauLeNNhfkgkdSaq6cbwndbZ3PnJC5re1TWLK5H75XaIj5lxkVb0+S2ktNsBIx2A4we9cClOMPeRLqLks0cR438QXOn6fb2lvIEl2/MFIPPqTXmKvJcTF5JCzseprp/iWpTxBIQCqbeOMA1yVvIqSZJOK7qdlFWKgkrFqffHxuOf5U5LiRF/1jD0xxmmMYVbcztnNJJMHYIgwPU1d2bO3c0rHW57aYASTMncFv5V7H4E1Zr20kX5mjCZGT0rwE5DsAcV7d8D9FnuUW7kVvs4UruPc+lceP5ZYeXMc8t7nX7SrHJGPWpQ6qASxI9RW/4i0f/RvOt4xlBkqB2rlFkUgZI9K+QXvGqd1ofO+kWNxeSrDBEzs5wDg8V7D4f006RpqWzbC/UlTnmrdrbtp90QEESuMIAAKvRxENk17+PxDklDoZRlciSLOHUHI98VaidlGD/Kn7egAINSeXnp0rx5K+5pc4/wAdWkM8FvHDGiyO3UKBV3Q/BFna2i3F8q3UxAYxknH5itmWwW7vY3ZAVi5GfWtEEpypLkdj0rqjiakIRhB27jcrqxHqtk66ajfNHEANqKvI9hWRqDSR6PcHbiXHAY5Fdfb3wmRY7ltgHJOM7qrXdlFNBOSrKp4yOv4e9d1CurK5ytWZ843sLyXcisjCQnOfSop9syZm3Fh0r2ePwdZossl6TO0hIVuVZRWGvw2t0Z7iW8cxMcBFTmvU+tU+51Rrxa1PNNPthKdyui49TgVZEcjz+XAhnfoCOgr1G3+H2mpEWCPKuOfMfA/Sn2GhwSSLFYhYYVblox94fWmsTB3aF7dJcsRPBuhPp+kAyiNHY5ZpByPpXQTJGNu1DM6879q4J/GtcQKY1DRDYg25YA1AUiDLiQAKeRjArzJ1nUldmKtvIpoLvaNyRoMcFRz+FTWaGAvI0zSI3ZuoP0p2FyV8wJGeQ2eT/hWJrGr2dmcS3Jcg/cj+Y/WiMXLRIta6JD/FWg2OuCOG6Ty7jqjRjmvOdY+HF/bM5t2WWPsxP6GvQY9esJ8HzbhkAzu2Y2ite3vYZ4StvLHMGGN3JH410QqVaKt0D3orY8Cn8NatFKY1spmwBu2DcK6nwl4Yka/gF6yW0hB2rIvU9s16bJMsMckEcflPIQWcA847Zqo0EfmLJty45yTzWdfM3C8bDTbWh4Z4hsp7PXbu3uIwsquT7EeoqmWVwAxG8cZr2nxR4Zs/EVunmu0FzH92dRk49D6iuEPw61YTOIvLuI1PBVwpP4GurC5hSrLV2l1Ks0cfKOdqhQB6VseD/Dk2vaoiKpFnE26eXHH+6Peup074d3BukOrOsEI5MKHcz+2egr0aytYLK3S3tIlhhQYCKMVljsxjSXLS1l+QJJu5m61cx2NtDawFUeXEa5OMDpUOmxQopTY29e7JkD8aq3tv9v1Z2cqyRNtA25x/hWrJM9qI0ijeUNwcHpWOGpclNLq9WZyd3oU/Jinne8yQqqRnhcH1xXMa2I70b/OklI+XG0Ln8q6iaKVvOigCtDIDuBbOD61yckJiUqyEleqq3H416VGPW5VN63MprdljdfKGQfvbclRVm+ZBFH5Ma+aF7nr+FJIkuELSBFJJAIPNV7qye4cSAMpHochvpXRY61Lqwsh5quUB81P7o4rp0vLWzgiDgGYrh1j5Ofesh7v+y7FI7eFfNfnDDJY/Ssz7RcxSMwTa8h5J7fhWcoc++xm4ur6HTwXlvBfKbRmeeTGY2G1R9K7mGYLpzzXUnlrGPmAJxXkckzKQs+9ioypxyfpiuz8L6sJtIuorgybIx/G+MiuatS0TRlWp2SZo6hq4t7XdBL57PwFXjj3rm7m+uL8mOcOwbGBIfue1OeVLmXeu7Y33CDxUqQW/mK+9y56CtIwjDpqYaIou4D5LlQgxjbwKktIt0bvNKrg8gAYIqPUXtwSqPiXqxAA/OstJ7jzOG5/h2njFaWujWKbWhtPLK0PmrGqgfLkt94VPDcXFqgEbSHPKKhxgVz8WpXJd45WzG5wVK8fWtG1dpIzIJ9jrwwzxiplFoHG26Kni2wlv7f7Z+9llH+s3HJA9gK4CRSrkY/TFenRTm3ZgdpTGAD/F9axNQ8LS3RefTirknJiJ5B9jRF23G+zOTJWTC8hsevWmBSG69PetSbw5qdmDJdRLbxjrJIwAqpElpGczeZOuex2A1a12C99TQ8JaFP4j1yCwtQAXb53PAUd6+vPDukwaNpVtZWwCxxIF4HX3r5c8OeMY/D9/FcWenW4jXh13Hcw+te/eBfH9h4miVIsxTjrGeorx81pVppNL3UZTZ3DgMpBHX1rjNd1Lw7pd20MlnHLKOX2L9361oeN9dOiaHNPC8azkbY9zD86+ctV8VSFpRGvmPI255GOcmuLBZcsRec9iYuTdoncWOpLcRrJMVyvCIRkgeoNbcJ+VSnIPrXm9kpBYhRhSDvzniu10S4MsIUnKqOOetdWOoac6N5Q5dUbiAcjjNOYhFLnIA7ioozwMmp0UlQcYHvXkddSR0I3ovzHae+adjGfSl2scHOB6CgI5Y8+xpXVxiLwQT07cVpwSbLfMxKqTg59KpjEeNwyegJqOZ2eIZORnPSqhW5WDhzFtnt5AHhJUklRu71VuVUQeeJHKg4Cj1qq67lPJ/GozMzK0MmBJj5P/AK9ehQqwqaIylBrUoa1cSQeVGFlkEh27olLZNa2k2iWtnjCrKerYwRUNtb3MsJjEjR7ed0bdfeotVvYdOtB58heQ9QTk/nXVJuSUIjUeayRfkYjcY5MsOoGTVQXcaK0t0PkXO7eMfkK5dNYumdpYJUihbhUJwxqrqNzcWrMk7xzK67gGbdj8R0rWOHezNfYvZljULyTVPP8AJkjt7ZedrMQWrnpZm3rbxW8UYPJwclj7mpriaSNN5ZSr87VHAHpTBJEylpo1jyuF7ZrsjHlVkdUYJLQhuXdHiTiNwfmRT94VKt3c6fcCW0Jgz1jU5BHvVe3eKF2Nwu4Y4xUdvPM87s+wZBAJ5/Sra6DtdHfWlwur2EUySBJ1OWVWJI9zV2RQJCMnA5zXJeF5JrG/+zzwuBKvXpxXXOxmkGw/Oo+53x614mYUbarY5JrklYj+cZ9RQMH7uc98VIyqOWKr9TioQEkO6GRWx3U9K8qLcdUPmvuSpIuff3p0jERkgEnFVtj7ulcVfay03iZbaMTLKvy7V6fWuihh5YiTt0CUlY27QSxXqiXy9zNvIX09/eptTuEtN4kKmJurH19qq28ptXePaxnYcq/GPpV4+bdK0EioYdvzF16/SvoIq1mzJOzK1pcRwxs0REynGWzwPaqOvJEyR3UMmPM4dUA/SnzFQ8IjwkSfeIHb6CrnnwbNsDorAblLpnH4etbJ8r5kD0lc5rcke3chlbB++c/p2pkbC3k3wwLvI/iGQKvatYOZYrpSXiP3mwAc+tVGfYuFU+u4Hr9a6E1JHRFqRVYYckyAO3JyM4rMMzCRo8gqx5YjOasBWDNu2jPJPPNVpnGdsYUZPTHX3p2N4onhikRt2cLjhT1q/pm6DzBg7ZVOcnPP0qlZ7YyT5jN3Krzj2Brc0yGWPT57xbciEgAvJzj1qZabmdaVkMtiqtGJCfMxhQOmKZd6rFasVhxuX+Mms6/uWVyLY7o2XJLHtWT54c754wAeOV4NChfVmEYc2rNC7YySb2wyuOSOlVyViZf3j5HG1R/XtUQuvMUxxOUbOB3GBUku6P78ryg9WYdKdjVJoRZNlyziRtp4+bkDPrUkc8UbZGT8wzmqfnR+YoYlhjHI4+tXYfKaNgmGZhwBTFI0p4TME8vZJwCWbitfTL1ra6xIB5ZHAVuTWIuYYMEEqOSCcYqzb3JKFliUAj5N3X8Kxcb6GUtY6mD441aS/wBQKgbbdfur6mubOSBlgfarOsybryQMckEiqEbYYY61TajoidtB7qyHBBx1rW8MX0+n6tBJaTNHIzBeuMisd3LcEk/Wp7CTbdwEgk7x/OlFq4meqfFvxBNeW+l28jIZhFlmWvMlDNyBnHWug8bsv2m2h3s8iRjcT2z2rAt9xO0dD2zUUoqEFFF01ayO1SZJrZFhfAHUgYBrq/D11HFEkYQDzfvP3/OuEt1aMlTyrdAw4Bra0mNormPzXIDfdRD0rGrTUouLNZpNHosIbOW+72qwjHcCW49KzrO9jlgAIYOpwQe1TCTPTJFfMVk4ycWZxV0aHmdOenY0m/Oapo+ccHHXmnBwDknA9awLsXEkYHGflzyDUjYeMFCcL1B7VS8zJ9qmhbDZXHr9aTGSbTleOPaqOsQsVhePAZHBJ9vetMhNnmLxk4I9KtaTpianqCQ3bBIeuAeW9q0oT5JqXYmWxjXZuJ0i8s2yRBwSXyDj/GuR1S8S61W5RyojXoAeuO9eo+JtKi0p1NqVCSZwj84+leR3zo7TMVQMj/MuME19FhJKauh4dXdyrM2QMiPd29hSzTQtaMsRYsOuB3pCyyBTEFjyPnLHIqbTZYFt54mUc/x9a7W7HU0UojLNCYWCE43KxHT2qGO1iYo95OSncDqPoKdcMIJFQyFo0+YkHFLZSxo0jyTCKJwdrFd2faqDYk1uOz8qFLRmK4+b5cVSsR5I3Q5LnhQ3arE95FNDbRxQgKp2lz/F71c1O3iVilrdRy/IGLqMYPpRe2glorMteHY7y41JXukZ1iBALdPzrd1ewguo0mlcq8f8cbbSPy60eFrCSDTEjkmLPJyVLcipjK9vczJZqDLCMtPJ9xR9O5rknPmk7dDln70tOhhGw2xyXMU8k4UnJdj8vvzVch2iMiOkUY5DqxUEepq8+ufu3SNJJnOWk3cI1Yk2oaddQ79RSaXqnlRvwtXCi3uiuR7FvS/EDJI0AvIMgnO85/GrfhTSxF4sXUJSLgTty+eB9K46x0d7mSSK0hQb1LsHPzBfxqzo9zd6XcFLO6j+zhh8hJY5FW8LGPN7N2bQp0b7Hqni7SZEU39rEAG+Ut6H1rnLa5mSDYSksmex4zXrPg/V7HxToflFRJIqBJlxjBrjPFPhebRGlmRPNtCch9uSo9K4cPX5X7CqrSRzX6WOTuoGuWBRTEytl2XkEVGl1bTXBiW3WMRnBkPBxUK6jMLgRIfLUtwjdWH1FWykNxDIXQRydflbJJ969HVaMv4dJFy9WNPIjSWPa4wARjP5VgatpUqTu0Ywg67TnbWhAwFkQjhpFPzHGPyNVYY4prgyKZVUD5iTx+NVBuPUIXizjruAiYrbSSLjqX4z/wDWqe2j86PyY7eSSU9WU5BrsZ3CLFlIp2buE/Sue8R+I/sAEEEEUU4/gABx9a0VWUtEjZVdCG4tRpdgLjWZERyf3dt/E31xVG18XX00zW882bWX5RFt4UdgK5a9u57u5ae7kMsrdSx6ew9BUCsQ3vVpL7Wpi5c2sjrdRt2dkZyViIIx/TFZLtII/JBIQcnI61oW1zJcaSrOCzRcb92CprMbJkLE788bsE5NWvM1g9CWNFEygnIPYHNSzzhmIWRg+OAOhqmUZSWZSo6elTW3lopOxWZv73YUjRPoKM/M0jJu6BcZ3VYhcRMChAI5O/t9KieZVZSyZHqDgfhTY4vNUyLxjnB70xOx09s4uYRK6rg8cnOfwqa1kWWYRoEVV+8O5rN09pFgVGj2kjOSOMVq6GIZVa42blGVBAwx9qwelzGXU4nxLam31KUhT5bNlT2NZODjpXpk9sl7LJ9qTdbYOA/Y+gxWG/heCeVjBI8Q9Cc/lSfmQceoJOAM/hWvpekXM8sUrKY4cglm4OM9q6mDSLCwTYTiXH3mOSfwrWtxbMESRo2iAyDngUlJLVDszkfFtssd4sqF3idQAzevoaxUl8vBxg+teoajb2l5ZtaBBs6g+prj7vwhfFXaz2yKvVd3IpKasCk1qXYlaKGPK7nflieBjPGK39CgWRxJFODInJjxyfxrF8pFmVGdXcgEqB0/Gul8MxxxebI4AYjjjt7mspvS5rUdo6G2LNri1ZzM0Ep5OTmmRR31oqB9s27oQeoqDUbuOSSKLYpgfgspzk1NpZCNsxlQcLvyD+FcVbDqceZnNCTRbtpHud+HYbThquw2+eCQT65p8JCR7WBHuPWnq0akEkgZ7ivCau2kdNyVLRcDdKqj86kEKqoKy7vbFCyhmxGhz3OOKGmCEGRDx3HFRySYc3cswFOVJ+Y8kHp+FSAmKQOmQ/Zl4IqspWZN0JBx264qaN94CycNnjFT8Ow9xZXuZZd91eySvjBZlzj0xXm3iS1gj1OYXHmqc5STPyyV6XyCSBgelZmuaTFqVpJGTtfqpC8g16GCx3s52qbMcHyO55tbz2A2xssjNn5hnt7VbsBGs/mR2xkQN8qe3vTLnQ7yGbbOhjYHBlx8uPWpFu7rT1ktrCVX2jLSxjOfxNfQXUl7rub3vsUNWt5p7ti0JhRugHb61as9M+VZJ4XmRV4MP3T9abpukarq9yrSrKI2PMjZwBXf6dpsdnYGOGY4BweOT7VnVrKmuVPUmdTlslucO1hvgEdnbS+bIepXge2a2dH8Nm1ZHlSJ5xyFY5XPv611SQSSADIVR/COhoMUkB3RqGz0XI/SueWJk9EYSrPYhu7SX7OVjjjicDJZSAM+gFc7dQGXasUzEo25gzcM2ejYp1zcM7+a5naRXOFHRPqe9WPNS2tW8y3RAyl2YnJc/wBKcIyiJXgcxr8/l3ckUqmOIDLIv3Sxrm7vaZvNHkwAL9yM/wBKfdXLi9+0XoaUSn5FbPA+lQXjNcbhFHGqngcYr0oR5UkdUItJXL8EUcaxXFrdAyPw4b/PSqmqW81rMDPJGiOAyeWOo+lMt4pIgFJARhjJHQ1cisZ5Ipb5o4pILcBWG7qavbdhe2p6D8N/FVrDqlhAkLxyMvluyjAb0Jr3Zoo54yrqrowPBGQRXyp4Wv47e6gM8XWTIJGCPxr3fw74jmlEcUjI6n7rCvFzLDNyU4nFXShIdrvgSzuC8lgwtXbqgUFSf6Vwt74O1XS0bEKtGTy0fzfma9Ym1J+USNWcDJycYrN1DWWWBgEVX7gHOK5aFavH3d15mNzxaPTWtbp5DNHFb8mRiclT/u08CORFWxuPORid3y7ea6DUYLO4nuRcRLiYlpHA5b6Vy3/CUaRpNwLG0h3xDA3t13V7cbzV7XZV3LYn1i3urPR7mZI1LRrlW7g/SvF5XZ5HaQlnYkknqTXull4is5/NttQh8lm42j5lIPqK8w8T6ULXU5vIRZ7Y/MGiGMVtRb1jJWKins9zmBxjNG3MmCQB61PdWzwxpJuV1YdR1HtUCqCu4kZ6Y71owtbRm5oNxseaIZA6qMZ5pJY5BIySozOD9B/9eui8D6Cl5pc8wdDcMeRnOF9PrTtY0W52xNKyRAdxn8qSqR5nE0i0na5zHmNPJDFIdip8vpTr+IIisqMCTgY6H/GpbqzKMGEZl7E//WqpLHMJMsHUAcDbjArTc0bsrAzSSAAjIUYORzWhZ2gZo2nZfKXnb6mo7ez3ZYkMjAAbmwSa1FiSBkV9isB9xW61Dl0RMn3Jrby7m4aPDlQfvcgfhXXW2l29tZfaPMVotuAg4OaoaUVNoDsiaQjIjzjH40jSRt5gmASRuqqSRx6VjK+yMZPm0FeWKRURVII/hPArJ1PUyskcETJsz84Qc/nV67tnSEyKvJ5HzdBWJJYq8oyyt6MD3pxir3NKaTHXM8aDdFKCSfqakE2bXeV+UcDPUfhUEsckIzs8vZwTjI/Co4HZss7qFb8xVM3UVYuW1zNBJuKgqRna3P5VuWU4uIzJEFAz8wBxiuUN4IyScuoGPlq9pGpGLCsTiTuFqJwuroicbbFVnihjN3ccDPyq3BasqfxBeyyHbcNGo4Cr0AqlqF613IWlJ2j7q9gKzskt0Gar4TCUuZnVWWp3cYMr3Ebk8kk8iug0PxezSBJJCW9H/pXnwHlruByT+lT2kql03qAwYHcKpqM1ZoXIj3/S7kzwBmKlyM/KcgVfXavzEfKoySR0FchoV1DawxGFlIZR8u7OSewrR1XxBHb2pzby4c7cEYNfL4jBT9taC0ZUZprUtxeK9PLOFSfCHBZlxiud1v4i2scphsbdJz0LNwBXIeK9VCxC3tI/KeT5pCev0rknV2IXPNetSyyhB8zT+8qO2p3beObuO6EsaojZ+YR9PpXa+HPGNvqKhLnCSkcED+deRx2jw2pl/H1ptlfNFdpMjHIPatq2Bo1o2tZmrp2WmjPomGRZZsA5LDPBzUpxuC4wa5Lwprn9oNFEIxtxznrXXOo3EA89MGvmcXQdCfKzODb3DaD2yO4POayrbe144jihZSSrfKARWsImBBByD6VIsXzblUbj1IFRRxDpX6g43KBjeNgiRfu8feDZ/SpI4/JLq2855wwGBVxt0Ywi7W7k/wBKhkU7yW+cY4BPeuqnjE9JolxfRlF3y2BlQOpJyaihSR3n81iqYIQ7xlRjrz0q58zj52Yg9scVizPKk7WkjRuqfNzwSP612Ua8at4xFGDvqN/tGyt7cWaXCiUnCso3EH1Nc74ke6uJoNPiu1uMDcxZMbfqa7G502DzIwYk8zGc8LXDavqAivr2SFF81sxqp6j6V3Yezd4msLOV4nMXYH2tzcOAYeAOoP0pw8qYlgSIyM7yvAPoBU0whgsVeRULk4wTzmqthFLeRzGJCFX5m2ngV6HS503uiOOdhKqXKsF6A4/pWheFo1cwRlFbkK46j1qpvePGI3DN91n6Groia4toR5ZaXPMm7P5infqKWg/RZWlcTyKWcDCgnAzW2PiNBoUarFbGS9UbSnVR/hWL4n1kaVpcVrbQrvYEF2wdvuK86kYOSWJLsc5Pc0vZxqK80cdX3nqehL8VtXivprmOGEPJ2ck4HpW/oPxYivphBrcHkFvlWRPu/j6V45syDnnFNCd+v4cUpUacvsozlC5714ivA2gzy2kkZUjG7cRuHtXkciZTZ5TNcMd4kLY4rQ0bWJ5/DlzYuwJjwEZuirVO+02xKRLBfPJcMOQV4J9BV04+zTRtRjaJmqlz5qs0jKzH75fkVLf+YkqtNNukA42NTrvS2trQTXE0aHoEzliaqR3eEUOgdlOQTWqkDstGE95IxYNFH+AqsCzDAj4zgHFWlK3DOQiAnnbt/rTLcO1wuchx93BqGxcrZ2vw+sr6TWFuGK262qgGMcFwfau2urD7beOt1O8CA71wMhz6VzXhqO70uzllmwZ5vuknBA+taBmn8tibppN7dOpFcFeo3L3GiZR964zUdNsI0dpDIvzffRsketcdq2p6dbTtHZSzXQ9ZBhR/jXdWehtq8FxEJP3q8CMn5nFeU+I9Ml0nVZbWaNkwcgMMcVtRkrWbuyFKVxLrV7ifIUpGn+woBrOzk5OSfc01aVuvHNXzvoM7HwVeM8c0Mjksn3OegNdJIJGlX7mW/jPXH9K43wZEGuZWcHbgDIOOa6qIhJeSAScZzTeruCWho6n5aWrYAyBggd/pXPlC77lfaSOExitYl47OYZDkHIYVhSTGYmQxldx+VsU46Iuih1xMZY1iLEDGcAZyapCLIw+5j/CFNWZFQyxoVKpjJY06OOPzDj5dvQjijY6k7CQ+UygRR8Lw2acXCNtUnHcjikEihv3bOZAeQelSb1LHcMAdWI5oEzjVw7FWJJp/MJ+6B7mr/ibRZdF1BoZfuk5U+orJZywCnnFK6epyLQmmbzDkBvfFRDPOCAKEcg7e1bOg6Ql3dRSXTNDZ55crnd7D1ov1Huem+EoVWyt3dVMuwds4/wAK3L63F4BH5KyshHLghV/Gs/T9Q0mztmSF5IIk4LbN26tOPNzZxvYTo/zbm+baxX6VxTb5uZ6GTi76nivikFvEF1GXJ2Njis92APyh61PGcfk+Ibvhtxbcc84rIXftDIQAfTk13J6HQm9jZs54f7OeOYFnPQDqKyxsSUAKcd+etSQSlFdUUmU9CR2qEv08zPB4oNXLRHonw9vEivVjQbQe7HpXrySEqCMH8M15H8O4BK5uVQuQMADqfwr1OzWVSxdJEU8hXGCK+ezmCclIzunNpF0Ng9F/KngHHU/SmhSBUiLgV4Q2MZc9Of6VXnOCDjoe1XSPrx71WlXJIY4qkIqEkHOODVDWrUT2jXEcYeaMcDbksKv7WMLkn7pBHGKRD2OK2pzdKakugHOWl9PBxJbAIse5UY7if8K5LUrm1S+VxEftLtn5ui+wrpdWS7F+yW5jeNgcjH8NZcttaX8KwLGIREMl5Rh3PoPavp6FSLXN3Kp2TuY99o++6ia2IvZZF3NGg6H0rMu7ZbRGaWeRHbrbpkHPvWrc2V/pNws9szwseFJfaQPpWtbveQEu8dpeeemGfyidn4nqa6uZrVO5vz28znoZ2ubJLQx+ZKeV3HmMVpeHbT7NDLcT/wARKJnkflT00W6N4UnxFAfmY9zXSSaYLZYPIEKjGAw6qfoe1TOpH4U9zOpJWsup5V49Rxfxll2KV4THSuVA6FvWvTvH2lyPApUrLLHlmbGN3tXmYzyeB7V0xfNFM5b3LNrvYHCMyr1AFVZCd7DG32qza3QhjZMH5upBqtK24+3tTlsXJrlRo+HIGubuSFQ5VozkIPyrTP8AxLo/IaCR7kHh3XIxWl4AihtrO4upQQ78KSONoq3e60JWMFtEsijPzkcA/wBaSk78thU3JOyRyM9rcTzNJNG7lufl6Vq2XhW+u4UlxbxRngbmGfxq3DeJbkedEAW7jjBq1JIs+yOBiSPv5XnP1pycuhclboSQ/D64ysjahaiLqfKUlvpzW9pPhex04tJtaaY/xydfwrnhb3gUPBO/DZOH4WrVp4jv7CcJfZkhxk7jkkex7V5eLo4ma9yV122Fzcp1UkcCujzuPL6BWwB+dZ/iHxDp2gWpdFikvXGIo0IJ+p9BTtW1G0m8PTXkIE0ew4A6qa8XJJcuTljyTXJhMM6yvUbSXQmTsdNpfjPU7HVjfmQMxPKdvwq/4+8TWPieK2uUiZNQHEvy4BrieScilBr2Fy3WmxmIaXoBinbTJ0xmpo7G5d1UwyLn+IqQPzp8r6DN7wwFksZUb7u/nHU11I8skfLtCjG7b1rK0TTZYYoFhQ73zuZuN30rSuont7r98pDDgKeR9aqe9hws9B7GUIVVPkHP1/CseaSSQNHhlA5XaMYrUgyZN5kIOTnk/pVS5gYKWQAjPJB4H1prccGkyiCTFj59wOcPzk+tWIVXCLK2CBlsj9KZOpRG3bQD2XqaZLFLyEYKcZ+Y5OKb1Oi99iUmKPICZcnIQelMuZvMUOQVGcbcZxUbs6yKDGWGOpOOamaQzKrnaGXqaLA2dvrOmwata+VKo46k9R9DXnc3htV1R7f7SViB+8Vya9MUNZzlNxZyc4xwKp31wgkLAOoHO9VGCffNckKjjp0OSCbdkcrD4StTIVtDLdSRDc5kwqj/ABrXtHe5VbVlgdI+ijgVj/aHN4zwzMpYnIP3SKqNLcm4bLrBgfw8ZFbcre51xjY1Nc1R4Jlt4LWKGJRyitkZ9as6Bq7W0oZSrORtIAyTWGIxcOjM+3H3nY5zTobpLGYyo/mSL9xuw/Cm4prlsW4pqxueLNC/4SFRd6b/AMfsYAaFvvOPWvO5kltJjHLE0UqnDKwwc16FBrEoKXDs6ztyHQBQfatn7VpGteX/AGhaq8nRl2Yb65rPmlT0aujFwa2PI1SRyG3Zz0xXSaL4TvNWaKVbdkgJ6tkbq9CtfBWl284u7eMbMZAOWA/CultA1r5YjkTJPYYAFRPEK3uGDq20SINB0aDTFjEaBHCgFV/xrooyynKuc9/embluS20AMOp6ZpVyoAYYPua+dzBzlJNlUmmWlMbD5vkJ5zjIpwRmyUIcD+4c1ArEDIA5HrShto+XIHXg15yNGSFux+U+9QzYIx1+lPMzBfmOQP7w6UnmoMlVVXPdeuKEBFMEWHkkl+D7Vnzt5UbE9cVoPIrORIPl6BiORUF3AEh+ZQ3HB9a1ja+odDhIryc3shwSuT1HUU68aK4m85ZzFIBzlOfwrektoi7PtGTTHt4GQrtGO5I616yxkItNImKa2K0UENxaBo4WlZeFkmbOPzqe6t0c220ssiYzgYB/AVRmURSoIiwXuM8D8KnEweRRuZC3Bwpx9M9q9CDU0pRZndp2ZoKwYruLMAckE9TVK5W886R7V4Crdp0zge1WISCo2qMdMdanBBQg/f6HNC91kptGJcacvkpB5xcSks0kg+bPt6CvP9c8J/6U7xqYtxOCPmDe9enfPIJTG+VHZcE/rSaRp8N/dQ25kEbznAZxkEemexrojWdNNsdr63PDLvQb6KRtkYlUDqn+Bq3oPhm9v583ELQ2yfMzSfLn2Fe6eIfCNlZQSyPO7g/dUEcH8K46SZIoWhjScoiZQv0c1dPEKorwKUbnG63qTxo1laxlIEAGQMZxVLRxmRckrIPurnirVxct5zgKZNxzsxjFQSuRKhWFUkPXJ5A966VorHbCFi5fx+ZAcKGkP8QpNOLxuqqEI/iYHNVZ5N/zl8yDgADj8K0tNgjigMk7YmY/cA6CnsiZqy1OicO8KyFABjgN1P0qhew7rMwxx7pWGVkPb2NTDX0WFoxDIcDA9KpwzRzTqypnaPubuc1nZpbHKou+pYsl8m3uYbrLqyY2rjk+9ecahbPb3To6lSDx9K9Fkd8L5h535IK5wPaneI/CH2vSzqUMwi5yqlfvVmnGD97S/wCY5s8w7YwKaVIPIq//AGZeB2Cws2O45pp066TG+IoW6BuM1s4XM7lSPIYbTz2revNcljto7e2YgquGc8nPt6VQktHtLXzd3zk7SNvT8azycmm/dQblu31G7t5hJDcyrJnOdxP866PTvFL3LpDqh3DPyzdMex9q5EdDmkBxUOV9xnpOGcnYV2Meg6/hVgBTAFDopP3uMcVy/hG4WUvbTMQR80Zz09vpXSXGMgKoGO54FJ9itytNDG4xHgsP72eay83EUrM8TBOmVGRW0jELgAFv7xowWZ1BLtjr601KxWqM5YJpnTb8vcs/QCrkVqICwm3OG5BA4p8YZSCSGYclWFWktJpJWkaRSuM47kVLkDkbF3dvFIpBcbhyB/jWdLlxt3MUkByrHgCmapcM8oi84hVqWA4hQKscjA5JU8gVzNWKhHlSMhFa1nYqg8sevP5VZlhjeRZZFRhIOm77taV22nRfNcSBHHAAfIx9KyHlt3lLIC6dBsGM1tGXMUpXCXTom5SSNmA9cfhVOxto5FkiCBpjnczHgD2q0syswSEeWi9nGTTAjHcVURrn74HWru7WNEy9YQWNqkZJmkkXrHj+tW9Mvbdb6MG0dZWbht+SR2pmnXEUK3RZIpXddqsVP6VZ0ewlS/WV2VAPnYY5x6VnK1ncUmrO52uny3FvZzrKcE5ZSBU9gJWADFGbG47lwPaoNJZED4kz5hOY8ZIqzpgBaQNuEjE5BP3Vrg2TOGotS/AVgdVYYJPOBwf8annaNZGXep9qzpr+G2i3lPOkHASM5wfXNZdzdLIfNgEiSDGVPdq5quF9vvoVC6Oj69aU4PYVzc+o6jbyF5PLKqudoGfzqRNfU2+3Uraa0dx8sicrXBPLq0dVqvI25uh0JX6jt1qisEiXJlLBhS6bJ5sJKTpMnYg81Zboc59OK5WnTbiCZGr8gMyj0z0z9at61Yz2WnRtLtYPyChyo+lU3UMm1gMdKahKL5cpZ4SNoDHIT6U42DXcyZWGQWyc1ASW4A+UelSXcZhuWRunaiIA9u1UWYMl7HJcGAMAwOPrU9s7q7RuRxzzzUi6EYrh53ZCN2RxyKhnDfaSI0Dccse1exhZx5uWD0Mp7GtE28jPI6KBwKlYiGNmLA57HnHtVWE4i3MdgxzzVKbW7ZTsjgaRBwZMHANd3K29DJJsnt5JJFZIJoFCHJOctn0qxYSpDON+xm3fMGBHPtXNT6sVci12QoTyEQDJ+veoZbq6cEJK6yHJB4JrR077m3IztvF+pSazaW1pabbIQn5mBAz7+9Yq+Hr65095FlknCKdr7uW/CshNQuoBFFK6SlsHd3FemeD9WsLmzFpNIsUpGAH4zWM+ahBezRDk4o8C1Wyls5dmGQqeHY9D3yDUSu11JukEToByVH6mu0+Ica/2tJFGEZ4zg7BnI9c1xLwIsygHCE9cYBr0YS54qTOynPmRXklKyeWp6DONtSefK0asjDzVGOTzVryisnmhAwAxhTnHuaih27iQA7N3xjFVct6j5JZVtwzH5sdQfvGqtu0ks/nGbaAclA3T8KlAcSFAF3seQW4/KoI4JY7uURiIPtJw3cfWnpYho6ayYXFwHcDYF6bu3evcNFsoJNEtUaNXQx5wR2rwrQo1kNqkbMrnG5Mcn2r3u3uYrXTbYyssYIWMZ9fSvCza7UYx7nLLc5jU/BOm/aJJ4iIXOSAvTP8AhXLXvg/T0Vr241COVsEeWRgg98V7JNEGtSG2gD17n8K8m8W6ZqN3rRXy4YolYBFTkH6571jg61aTtKdhRimecalpt8bC5hubecAMWhaQY3KORj1riipUkMCK948Rafc3VlEjWt47wnaTHyEGOvvXkGt2Eo1CbyopODyCuOfavepy9pG/UzvrqYp6UpbOAfwqRoZF+9E4+oqS0sri5lCQxkk0OLuVc0PC0BuNVRPnK4OdpxXrH2ZDpZaaMJCvALjOPxrl/B2jSWkXmbALrOWLDoPate9uZpU8m5jaSMnOwcZ/Kpn7zUU9hNX2GpFaPCzrC05UZBBwKZaQwT48mHbk4ZjJnH0qFZEaGRkjaNVPMY6Ae9Mt5lRY0ffHbj5jsHzA+tTY15LeZJ5aRtI7RKIlJGc8/iKof2lGrxsCBDGeQuQT7Cmalfwy3ZQ7liI4GD859TWZcCSS4QBNgALYq4x0940jG/kdRcIHPmbPNQ8YZe9KkTm3aRQDIucAfKfyqwqSyxlI7lRsHUrnBqGSGZyHUHzxw3y9vpXMwjroZbwR3VqZFR2cMTICM8fWq7SRBFSNCozxk1NcmbTJptrND5h+6OQRUckESxJNBKxLdn710xKSI5Z1jl2wpywwy5PFTWl5EzKPIVcAg/MeaihaTIIjjYjOB3NXI7BhD56oCf4kz0oditjZ0eOyvcpbO1vMeqv3+hrpYoYrW3NtahN5wsjy8kj2rire3uLY28mGaHd/Ap/ImuykkldlAAGMYGa5Kys99DKV7mlpsSiBwQd44B3cgVUvtQKsYYJRHGnDPjJarV9P5VnDbjBklABCdSMfpXNRTGG7aC4gBti21VQ/MD6k1nTjf3mZxjzNvqXRvmilENyFYLnI6g/WrGkMJIBHc3DMsfzFwOWaqpZobtIRJEEK7sdB+JpZ5pmuVjjuoQTxz2FXJX2L3XKzYtomu5GI/dop3eoOKpXBeaZxqDoyJnCqMkn6VZOrQW6Oiyxloxh8ZHP9a5W91lprstCnlr3aM8gf41NOEpPYUYyk9Ea7acY9t5azTwn+BAQPxNatlrjiYQXKmY/31HP41wou2kMy+dLHC3dmJJq3o96yKtv5reaTleOvtmithI1V7+ppKm0rs9ISRJYy0ZyB1BpyESrgAEVQ8O3MF2h3bmkHDIeK1b2IQhRBj5q8SrheWXIc92nqQ3GnC5iBEiIw7OcflWHnyJDHN8jjoD3+la885yqs3PT3NZ97As6gbAF65atYYK61Y/aW0Mu81CaMOwKlAORVDT7+0vBLM5G5PvLjgf41r3qRw2jJMkYaT5BtAya429gS0TbCjruPzYOK9TC4eMVfqC992LWpaq80rJbblhxh93BIqvZtKSsnybCcDH9RUTuDbgRx4j6/Mc598VLbzwW8W7JGDk4HB9sV2PayNVFJbE1xaL5P7kMXPJGMqaoK0cKlmmRJgMbV9Ku3OoO0DyoAiYyFI/nXNtK0krTSbWY88DgD3NVGLe5UE3uaUU0TqolmV5OSODn6VNAA8Yw7hs881lI5yHk2ue3b8qngvbq0kCxoqo3+sHXI9apxfQmVPSyNljuB2hXIGCOpIrE1K1KmSWJhuI+5jAq2Z2HlNbmbYOSMcirQfzGLCPerdwPu/UVMW0yUnTdzlY5ZQAgbYSMOvvQiKu4JL+87g9PwNdBPpax4McQSbJbLHg+2Ky5rGQqWliCKD0H8X0rVSUtjdVFsYUi7S/zMUzklRn9avaZbRz3CAJ5gGCWztz7Vd8lGDCUYA4CY6/Wtrw14fF/ehYoyzNgbewHqPSlOooxbYSkrXNbwXZR3OrC4eIIkB4DA5PpXpt5a3H9lxqPmuZHDBcjCjNT6FpFppFkkUca7l6vtySaxPF+uTabHL8sZlcYiIbPHuK+flWeLrWp7I5G9dDZ1XxXpujWgS/uEW5C4CIdzZryfxD43utQZ47XMcW7LMTg/nXOX1y80xlwGcnkjn86pShSm+VBICeRt4/KvWoYKnS1erN4UEtZGlc+KdbmtPs63k6wjj7/WqE7y+SWH72Nhzkd/aqc6tM7P8gXIHt9Ku2yysWQRlVUdVbI/WuyMYxWiKnTtqinPE4G25yo9OvFbmkQIhWVNmMfeBxVeNWcbSpZvRupp6kW0gd1IUnGF6fSm3fQ550103N/UJZUtgxxsLDO3Gao3VwJ7wfvnCDABQUjzpsOSEgBydwzn8qbY3kFukl1J+7t8/KCvJ+lZJKPQSi+XUfexW8TIC8jK5GWY4X8TUd+MRuSokBHG1hyKpX+vCe5d3y0ePlXbyPesm+1KSTDEtjqFOM4pxjLS5ooMYw3gM27cD8oHOPwqzHE6IZJt0xJwo24xUFtfyH7yqVb5eOMVee5lEawvcqEIOAD0qnc3NvSdRNxdOlymCfukHGa3CHyxlbaFGVK9fpmuJsC2T++ZW74H+c11Wk3zmLddRlkiXBI6fWueceqMqlOzuie6trbUIAksa+cRgOW4U+5rmprT+zGkjli3HHBzlefQ11c8KtGJRIrxyD5VC81HE1u0f2e8hEtvj7ueV+hqYtxWmwozT0OESC4icSOjle2DWlbmeKPe29GI4Vv610baQoVbnTbkFEPMUvanwaXLe3AluL1ZZGPzQhcDHpmrdaPU0dRFbRVvNQlRZZmkhXnAPQ11Gm2yxzymdjKysMKOQpq3YaaLERRW1mDG5/eMAfl9/enX1tdSNLHC0kLoM5jXBb3zXLKoqkuyOadXVqJX1MTyXISRI/LAG7K4OPY1m67eR6YCYI4ZJJR8jE52irOol44Z3kuJAwQBixwf/wBdef3Uzz3BW6ZlDY5PJx9K1pU099kaUoc2+yLN7LNd/PvLSnqcHatZ0FzsuGHk7ig+Vt+Mn1q2mYopEaVzG6/KF4/OmQIksWy4hUyKuIwo2/iT3rqOtJJDVv7szGOUjbnKljmrburRhkTYrfK5zz+FZeoQxhVwwjI7nPNXdOBltwz/ALxFPIXjOPehj8x2nAm5aOCMPEoPLnk0seBMrI7hg3KjGPzqLyxcSkRHykGTtUdPxpbeNZlxKpDhjgk/L+VJjudnoN1HDckpcySCUAEPgAH0GK7RJllQF9zMvAHvXnGgoj2TNM5EcTYHGCa9AtSUQAIUQgEEnqK8+vFXPPr/ABFlthwWjwfT1qvdGLdwOgzk9BV66aGeBESLa2PmPqKzzDHDhcbdo6k1hExRUuYYrgbmjBVuSStcNq5jN+/lOwIY9utd9NITauFO4KDgj0rzC4RvtcskcjgFjyV6/jXbQvqb0Em2y1cmO3ZG2u7queDhfxrN+1TRuPKIUHnKrnH4U66CqI/MUsx9Wxn61TEYiUGPgk5zng+1dairHQoaak89ws8bpcyCRG6Mi4INZ63UDBoxx6E5qcKsw2+UeTkkHH5VXvLN7VQ6q0atx0qlZFRSWhdeSJ4I44mBAAJI7VE8Dsu9cjcdoOKaNqRbdmH6jb0IpksgZCJM7h90ZxzQUl2NCx3FXhkkJ5wB0xV+wQC7BYsrN8p44P0rL06MvKRC21SOWbmtNUEONzNK8Z78D6isprUyavoaV9FGSnmAuFOcgZINXJ7T5Y+EwB06H+VOtwnko2MsRnNTthsFs/nXn1MS07djlSZRgsQpLeYyEnJC85/GrtjO1jIWtFEZPU/xUpQS8lmUjniopCgYA456Z71hKtKejLd+p1djqtzcIcEsQOTXnXijUJr68kLqdinG0E5rcvNSksrAxRO3mSfKe2BXEzyZk4mZ2JP1HtXdgqKiudIdKPvXYzzipR441CqOEJyD9RVR2eZi/MY9Fxj8qkllmIdjFhlOAT0qAR7gGIYd8+h9q7rHYu5LHGnmASPGGI4BGPxNKAI93llZMHG7ORVa5uSyhrhVO3heOT9ajyYmj89fKDHICDJNNIHqbNvd/ddiSVHAIpL2Qzou0jaeQB0qsszh8MMlexGBiiLAlbyyC7HIyOBQYcqTuXdKZo7zy5SE3LgN1xVHxLMFMduhQgkksBkCpIFZ7ob+Gz0zx+FZ2sNKbi4ifZkc5zjj2pW1uTFPmM5L7lBKfunAIHOKuTSxSssyRuwXhWKgAfWqsKhXaNlUJ1OepH1qZEVi5V8q3CRD5qZsk+pJIVuISIwpcd84J+lMiQxRrmEbSOWAy1P+z+WCIFZ2x8wYdKspOI41dlweg/2aBMmEURQs7srtyOK1rCcxhAUDw7eQTWb5bnCxyGRz+BAqykjeUsUajdjLMeM1kW9dDbtNQeSRWghIi+7hRmrrQmTBkDIobBx1rGg1Ii3W2tYXGznd2z71r2tyt1bL5jnzEPzYHU1nJW1sYSjJO6LMsMH2a4Bn+zpH9+RzgAVyUvjyLTpwmmQeeicb5OA3vVL4iaq5lTTYmPlKN8mOCze9cUMHmrhTTXvGEm9menQ/Fi6dGS40+MlvlwkhC4+ldz4V8bWWvWiww2skEkQ+aPdnA9Qe9fPGCRkVo6BqN1puowz2srRuGAO04yKmeFpyVkrGfL2PY/HiytCk8AMPmcHzRyR61xFxeWylI4w7SIMEk9TXpfixftfhe2nXLABWPyk44715s1qZIijMuwndgLzU4aV4a9Duw7vBAtwWjAnc5BxzzgU+BZLhx5TlwSVCnjAqnMYxEAGKovUhep9qsWlxPtVbeNlZer47VvY2aF1KONQEEqv2VTwQav2SLb6fGWkwy9aS0sW1O4NshjkLHc5UZIxV67szaokZt3WRuhccEVLa+HqQ5dCgLYxRtNHtd5P4ScYqCG3eJg0jMj53ZqV5mViojVXxj5RnH0rQ0vT5pGVpw0oPIAboexNKUuVXY3Ky1NjSbdDDbwyE9d785JruI1RFGMdOBjrXHWVpOL1C7Igzhiic/SuwQIrlXl3f3RjGK8+s7s4q72H5wflBzn+FqbKqsp3qCD/CKnIVuSFUfzpr4cHac7elYJmBQljGCFXC4OM8V59qp8tbgHDlSeFHGa9JfATDBc+x5rzfxZZm31OVixCPyPQ12Yd3epvQ1djASRpI0UsPmPzF+cCpN0SJ5e1MrnHHNRXMaW+1o3yW6qB0qvJJ5Ds54XGBuOTXejucbrQvWNysFyr3KDy+wIrY1+9sb7TVRiikjCovWuYu7xXt1cMJO2OmBVaTzDbnbtKHBDYGR9KHBSakTyMdaQFGjaMkgHgFc/nVmQq5IdQc/MML0NWtMtmmHlNKYzjKuvP1zV0WMVqGly0wXGSW70OaT1IdRXsVrC0MUaSyKY2c8KO/1qaCVrK4An8ySRzgKnQfWrNuzyB9+xUbnax5zTbCMteY/d7uFUbw1ZSb1uJO97m/aJvtovOX58Zq2p2kKe9QlGiYJuDBRjjvTg2Dgg14dR80mzAkYgH5R+FV5oVmI80cKcgjtU/JBxg5o4Z/bvUxbT0BnN69xcJEo3ELncw/SsVJDksseCRgjHP1FbnilXi1GJgcowyAfasydd5/cxqxIyX6Yr3sO700axtZNFfzF8oh7Vmjzn3NRlAY186MJGeVVP61o2cKtCyqDG3QnPX8Kbcw/Z8SASuo9AOa2ug9prZHNag/kXcRiO6Mc7M8Z9astKzuhcFlbGMCrMqW14SwVhkdMcg1H9mhgQmMZYnqRkgVRrGXTqPRPMbdvyB/DVh1VLUIwYOWLAg9qqiQW6riAsH5yeM06FJJyzMoY9hnhakTjfcltJh9rQIBgckYzVjW7aO9ALYXHQbearQshlUgtuU53FcCtHWrxYYPNdCFYYHP3uKa3MKqs00cXNbGOCVWVnl3cEngCoxaXSYkiBQZwCW2mtNpNwLSTOsZORjjb7VVkt1mcNK+XPQgEDHvVMbta7FtUuDLh7lVK+pzWjYRwKzm5kMnzZEeNoJ9ayILd5ptsbhQDy6r0q4RLExlldXUZAHepY7O9rl63jIdfL3EDPzHvVu1jkcPHKflHPC80vlrAI2JVeeO+Knku7eABVkczH5sg1le50EduwjVxEGj5xg5rW08yKisiAkcZJ4qg0l2VaZZ9tvJgFGA5960tJhWaQKLyHygRxuwfyqZNW1InKxyHxGtZodcEskW1JUBVscGuTfpXsPiuGLWdLntooHknthvSTOR+FeUQ2c085iSKQsOoCk4rSk2469DkS5kVlwOuc4qe0LxXMbxj50YMM+tdHofg/VNUlZLOzkfbySRjH516B4J+Gr216lxr1tuUfdiDDk+/PSpq16dP4n8uo3Hl3ZveFNRGvabLGsgR2hCyxSsTg46gCuH1CJbG8ktpnfeCQ7AcH0r1G68O6Y0m+wd7S6T/lpB90D0IqjrOmpc2zPewwzyBdomQ7CffHTNcNKtBSbWz6DpTUHboePXt3K6m3t4VMYb75GCatpJNHJbpHEwlYYCq27NdM+iW85TyLe7bZ18tQw+prUg0m2soxcBPszDgyS/Ka6pV4o63USE0Kzs7S2lN5cxxXbDc2zkgelWpbk3CMEBlbZhcgYx6mm2ghLMtlNaSSsckx4c/jmpJ7K6Yvsjjd2xuGNox+Fcrd5XZz2TdzGt/KhlEYi+duCWGBmtSyslMsRUeY79drcZ/pWrY6ccKbyNA4GFVWyuPxrsfD2j20sBaSNSD/COB+lZVsQoK4p1V0Ob0+2ZHLXGAewxnNaibWyFC7m/zmjWrMWF4FWY+VJ91AKfaQLPEyTuSzHgrwQPSsXJNcxzPXUrvH5e1QC+PQ04huoUD1Galv7Y2zp/zzxwMc1XSTLn5gAPahO6uISbiIh8bu27isPXLGO8tmeRCXjUkYGcVulUJw5465PU1TPzO20lgvBIPFawlZ3Q4uzujyOWOQMz7BtJ25biq1tBJMjIV+Xpk813ninRRcDzbcKqZyw7k+tcVM8mmXJjlhkMZ5VlHFepCoprQ9GnUUloZOp2L2zlXPBH3QvWrFkrLaxszJgDBXuBV6NzqM7vKfL2DI38Zpv2eKZGMm3zhwQeB+FaeTNZSVtRtq07+bJaYwBjC/yrRhbKBpZG8xuGCjIH41SsojEFRTtJbJx6Vd3BPkhYMj8FsEVEtWYSsNmmijOyQFumM5wfyqlPf2mhh2B3XEnKqvIFW7u4t9OtpLu4O6RRtjXOATXnF9dyXVy8sr7nY/gKpRT32MZTtojaufFGrzSMwvyqMeAqgbfpWz4a8X3DTpBfnzAeBJ3zXBjJYZORUqbgwK5B9QaTpU5qziQe8RSCRRLGRk9Rn+tIrkyADC++M1zvgy9jlsII/MaRiNuDWrJMqsViydp+ZuufavIqYaUJuKFfuSeJ7GOeFJVLM0fYDOa4+6cxTEFmKdeflxXWxTyvbvKW2HoA/esPUrdrgeZbR5HRsc5rvwycI8suhpSnbRlGOREBaP8A1h6ZYkgVXnmuJkMvl+Y2cZVsVFIwaMwAbH6knjmp9P8ANxsVVZAeh4FdZqkr3KbRuBl2dXZuQOn51Er3DnakYGw8vnBI9Kva5IEyqLiX1ByBVaytlVVLsCSNxbPB9qLmyStdjvJO7MsrMM8c5/CrkkhVXQ+Yu0cbeCfrUczpHa5Vjtz0UYzVOHbK+2R2V2ORzkYpbj5bmhas0pgjwXTOSmMfnUOsTma6USJmIEbVHStLTIETzGZ8grgZHFc9rF1s/crg4P36qO5xVHedkPuvJXfJbuTOw2mNF6fjWcDOFIcMfdmwBVWMtE+6JwCBnI607zppEIdwferWmiK5eb4i9Zu6F0uURRweuMj2p7ojSo0d0CoPCYqpBK+5VeY9cbtucCr1vJtmeGFAzMOZO+KTE421NJxuVovJbcvO7PT3rPu5I7e08wxFQTzIern0ArpHt0luZN5Y7AW69T7153ql5Ne3TmduFYhVHQc9qxRpOrZaD7vVrq5XZ5hWM8bV4qnFJJFIskblXHO4GmqBjNKygNgU9jlbb3PYPhbqUWsSGK+mkF7HwqhfkYV6hBELck+YqN1BWBVJHoTivDvg3O6eKViG0pKmGyP5V7ZqEjQNiM4C9BXlYqN6vL5Gb3GKftAEsdy58tiyxRgLv9jVKPU50ldpZVVGbaYwMMn/ANaqWoX80ekX8ybVkQHDDivFNV8RaneyStPctlWKjHHFa0MN7S/YuMLux9ETSxywN+8RuOmcH8x1ppR44lYFJImAyzHI+gFfOkWu6gkqGK4aNgOCpIr0zwbrd5qWmgXTKzIRhgCCfr2p1MI4RvccqbgrnXSeK9K8OxTt5TS3shyIgAMfh6V414t8SX+u6lJPcq6oT8qDoB9KseNGd/EcweRmHUZxx9KwjO6zDGOOldNHDxpe8t2dtKmuVS6sjtY7jcJLd3Qk9QcYrd0XxVqmmXiF7lniHDqxyGFc+JpPNYbjh+oqeNVZQpAwK3kk1aRahGWh75o15baxYpc2hUg/eUDO01vWOpT2SlY0DEDlfSvKPhW5TVmhUny3jyVycZr1CYBZzivHrwUZ8m6POqx5JNCXM0t07SzAbjxgnpUKI8QCW7bdgzyMiue8Xa1c6RZebaLEZD3dc/1rz648fa6bZ/3sP/fsVdKhKa93YcKTlse2280eGMzyyO/VmPA+lTG0SZDsJ9a8N8P+NNae6iSa4WVXYDDr0+npXrUF7OsaOrYLAH6VFWhKm9xTg4OzLEoxIUYncvcdajcHB4LHNEjl1Vm6kj9ar6hK8CW/lnG98H6UktkQglViD+7yc4IPpWRqWkw3iM0ahJemWXIFbfIJYE8nPWnSxDYjAlS3UDpVxm09Ck2tUeeSeHJo3dri3MgAOGDAr+VZC2M6hg1sqbGyOOcfjXo2rkpYyqpONu6vDNb12/ub6WBpikMbYCJwD9a9Cg5VNTeNVvRnbRiKSBo1jMdw38TNxW5aeHby00GS5iQXs4G7yyQox7k9fpXjEV7cwuzxzOrdM5ru/Cms3pspIWlLKy/xEkg+o5q6lN2vFilNpeRn/EHzZ5rRljVECZIHY45zXFhNxOevau38U24XTEkLyO+f4mzXEBiHFaWskgslYXyyqknGBxSKxyM569RUknLHNNiXIYkngE0LcT8jufh/NvmVGQlA/B6V3ci2YuHVZ/32fmQ+hrkfBlnHHpqSqW3shY8961yS6SnO0qOCveuetDmndMlLmlYt3afaZNsiZRSAApwcV3/hvTbO9CXlrE0KKuwxMmMkd68yguJUjZlb5lPBxzXd+FNevZrONpGQsrbQ23nFcmIjLk90ud4KxmfEPwnBFHPfWyhZMZZV6g15aDJEM4cN0Poa9d8aarcuk3KqemQK8+v4kkcll6KDgcCujCSk4LmY6dVxWpjROHkKtHKwHPUYFPSSORmBQRhR09T/ACpjyNGDtPWqsBMz/P8Aw9AO9djR0QbkXJXjkTczAYOP/wBQp+mqRM67FBccbxgYqrBCGuPvMuP7uB3rqBbRx20RUYMn3j3pPSyFOpypmfq9x5VhDFEcIoO8jvXFXchkdpNgUHjntXaeOoI4LOPykC5QGuHdf3QbkluDzTg1y3Rzx11FhQuCysvyjncf5VNHIpDKNqnp71WsUV3XcM1qTbQxQIgA9BzSudFNXjcz0XcSEbLDkdqmt5WjZZCGJ6Dng1JLboLqJMsVbk5NJLbRBZSF+5yOfamiJI//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    During treatment with tretinoin, malignant promyelocytes in acute promyelocytic leukemia (APL) begin to differentiate to neutrophils. The cells acquire secondary granules, and the nuclear chromatin becomes condensed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard A Larson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25205=[""].join("\n");
var outline_f24_39_25205=null;
var title_f24_39_25206="ECD skin biopsy";
var content_f24_39_25206=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F65663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F65663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 605px\">",
"   <div class=\"ttl\">",
"    Skin biopsy in Erdheim-Chester disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 585px; height: 245px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Left temporal lesion showed dermal infiltration of foamy histiocytes with giant cells (H&amp;E, x100).",
"    <br>",
"     (B) Scalp lesion also showed infiltrating histiocytes and multiple Touton-type giant cells with dermal fibrosis (H&amp;E, x100).",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Kim MS, Kim CH, Choi SJ, et al. Erdheim-Chester disease. Ann Dermatol 2010; 22:439. Copyright &copy; 2010 Korean Dermatological Association.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25206=[""].join("\n");
var outline_f24_39_25206=null;
var title_f24_39_25207="Pectus carinatum";
var content_f24_39_25207=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pectus carinatum",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25207/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25207/contributors\">",
"     Jed G Nuchtern, MD, FACS, FAAP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25207/contributors\">",
"     Oscar H Mayer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25207/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25207/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25207/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25207/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/39/25207/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pectus carinatum is an uncommon deformity of the chest wall that presents during childhood, and usually worsens during adolescence. Most patients have no associated symptoms, and repair usually is for cosmetic indications.",
"   </p>",
"   <p>",
"    The definition, clinical features, and management of pectus carinatum will be presented here. Pectus excavatum, which is the most common chest wall deformity and is characterized by depression of the sternum, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18071?source=see_link\">",
"     \"Pectus excavatum: Etiology and evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21704?source=see_link\">",
"     \"Pectus excavatum: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pectus carinatum is a protrusion deformity of the anterior chest wall. The term is derived from the Latin phrase for \"chest with keel\". Other terms for the deformity include chicken breast, pigeon chest, pyramidal chest, thorax cuneiform, or sternal kyphosis. There are two main types of pectus carinatum deformity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Chondrogladiolar prominence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chondrogladiolar prominence, also known as chicken breast or keel chest, is the most common type of deformity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. The middle and lower portions of the sternum protrude and arch forward. The costal cartilages are concave and usually symmetrically depressed, accentuating the sternal prominence. The deformity is asymmetric in 30 to 50 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Infrequently, patients can have a combined pectus carinatum on one side of the chest and pectus excavatum on the other [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Chondromanubrial prominence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chondromanubrial prominence, also known as Pouter pigeon breast, is a more complex and substantially less common form of pectus carinatum deformity, representing about 5 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In this form, the upper portion of the sternum protrudes anteriorly, and the body of the sternum is deviated posteriorly. A final anterior deflection of the distal sternum gives the characteristic Z-shape to the sternum on a lateral view.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pectus carinatum is an uncommon deformity that occurs in approximately 1 per 1500 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/2\">",
"     2",
"    </a>",
"    ]. It is four times more common in males than females. There is a strong familial incidence, with up to 25 percent of affected patients reporting chest wall abnormalities in family members [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/2,5,8,9\">",
"     2,5,8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most reports suggest that pectus carinatum occurs fivefold less often than pectus excavatum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/6\">",
"     6",
"    </a>",
"    ]. However, one group from Argentina reported pectus carinatum as being more common than pectus excavatum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/10\">",
"     10",
"    </a>",
"    ]. Pectus carinatum appears to be more common in the Caucasian and Hispanic populations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pectus carinatum that is not clinically obvious can be an incidental finding on imaging of the chest performed for other reasons. In one series, subclinical pectus carinatum deformity was noted on 2 percent of computed tomography (CT) scans of the chest [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of pectus carinatum is unknown. Several mechanisms have been proposed:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abnormal anterior cartilage growth [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/2,4\">",
"       2,4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Abnormal growth of the sternum or ribs [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Biochemical abnormalities in costal cartilage [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pectus carinatum also occurs in association with a variety of genetic syndromes and disorders, many of which affect connective tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Associated abnormalities'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Previously proposed mechanisms based upon an abnormal diaphragmatic attachment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/17,18\">",
"     17,18",
"    </a>",
"    ] are no longer considered valid [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;In more than 90 percent of patients, pectus carinatum deformity is diagnosed after the 11th birthday. The defect often worsens dramatically during the adolescent growth spurt [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/4\">",
"     4",
"    </a>",
"    ]. Fewer than 10 percent will have a severe defect by three years of age. Spontaneous improvement of pectus carinatum does not occur. Most patients with untreated isolated pectus carinatum deformity have no associated morbidity or mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/2,5,8,9\">",
"     2,5,8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;For many patients evaluated for pectus carinatum, cosmetic appearance is the primary concern and there are few physiologic complaints [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By contrast, in one series of 260 patients who underwent surgical correction of pectus carinatum, the majority of patients complained of exertional dyspnea, exercise limitation, frequent respiratory infections, or asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/4\">",
"     4",
"    </a>",
"    ]. These symptoms improved in almost all patients after surgical repair based on subjective reporting by the patients. After operative repair, the mean improvement in vital capacity as measured by incentive spirometry was 12.5 percent in a subset of 105 patients. However, the preoperative baseline vital capacity as a percent of predicted was not reported. In most other series, objective abnormalities are usually lacking. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Additional testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Associated abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Associated musculoskeletal abnormalities are frequent, occurring in 22 percent of patients in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/5\">",
"     5",
"    </a>",
"    ]. Spinal anomalies or scoliosis are most common, occurring in 15 to 30 percent of affected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/4,23,24\">",
"     4,23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pectus carinatum may be associated with Marfan syndrome, Noonan syndrome, cardiofaciocutaneous syndrome, Poland syndrome, osteogenesis imperfecta, Coffin-Lowry syndrome, and Morquio disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=see_link\">",
"     \"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24490?source=see_link\">",
"     \"Diseases of the chest wall\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=see_link\">",
"     \"Clinical features and diagnosis of the mucopolysaccharidoses\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of pectus carinatum includes documentation of the severity of the defect by physical examination and imaging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;On physical examination, the anteroposterior diameter of the chest is increased, and chest wall motion is often less than normal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/4\">",
"     4",
"    </a>",
"    ]. Occasionally, there is tenderness on palpation of the anterior chest wall over the deformity.",
"   </p>",
"   <p>",
"    The examination should document the type of deformity (chondrogladiolar or chondromanubrial, or mixed",
"    <span class=\"nowrap\">",
"     carinatum/excavatum)",
"    </span>",
"    and degree of asymmetry. The patient should be examined for scoliosis and other associated abnormalities. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Definition'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H10\">",
"     'Associated abnormalities'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Photography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photographs are helpful for objective documentation and comparison with previous examinations. They are particularly helpful in young patients with evolving deformities, and in patients undergoing surgery to measure outcomes after treatment. Special photographic techniques illustrate body wall topography more precisely than plain photography, but are not widely available [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/5,25,26\">",
"     5,25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Chest imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiographs are useful to establish the severity of the deformity (lateral projection) and to detect scoliosis (anterio-posterior projection).",
"   </p>",
"   <p>",
"    Computed tomography (CT) of the chest can be used to monitor sternal protrusion by measurement of the angle at the point of greatest sternal rotation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/27\">",
"     27",
"    </a>",
"    ]. The pectus severity index (PSI), also known as the Haller index, is defined as the width of the chest divided by the distance between the sternum and spine. The normal value is 2.54 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/28\">",
"     28",
"    </a>",
"    ]. In patients with pectus carinatum, a lower PSI indicates a more severe deformity in contrast to patients with excavatum, in which a higher PSI indicates a more severe deformity. In one group of 260 subjects with pectus carinatum, the mean PSI was 1.81 (range 1.19-2.10) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/29\">",
"     29",
"    </a>",
"    ], and in another study the mean PSI was 1.73 (range 1.42 to 1.98) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/30\">",
"     30",
"    </a>",
"    ]. The chest CT can also be used to calculate the asymmetry index (ratio of A-P diameter of the left to right thorax) and the angle of sternal rotation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/31\">",
"     31",
"    </a>",
"    ]. &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    In our practice, we only use CT scans for preoperative planning for patients who are selected to undergo operative repair. In patients with focal protrusion of one or more costal cartilages, sonographic imaging can be helpful in differentiating a malformed cartilage from a neoplastic rib mass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Additional testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, no additional routine testing is needed to evaluate patients with pectus carinatum, and a thorough history and physical examination are sufficient to determine if any additional testing is necessary. Tests are usually limited to investigation of associated disorders (eg, scoliosis), symptoms (eg, dyspnea), or possible syndromes.",
"   </p>",
"   <p>",
"    When cardiorespiratory function is measured in patients with pectus carinatum, results are usually normal. In one report of five patients, pulmonary function tests and work exercise performance were normal and did not change after surgical repair [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/32\">",
"     32",
"    </a>",
"    ]. In rare cases associated with severe scoliosis, restrictive lung disease can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/20\">",
"     20",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pectus carinatum is primarily a cosmetic concern. The decision of whether to treat depends on the severity of the defect (anterior chest protrusion, sternal angulation, and asymmetry), and the patient and family's level of concern. Thus, the indications for treatment cannot be captured in an objective measure. In this topic review, we define a \"mild\" deformity as one for which most patients would not choose to have surgery; a \"moderate\" deformity as a distinct deformity for which many patients would choose to have surgery; and a \"severe\" deformity as a substantial cosmetic problem for which most patients would choose to have surgery.",
"   </p>",
"   <p>",
"    Both bracing and surgery provide safe and effective treatment.",
"   </p>",
"   <p>",
"    Bracing is a relatively new approach to treatment of pectus carinatum. The optimal indications for bracing, and relative advantages and disadvantages compared with surgical approaches are not established. In our practice, we generally take the following approach, recognizing that it is based on limited data:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Candidates for bracing &mdash; We offer bracing to patients with mild or moderate pectus carinatum if expertise in this technique is readily available. During the evaluation for bracing, it is critically important to evaluate the flexibility of the chest, because bracing is more difficult in patients with skeletally mature, stiffer chest walls.",
"     </li>",
"     <li>",
"      Candidates for surgery &mdash; We believe that surgery is more likely to be effective than bracing for patients with severe pectus carinatum, for those who are unable to be compliant with the rigorous bracing schedule, and possibly for older patients. Surgery may also be more effective for patients with greater degrees of sternal asymmetry, as described below [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/31\">",
"       31",
"      </a>",
"      ]. Surgical intervention is also an acceptable approach for patients with milder degrees of pectus carinatum.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bracing",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with a flexible deformity, the deformity may be improved by bracing. A flexible defect is one that can be manually corrected by moderate compression on the initial physical exam [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The advantage of bracing is the decreased morbidity and improved cosmesis of a nonsurgical approach, as well as substantial cost savings as compared to surgical correction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Protocols",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of bracing protocols have been described:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients wore the brace for 23 hours per day for approximately two to six months until the defect was corrected, then for eight hours per day until skeletal maturation is complete [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. Of these patients 55 percent maintained correction during an average of 13.8 months of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients wore the brace for 14 to 16 hours a day for a minimum of two years or until growth was completed [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/6\">",
"       6",
"      </a>",
"      ]. There was significant improvement by six months and almost compete resolution by 12 months, with no further improvement after 18 months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several case series report that bracing leads to improvement or resolution of the pectus deformity in at least 75 to 90 percent of patients who comply with the protocol; the efficacy of bracing appears to be associated with degree of compliance with the bracing protocol and with earlier pubertal status at the start of bracing [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/6,34-36\">",
"     6,34-36",
"    </a>",
"    ]. In one of these series, self-reported satisfaction with physical appearance doubled from 2.9 pre-bracing to 4.3 on a 5 point scale [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/35\">",
"     35",
"    </a>",
"    ]. Among compliant patients, those that had not reached Tanner Stage IV required 4.2 &plusmn; 0.9 months to reach full correction, while those who started bracing after reaching Tanner stage IV needed 8.0 &plusmn; 7.1 months of bracing to get a full repair. In this series, 45 percent of the patients entering the protocol were deemed treatment failures, most of these due either to loss to follow-up or to marked noncompliance with the protocol; only 2 percent of the patients did not achieve improvement despite good compliance with the protocol. Thus, bracing protocols appear to be challenging to complete, but, among those patients who do, there is a high success rate. The authors suggest that the use of a brace in which the patient can adjust the compression pressure is associated with a higher rate of compliance and with greater overall success. In another series of patients between 5 and 28 years of age treated with bracing, there was a trend toward greater satisfaction in patients who had bracing before 19 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A small series suggested that four patients who failed bracing despite compliance had a significantly higher pectus severity index and asymmetry index and greater angle of sternal rotation as compared to 24 patients for whom bracing was successful [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/31\">",
"     31",
"    </a>",
"    ]. This suggests that patients with complex pectus carinatum defects may not be good candidates for bracing, though more research needs to be done to clarify this. &nbsp;",
"   </p>",
"   <p>",
"    One series of 209 patients described the use of a customized brace with a dynamic compressor system, which was adjusted to reflect the compression force needed to correct the deformity and also allowed lateral expansion of the chest [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/10\">",
"     10",
"    </a>",
"    ]. The length of treatment and cosmetic outcome were closely associated with the initial pressure needed to correct the deformity (ie, the stiffness of the carinatum defect). Patients requiring pressures lower than 2.5 pounds per square inch to correct the deformity at the initial assessment completed treatment rapidly, in an average of five months, and had good cosmetic outcomes based on a subjective assessment by clinician and family. Patients requiring compression force higher than five pounds per square inch required a longer period of bracing, averaging 12 months treatment, and were less likely to have good cosmetic outcomes. &nbsp;",
"   </p>",
"   <p>",
"    Complications of bracing are minimal. There are some reported problems with mild skin erythema, but skin breakdown is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/6,10,34,35,37\">",
"     6,10,34,35,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is the usual treatment for patients with pectus carinatum who have moderate to severe defects, whose chests are not flexible, or who have pectus carinatum combined with pectus excavatum. It is also used when bracing has not been effective, either due to poor compliance with the bracing protocol or poor patient selection. The techniques used are similar to those used to repair pectus excavatum deformities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21704?source=see_link\">",
"     \"Pectus excavatum: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The typical surgical technique, known as a modified Ravitch repair, usually includes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/2,8,20,30,38,39\">",
"     2,8,20,30,38,39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Resection or reshaping segments of all of the abnormal costal cartilage, preserving the perichondrium from which new cartilage grows",
"     </li>",
"     <li>",
"      Reshaping and repositioning the sternum",
"     </li>",
"     <li>",
"      Inserting a removable or absorbable strut (",
"      <a class=\"graphic graphic_figure graphicRef75569 \" href=\"UTD.htm?8/42/8871\">",
"       figure 1",
"      </a>",
"      ) or synthetic mesh \"hammock\" underneath the mobilized sternum [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one series, 76 of 90 patients had subperiosteal resection of the deformed cartilages, transverse osteotomy of the anterior sternum with insertion of a cartilage wedge, and support with a steel strut for four to six months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/30\">",
"     30",
"    </a>",
"    ]. The remainder had more severe deformities that required a more extensive procedure.",
"   </p>",
"   <p>",
"    Postoperative morbidity is approximately 4 to 11 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/2,8,9,30\">",
"     2,8,9,30",
"    </a>",
"    ]. In the series of 90 patients cited above, complications included wound seroma in five, pleural effusion in three, and pneumothorax in two patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/30\">",
"     30",
"    </a>",
"    ]. Thirteen patients had a hypertrophic scar. Mortality is low in the absence of associated anomalies.",
"   </p>",
"   <p>",
"    Two groups have adapted the technique for pectus carinatum repair to a thoracoscopic approach, but the procedure is limited to unilateral repair or one side at a time [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. In one of these reports, a supporting strut was kept in place for 20 months, and at the time of the report, 21 struts had been removed with no recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/42\">",
"     42",
"    </a>",
"    ]. All of the 37 patients assessed the surgical outcome as either excellent or good.",
"   </p>",
"   <p>",
"    Nuss and colleagues developed a minimally invasive technique for pectus excavatum that employs an intrapleural support bar [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/43\">",
"     43",
"    </a>",
"    ]. This technique has also been applied to pectus carinatum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/33,44,45\">",
"     33,44,45",
"    </a>",
"    ]. The patients in these series had either symmetric or asymmetric chondrogladiolar pectus carinatum, and their chest walls were flexible enough that the defects could be manually corrected by moderate compression on the initial physical exam [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/33\">",
"     33",
"    </a>",
"    ]. The bar was removed between 12 and 24 months after insertion, and 14 of 20 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/33\">",
"     33",
"    </a>",
"    ] and 13 of 14 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/45\">",
"     45",
"    </a>",
"    ] had good or excellent results. Complications were minimal, with the most frequent being adherence to the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Timing of referral and intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest referral to a pediatric surgeon as soon as pectus carinatum becomes apparent. The timing of bracing or surgical intervention depends on the age of the child and the severity and progression of the deformity.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For the minority of patients who present before puberty, the surgeon provides education and monitoring. Children presenting between 5 and 10 years of age are often good candidates for bracing, because their chest wall is compliant.",
"     </li>",
"     <li>",
"      For the majority of patients, who present during the pubertal growth spurt, the surgeon can offer a trial of bracing or surgical repair, depending on the patient&rsquo;s characteristics and preferences.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Opinions vary on the optimal age for surgery. In general, we recommend surgical repair toward the end of the pubertal growth spurt, typically around 13 to 16 years of age. This timing takes advantage of the ease of remolding an immature chest wall while minimizing the time that the defect can recur with future growth. Good to excellent surgical results have also been achieved in adult patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/46\">",
"     46",
"    </a>",
"    ]. Repair in prepubertal children may be associated with development of asphyxiating chondrodystrophy if extensive resection of the costal cartilages is performed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Repair in patients with Marfan syndrome is usually delayed until skeletal maturity is attained, because recurrence is more likely with earlier repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cosmetic outcomes after surgery, reported using subjective criteria, are good to excellent in more than 90 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/30,38,49,50\">",
"     30,38,49,50",
"    </a>",
"    ]. Recurrence is uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/51\">",
"     51",
"    </a>",
"    ], and when it does occur, it is most often in patients who had surgical correction before their growth spurt [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Continued surveillance should be maintained for scoliosis. It is not known if correction of the deformity affects the incidence of scoliosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25207/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pectus carinatum is an uncommon deformity of the chest wall characterized by protrusion of the sternum. In the majority of cases, the middle and lower portions of the sternum protrude, and the defect is symmetrical. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In more than 90 percent of patients, pectus carinatum deformity is first noted during early adolescence, and it often worsens dramatically during the adolescent growth spurt. The defect does not resolve spontaneously. The vast majority of patients have no physiologic symptoms, and cosmetic appearance is the primary concern. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A minority of patients with pectus carinatum have associated spinal abnormalities, such as scoliosis. It is more common in patients with Marfan and Noonan syndromes, as well as a few other syndromes. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Associated abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation of a patient with pectus carinatum should include chest radiographs to establish the severity of the deformity and to detect scoliosis. In our practice, we reserve the use of CT to evaluate patients who are being prepared for surgical repair. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Chest imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pectus carinatum is primarily a cosmetic concern. The decision of whether to treat depends on the severity of the defect, and the patient and family's level of concern. Both bracing and surgery provide safe and effective treatment. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest bracing as the initial approach for patients with mild to moderate pectus carinatum defects (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Success is more likely in patients who have flexible chest walls, and in those who are willing to adhere to strict bracing regimens. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Bracing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest surgery as the initial approach for patients with severe pectus carinatum and for those who are skeletally mature (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). It is also an appropriate technique for patients with less severe pectus carinatum who are unwilling to adhere to bracing regimens, provided that they have entered their pubertal growth spurt. We do not recommend surgery for patients who have not entered their pubertal growth spurt. This is because of the small but definite risk of asphyxiating thoracic dystrophy in younger patients who undergo a modified Ravitch pectus carinatum repair. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/1\">",
"      Lam CR, Taber RE. Surgical treatment of pectus carinatum. Arch Surg 1971; 103:191.",
"     </a>",
"    </li>",
"    <li>",
"     Shamberger RC. Congenital chest wall deformities. In: Pediatric Surgery, 5th ed, O'Neill J, Rowe MI, Grosfeld JL (Eds), Mosby, St. Louis, MO 1998. p.787.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/3\">",
"      H&uuml;mmer HP, Willital GH. Morphologic findings of chest deformities in children corresponding to the Willital-H&uuml;mmer classification. J Pediatr Surg 1984; 19:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/4\">",
"      Fonkalsrud EW. Surgical correction of pectus carinatum: lessons learned from 260 patients. J Pediatr Surg 2008; 43:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/5\">",
"      Shamberger RC, Welch KJ. Surgical correction of pectus carinatum. J Pediatr Surg 1987; 22:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/6\">",
"      Frey AS, Garcia VF, Brown RL, et al. Nonoperative management of pectus carinatum. J Pediatr Surg 2006; 41:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/7\">",
"      Fokin AA. Pouter pigeon breast. Chest Surg Clin N Am 2000; 10:377.",
"     </a>",
"    </li>",
"    <li>",
"     Landolfo KP, Sabiston DC. Surgery of the Chest, 6th ed, Sabiston DC, Spencer FC (Eds), WB Saunders, Philadelphia 1995.",
"    </li>",
"    <li>",
"     Heinle JS, Sabiston DC. Textbook of Surgery: The Biological Basis of Modern Surgical Practice, 15th ed, WB Saunders, Philadelphia 1997. p.1888.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/10\">",
"      Martinez-Ferro M, Fraire C, Bernard S. Dynamic compression system for the correction of pectus carinatum. Semin Pediatr Surg 2008; 17:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/11\">",
"      Donnelly LF, Frush DP, Foss JN, et al. Anterior chest wall: frequency of anatomic variations in children. Radiology 1999; 212:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/12\">",
"      Haje SA, Harcke HT, Bowen JR. Growth disturbance of the sternum and pectus deformities: imaging studies and clinical correlation. Pediatr Radiol 1999; 29:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/13\">",
"      LESTER CW. The relation of pectus excavatum to pectus carinatum; olassification of anterior chest wall deformities and the effect on treatment. J Pediatr 1958; 52:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/14\">",
"      Rupprecht H, H&uuml;mmer HP, St&ouml;ss H, Waldherr T. [Pathogenesis of chest wall abnormalities--electron microscopy studies and trace element analysis of rib cartilage]. Z Kinderchir 1987; 42:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/15\">",
"      Goretsky MJ, Kelly RE Jr, Croitoru D, Nuss D. Chest wall anomalies: pectus excavatum and pectus carinatum. Adolesc Med Clin 2004; 15:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/16\">",
"      Kotzot D, Schwabegger AH. Etiology of chest wall deformities--a genetic review for the treating physician. J Pediatr Surg 2009; 44:2004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/17\">",
"      BRODKIN HA. Congenital anterior chest wall deformities of diaphragmatic origin. Dis Chest 1953; 24:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/18\">",
"      Brown AL. Pectus Excavatum (Funnel Chest) Anatomic Basis; Surgical treatment of incipient stage in infancy; and correction of the deformity in the fully developed stage. J Thorac Surg 1939; 9:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/19\">",
"      Robicsek F. Surgical treatment of pectus excavatum. Chest Surg Clin N Am 2000; 10:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/20\">",
"      Robicsek F. Surgical treatment of pectus carinatum. Chest Surg Clin N Am 2000; 10:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/21\">",
"      LESTER CW. Surgical treatment of protrusion deformities of the sternum and costal cartilages (pectus carinatum, pigeon breast). Ann Surg 1961; 153:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/22\">",
"      LESTER CW. Pigeon breast (pectus carinatum) and other protrusion deformities of the chest of developmental origin. Ann Surg 1953; 137:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/23\">",
"      Waters P, Welch K, Micheli LJ, et al. Scoliosis in children with pectus excavatum and pectus carinatum. J Pediatr Orthop 1989; 9:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/24\">",
"      Frick SL. Scoliosis in children with anterior chest wall deformities. Chest Surg Clin N Am 2000; 10:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/25\">",
"      Saxena AK, Schaarschmidt K, Schleef J, et al. Surgical correction of pectus excavatum: the M&uuml;nster experience. Langenbecks Arch Surg 1999; 384:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/26\">",
"      Morton R. Fundamentals of stereophotography in medicine. J Audiov Media Med 1989; 12:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/27\">",
"      Egan JC, DuBois JJ, Morphy M, et al. Compressive orthotics in the treatment of asymmetric pectus carinatum: a preliminary report with an objective radiographic marker. J Pediatr Surg 2000; 35:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/28\">",
"      Fonkalsrud EW, Anselmo DM. Less extensive techniques for repair of pectus carinatum: the undertreated chest deformity. J Am Coll Surg 2004; 198:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/29\">",
"      Fonkalsrud EW. 912 open pectus excavatum repairs: changing trends, lessons learned: one surgeon's experience. World J Surg 2009; 33:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/30\">",
"      Fonkalsrud EW, Beanes S. Surgical management of pectus carinatum: 30 years' experience. World J Surg 2001; 25:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/31\">",
"      Stephenson JT, Du Bois J. Compressive orthotic bracing in the treatment of pectus carinatum: the use of radiographic markers to predict success. J Pediatr Surg 2008; 43:1776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/32\">",
"      Cahill JL, Lees GM, Robertson HT. A summary of preoperative and postoperative cardiorespiratory performance in patients undergoing pectus excavatum and carinatum repair. J Pediatr Surg 1984; 19:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/33\">",
"      Abramson H, D'Agostino J, Wuscovi S. A 5-year experience with a minimally invasive technique for pectus carinatum repair. J Pediatr Surg 2009; 44:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/34\">",
"      Kravarusic D, Dicken BJ, Dewar R, et al. The Calgary protocol for bracing of pectus carinatum: a preliminary report. J Pediatr Surg 2006; 41:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/35\">",
"      Lee RT, Moorman S, Schneider M, Sigalet DL. Bracing is an effective therapy for pectus carinatum: interim results. J Pediatr Surg 2013; 48:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/36\">",
"      Banever GT, Konefal SH, Gettens K, Moriarty KP. Nonoperative correction of pectus carinatum with orthotic bracing. J Laparoendosc Adv Surg Tech A 2006; 16:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/37\">",
"      Lee SY, Lee SJ, Jeon CW, et al. Effect of the compressive brace in pectus carinatum. Eur J Cardiothorac Surg 2008; 34:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/38\">",
"      Davis JT, Weinstein S. Repair of the pectus deformity: results of the Ravitch approach in the current era. Ann Thorac Surg 2004; 78:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/39\">",
"      Robicsek F, Fokin A. Surgical correction of pectus excavatum and carinatum. J Cardiovasc Surg (Torino) 1999; 40:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/40\">",
"      Robicsek F, Watts LT, Fokin AA. Surgical repair of pectus excavatum and carinatum. Semin Thorac Cardiovasc Surg 2009; 21:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/41\">",
"      Kim S, Idowu O. Minimally invasive thoracoscopic repair of unilateral pectus carinatum. J Pediatr Surg 2009; 44:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/42\">",
"      Schaarschmidt K, Kolberg-Schwerdt A, Lempe M, Schlesinger F. New endoscopic minimal access pectus carinatum repair using subpectoral carbon dioxide. Ann Thorac Surg 2006; 81:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/43\">",
"      Nuss D, Kelly RE Jr, Croitoru DP, Katz ME. A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J Pediatr Surg 1998; 33:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/44\">",
"      Hock A. Minimal access treatment of pectus carinatum: a preliminary report. Pediatr Surg Int 2009; 25:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/45\">",
"      K&aacute;lm&aacute;n A. Initial results with minimally invasive repair of pectus carinatum. J Thorac Cardiovasc Surg 2009; 138:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/46\">",
"      Fonkalsrud EW, DeUgarte D, Choi E. Repair of pectus excavatum and carinatum deformities in 116 adults. Ann Surg 2002; 236:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/47\">",
"      Haller JA Jr, Colombani PM, Humphries CT, et al. Chest wall constriction after too extensive and too early operations for pectus excavatum. Ann Thorac Surg 1996; 61:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/48\">",
"      Phillips JD, van Aalst JA. Jeune's syndrome (asphyxiating thoracic dystrophy): congenital and acquired. Semin Pediatr Surg 2008; 17:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/49\">",
"      Willekes CL, Backer CL, Mavroudis C. A 26-year review of pectus deformity repairs, including simultaneous intracardiac repair. Ann Thorac Surg 1999; 67:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/50\">",
"      Tjan TD, Semik M, Rotering H, et al. Pectus excavatum: special surgical technique, perioperative management and long-term results. J Cardiovasc Surg (Torino) 1999; 40:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/51\">",
"      Ellis DG, Snyder CL, Mann CM. The 're-do' chest wall deformity correction. J Pediatr Surg 1997; 32:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25207/abstract/52\">",
"      Colombani PM. Preoperative assessment of chest wall deformities. Semin Thorac Cardiovasc Surg 2009; 21:58.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6342 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.150.3.100-EF161DC620-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25207=[""].join("\n");
var outline_f24_39_25207=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Chondrogladiolar prominence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Chondromanubrial prominence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Natural history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Associated abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Photography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Chest imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Additional testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bracing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Protocols",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Timing of referral and intervention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6342\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6342|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/42/8871\" title=\"figure 1\">",
"      Ravitch repair pectus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=related_link\">",
"      Clinical features and diagnosis of the mucopolysaccharidoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24490?source=related_link\">",
"      Diseases of the chest wall",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=related_link\">",
"      Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18071?source=related_link\">",
"      Pectus excavatum: Etiology and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21704?source=related_link\">",
"      Pectus excavatum: Treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_39_25208="Automated external defibrillators";
var content_f24_39_25208=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Automated external defibrillators",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25208/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25208/contributors\">",
"     Laura S Gold, MSPH, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25208/contributors\">",
"     Thomas D Rea, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25208/contributors\">",
"     Mickey S Eisenberg, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25208/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25208/contributors\">",
"     Richard L Page, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25208/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25208/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/39/25208/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sudden cardiac arrest (SCA) refers to the sudden cessation of cardiac activity with hemodynamic collapse and is most often due to sustained ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). SCA is a major public health challenge, accounting for approximately 5 to 15 percent of total mortality in industrialized nations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=see_link\">",
"     \"Overview of sudden cardiac arrest and sudden cardiac death\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Survival from SCA remains poor. In most studies, fewer than 10 percent of patients in any cardiac rhythm and 20 percent of patients whose initial rhythm is VF survive the event [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. These low survival rates are observed even with in-hospital arrests [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=see_link\">",
"     \"Outcome of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although several interventions can improve the likelihood of VF resuscitation, the single most important is early delivery of an external electric shock to reset the cardiac rhythm and restore spontaneous circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Early defibrillation is consistently associated with a greater likelihood of survival, which decreases by approximately five percent with each additional minute from collapse to defibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the development, use, allocation, and efficacy of automated external defibrillators (AEDs). Other aspects of electrical cardioversion and defibrillation are discussed separately, as are basic and advanced cardiovascular life support. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/35/17977?source=see_link\">",
"     \"Basic principles and technique of cardioversion and defibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11050?source=see_link\">",
"     \"Cardioversion for specific arrhythmias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/25/36248?source=see_link\">",
"     \"Basic life support (BLS) in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link\">",
"     \"Advanced cardiac life support (ACLS) in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/24/8585?source=see_link\">",
"     \"Supportive data for advanced cardiac life support in adults with sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     AED TECHNOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Development of the AED",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first defibrillators were developed in the 1940s and operated through electrodes placed directly on the heart [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Closed chest defibrillators were developed and applied clinically in the 1950s [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. These manual defibrillators required the user to interpret the patient's electrocardiogram (ECG) in order to distinguish shockable from nonshockable rhythms.",
"   </p>",
"   <p>",
"    The ability to achieve early defibrillation with manual devices was limited by the small number of qualified rescuers who could interpret cardiac rhythms. Since automated external defibrillators (AEDs) are programmed to analyze cardiac rhythms and directly inform rescuers whether a shock is indicated, their advent was a critical factor in expanding rapid defibrillation programs.",
"   </p>",
"   <p>",
"    An important distinction exists between automated external defibrillators and automatic external defibrillators.",
"    <strong>",
"     Automated",
"    </strong>",
"    external defibrillators assess the cardiac rhythm and advise rescuers on whether or not to deliver a shock, whereas",
"    <strong>",
"     automatic",
"    </strong>",
"    external defibrillators assess the cardiac rhythm and deliver a shock automatically without any rescuer input. The vast majority of external defibrillators are the",
"    <strong>",
"     automated",
"    </strong>",
"    type, whereas",
"    <strong>",
"     automatic",
"    </strong>",
"    external defibrillators are rarely used; the remainder of this discussion focuses on automated external defibrillators.",
"   </p>",
"   <p>",
"    Unlike their predecessors that weighed over 15 kg and cost over $10,000 (in 2008), modern AEDs weigh between 2 and 4 kg and can cost less than $1000 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/13\">",
"     13",
"    </a>",
"    ]. Some AED models can be purchased without a clinician prescription.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     AED training",
"    </span>",
"    &nbsp;&mdash;&nbsp;AEDs are designed to be straightforward to operate, and multiple studies have demonstrated that laypersons can operate them safely and effectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/14-18\">",
"     14-18",
"    </a>",
"    ]. Nevertheless, they can be challenging to use, especially for the layperson [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The best approach for training laypersons to achieve and maintain AED operational proficiency is not well established, although face-to-face, video, and web-based training approaches have demonstrated merit [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. A study of older laypersons previously trained in AED use showed that emergency dispatchers were successfully able to assist rescuers to use AEDs via telephone instructions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A website (",
"    <a class=\"external\" href=\"file://www.learnaed.org/\">",
"     www.learnaed.org",
"    </a>",
"    ) sponsored by the University of Washington is available to assist persons with AEDs or those who are considering purchase of an AED. This site is not intended to replace formal training.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     AED operation",
"    </span>",
"    &nbsp;&mdash;&nbsp;AEDs utilize two self-adhesive electrode pads placed directly on the bare chest to detect the cardiac rhythm and to deliver shocks when indicated. International standards require that AEDs have a sensitivity of &gt;90 percent for detecting coarse ventricular fibrillation (VF) (at least 0.2 mV in amplitude) and an overall specificity of &gt;95 percent, a level of discrimination that compares favorably to manual field interpretation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most AEDs deliver between 120 and 360 Joules, with the output depending upon several factors including the number of shocks previously administered, the impedance of the chest wall, and whether a monophasic or biphasic waveform is used. Some AEDs can be modified to deliver less electricity for use on children less than eight years of age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/35/17977?source=see_link&amp;anchor=H11#H11\">",
"     \"Basic principles and technique of cardioversion and defibrillation\", section on 'Monophasic versus biphasic waveforms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    AEDs typically provide audio prompts that direct rescuers to stand clear of the victim during rhythm analysis and to press a button to deliver the shock. The AED can be programmed to reanalyze the ECG rhythm after an initial shock to determine if further shocks are indicated and to prompt rescuers to check for signs of life and perform cardiopulmonary resuscitation (CPR). If the patient has an implantable cardioverter-defibrillator (ICD) that is delivering shocks, the ICD should be allowed to complete its treatment cycle (typically 30 to 60 seconds) before the AED is attached.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Pad placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2005 Advanced Cardiac Life Support (ACLS) guidelines make the following recommendations regarding placement of AED pads [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AED pads should be placed in the sternal-apical (anterolateral) position (",
"      <a class=\"graphic graphic_figure graphicRef58585 \" href=\"UTD.htm?10/13/10448\">",
"       figure 1",
"      </a>",
"      ), with the right pad placed on the right superior-anterior chest below the clavicle, and the left pad placed on the inferior-lateral left chest, lateral to the left breast [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acceptable alternatives are biaxillary positioning, with pads placed on the right and left lateral chest walls, or placement of the left pad in the standard apical position, with the other pad on the right or left upper back.",
"     </li>",
"     <li>",
"      Pads should be placed at least 2.5 cm (1 inch) away from any implantable devices.",
"     </li>",
"     <li>",
"      AED pads should NOT be placed directly on top of a transdermal medication patch since it can interfere with therapy and also cause skin burns. The medication patch should be removed and the skin should be wiped clean.",
"     </li>",
"     <li>",
"      Chest hair can potentially interfere with optimal pad adhesion and may need to be removed. This can be done by rapidly removing an adhesive AED pad or by shaving the chest in the area where the pad will be placed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Other features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional features present in most AED models include the ability to continuously record the arrest rhythm ECG, derive measures of cardiopulmonary resuscitation (CPR) performance such as chest compressions or ventilations, and record the voices of rescuers involved in the event. The combination of these features enables case review that may be used for quality assurance or research. Such data indicate that CPR often does not meet guideline standards and is frequently interrupted [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/26-29\">",
"     26-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Newer AED models incorporate more dynamic prompts or real-time feedback to guide rescuer CPR actions. It is not known if these features will improve survival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     AED ALLOCATION STRATEGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;AEDs are effective only in those patients who present with ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT); pulseless electrical activity and asystole are not effectively treated by defibrillation. Although the proportion of",
"    <span class=\"nowrap\">",
"     VF/VT",
"    </span>",
"    arrests is declining relative to nonshockable rhythms,",
"    <span class=\"nowrap\">",
"     VF/VT",
"    </span>",
"    arrests still account for tens of thousands of deaths each year, and the improved resuscitation provided by AEDs can have a significant impact on public health.",
"   </p>",
"   <p>",
"    AEDs enable people who are not trained in rhythm interpretation to provide life-saving therapy, which vastly increases the pool of potential rescuers who can provide early defibrillation. However, their allocation and use require programmatic support, training, and maintenance, all of which can contribute to overall cost. Thus, an important consideration regarding these devices is efficient distribution of AEDs throughout communities.",
"   </p>",
"   <p>",
"    Strategies for AED allocation include providing them to traditional emergency medical services (EMS) and to nonmedical emergency responders (eg, police officers and firefighters), as well as placing them in public locations, in hospitals, and in the homes of individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Emergency medical services AED programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial large-scale implementation of AEDs was by emergency medical services (EMS) in the 1980s and 1990s. This had the potential of allowing the strategy of earlier defibrillation to be advanced by allocating AEDs to EMS first responders (emergency medical technicians), many of whom were not typically trained in rhythm interpretation.",
"   </p>",
"   <p>",
"    Some EMS AED programs were associated with improvements in survival, but others were not [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. Meta-analyses found that EMS AED programs resulted in a significant 9 percent increase in survival [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. However, weaknesses in individual study design limit the strength of these conclusions.",
"   </p>",
"   <p>",
"    In some reports, survival from SCA due to ventricular fibrillation (VF) did not improve despite reductions in the time to defibrillation observed with the adoption of the AED [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. One explanation for this discrepancy is that the resuscitation algorithms that were originally used for AED rhythm analysis and processing required considerable interruptions in CPR compared to treatment with a manual defibrillator [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/26-29\">",
"     26-29",
"    </a>",
"    ], and that the increase in \"hands-off\" time reduced the chances of successful resuscitation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link&amp;anchor=H4#H4\">",
"     \"Advanced cardiac life support (ACLS) in adults\", section on 'Excellent basic life support and its importance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More recent AED algorithms have been modified to reduce CPR interruptions during resuscitation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/7\">",
"     7",
"    </a>",
"    ], and subsequent reports suggested that survival increased in parallel [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/37,42\">",
"     37,42",
"    </a>",
"    ]. In a prospective study that compared outcomes before and after training in minimally interrupted cardiac resuscitation, there was a significant increase in survival to hospital discharge after training (5.4 versus 1.8 percent before training). The benefit was greater in the subgroup of patients with witnessed cardiac arrest and ventricular fibrillation (17.6 versus 4.7 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Police AED programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Police officers can sometimes respond to sudden cardiac arrest (SCA) victims more quickly than EMS providers [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/43\">",
"     43",
"    </a>",
"    ]. A program of providing AEDs to police officers and training them in their use was initially introduced in the late 1980s in Rochester, Minnesota [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/44\">",
"     44",
"    </a>",
"    ]. Police often arrived at SCAs due to ventricular fibrillation (VF) prior to EMS and defibrillated patients an average of 5.5 minutes following collapse [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/44\">",
"     44",
"    </a>",
"    ]. Ten of 14 patients survived to hospital discharge. In a later series of 193 patients, survival from witnessed VF to hospital discharge was 46 percent. Most were neurologically intact [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/45\">",
"     45",
"    </a>",
"    ]. In contrast, survival from SCA not caused by VF was only 5 percent.",
"   </p>",
"   <p>",
"    Implementation of police AED programs in Pittsburgh, Pennsylvania and Miami-Dade County, Florida has also been associated with greater survival [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. However, other police AED programs have not shown survival benefits compared to standard EMS, particularly when the police have not arrived before EMS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/48\">",
"     48",
"    </a>",
"    ]. Thus, one of the keys to a successful police AED program is committed medical and police leaders who can motivate police about their potential lifesaving role.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Public access defibrillation programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance studies have identified particular locations where sudden cardiac arrest (SCA) occurs with high frequency, including public transit facilities, shopping malls, public sports venues, industrial sites, golf courses, casinos, dialysis centers, and fitness centers [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/49-53\">",
"     49-53",
"    </a>",
"    ]. AEDs strategically located in such places can be used by laypersons to deliver defibrillation prior to EMS arrival, a concept referred to as \"public access defibrillation\" (PAD). The benefits of PAD on survival rates and neurologic outcomes after SCA are illustrated by the following findings [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/54-59\">",
"     54-59",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Public Access Defibrillation (PAD) trial, a prospective multi-community randomized trial, evaluated survival to discharge in 526 patients with SCA. Following SCA, survival to discharge rates significantly increased in high-risk public sites where CPR-trained lay responders were equipped with AEDs compared to sites where lay responders were CPR-trained, but did not have access to AEDs (23.4 versus 14.0 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/59\">",
"       59",
"      </a>",
"      ]. Furthermore, PAD programs implemented at high-risk sites offer reasonable health benefit for the cost, ranging from $35,000 to $57,000 per quality adjusted life-year, which is comparable to other widely-accepted medical interventions such as bone marrow transplant ($52,000 per quality adjusted life-year) and heart transplant ($59,000 per quality adjusted life-year) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/60-64\">",
"       60-64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The largest of several cohort studies evaluated the outcome of over 13,000 patients with an out-of-hospital SCA. Survival to hospital discharge was markedly greater in patients who received an AED delivered shock compared to patients receiving bystander CPR alone (38 versus 9 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Survival with intact neurological function is higher in patients with SCA who receive treatment with an AED available at the site of the arrest. In a study of 2833 consecutive patients with out-of-hospital SCA, neurologically intact survival was significantly higher among those treated with an onsite AED in addition to basic life support (BLS) (50 percent versus 14 percent with BLS alone, adjusted odds ratio 2.72, 95% CI 1.77-4.18) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nationwide dissemination of AEDs in public places in Japan from 2005 through 2007 was associated with an increase in the proportion of shocks for witnessed VF arrest administered by laypersons with AEDs from 1.2 to 6.2 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/66\">",
"       66",
"      </a>",
"      ]. As the number of public access AEDs increased, mean time to shock was reduced (from 3.7 to 2.2 minutes) and survival with minimal neurologic impairment was improved (from 2.4 to 8.9 per 10 million population).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The survival benefit observed in these programs has led to advocacy for lower-risk sites to implement PAD programs. As an example, guidelines have been established for school-based AED programs which have increased dramatically over time, partly because of legislation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. PAD programs are also mandated in many federal locations. Use at lower-risk sites will increase the number of SCA survivors but with a lower cost-effectiveness. At present, PAD program AEDs are involved in only a small fraction of all out-of-hospital SCAs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/57,69\">",
"     57,69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     AEDs for use in private homes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since approximately three-quarters of sudden cardiac arrests (SCAs) occur in private homes, one strategy to reduce mortality is to distribute AEDs for use in the home.",
"   </p>",
"   <p>",
"    Home use of AEDs was investigated in a randomized trial of 7001 patients with previous anterior wall myocardial infarction who were not candidates for an implantable cardioverter-defibrillator [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/70\">",
"     70",
"    </a>",
"    ]. The median age was 62 years and the median left ventricular ejection fraction was 45 percent. The designated rescuers were predominantly female (83 percent) and their median age was 58 years.",
"   </p>",
"   <p>",
"    Patients were randomly assigned to AED use followed by calling emergency medical services (EMS) and performing cardiopulmonary resuscitation (CPR) or to the control response of calling EMS and performing CPR. Access to a home AED did not improve survival as compared to conventional resuscitation (6.4 versus 6.5 percent, hazard ratio, 0.97; 95% CI 0.81 to 1.17).",
"   </p>",
"   <p>",
"    Several factors may have contributed to the lack of benefit in this trial:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of sudden cardiac arrest (2.3 percent) and overall mortality were lower than predicted.",
"     </li>",
"     <li>",
"      One-half of the tachyarrhythmia arrests that took place at home were witnessed (58 of 117), and an AED was used in only 32 patients.",
"     </li>",
"     <li>",
"      Spouses and companions in the control group received training in resuscitation, with frequent reminders.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In determining whether AEDs are appropriate for home use, cost and the increasing role of implantable cardioverter-defibrillators in individuals at high risk of SCA must be taken into consideration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     In-hospital AED allocation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed defibrillation is common during in-hospital arrest even though medical personnel are often trained in advanced cardiac life support and ECG rhythm interpretation and are capable of implementing manual defibrillation.",
"   </p>",
"   <p>",
"    The frequency of delayed in-hospital defibrillation (defined as greater than two minutes from the time of recognition of arrest) and its adverse effect on survival were illustrated in a study utilizing 6789 patient records from the National Registry of Cardiopulmonary Resuscitation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/71\">",
"     71",
"    </a>",
"    ]. Delayed defibrillation for ventricular fibrillation or pulseless ventricular tachycardia was observed in 30 percent of sudden cardiac arrests (SCAs) and was associated with a significantly lower probability of survival to discharge compared to survival when defibrillation was performed within two minutes (22 percent versus 39 percent).",
"   </p>",
"   <p>",
"    The possibility that AED could improve survival of in-hospital SCA was suggested by small studies showing that AEDs allocated to specific clinical and non-clinical areas of the hospital allowed for more rapid defibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/72,73\">",
"     72,73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequently, the outcomes of in-hospital SCA were analyzed using data obtained from 253 US and Canadian hospitals as part of the National Registry of Cardiopulmonary Resuscitation. Amongst a cohort of 11,695 hospitalized patients who suffered SCA between 2000 and 2008, 39 percent of cardiac arrests were treated using an AED [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with a shockable rhythm (ie, pulseless ventricular tachycardia or ventricular fibrillation) had similar survival to hospital discharge in the AED and non-AED group (38.4 versus 39.8 percent, adjusted relative risk (RR) 1.00, 95% CI 0.88 to 1.13).",
"     </li>",
"     <li>",
"      Patients without a shockable rhythm (ie, asystole or pulseless electrical activity) had a lower rate of survival to hospital discharge when an AED was employed (10.4 percent versus 15.4 percent in the non-AED group, adjusted RR 0.74, 95% CI 0.65 to 0.83).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results suggest that, for patients with a shockable rhythm, AEDs provide no survival benefit compared to usual external defibrillation in a hospital setting. More worrisome is the apparent worsening of survival due to AED use in patients without a shockable rhythm, presumably due to the delayed administration of rescue breathing and chest compressions during the time that the AED is performing its analysis (which for most AEDs requires &ldquo;hands off&rdquo; of the patient).",
"   </p>",
"   <p>",
"    The optimal strategy of AED distribution and its ultimate benefit may depend upon a particular hospital's staffing, geography, and patient profile [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     AED CHALLENGES AND OPPORTUNITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although AEDs have saved many lives, they have several potential drawbacks.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AEDs require the presence of a bystander to apply and operate.",
"     </li>",
"     <li>",
"      Only about 50 percent of sudden cardiac arrest (SCA) events are witnessed. Thus, effective defibrillation is often impossible by the time the victim of an unwitnessed SCA is found.",
"     </li>",
"     <li>",
"      AEDs require interruptions in cardiopulmonary resuscitation (CPR) while they assess the cardiac rhythm. This analysis time is typically longer with AEDs than with manual defibrillators. Ongoing efforts are aimed at minimizing this time, and technical advances may eventually enable accurate rhythm interpretation even while CPR is ongoing [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/76,77\">",
"       76,77",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link&amp;anchor=H4#H4\">",
"       \"Advanced cardiac life support (ACLS) in adults\", section on 'Excellent basic life support and its importance'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The cost of AEDs can be an important obstacle to potential health benefits.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prognostic information on SCA patients is available from the shape and pattern of the ventricular fibrillation (VF) waveform recorded in the ECG [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/78\">",
"     78",
"    </a>",
"    ]. AEDs can analyze this information in real-time to potentially guide rescuers to the best course of treatment with CPR, defibrillation, and medications [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/79\">",
"     79",
"    </a>",
"    ]. Although this research is intriguing, the survival effects of dynamic processing of the VF waveform are largely untested.",
"   </p>",
"   <p>",
"    Wearable automatic external defibrillators have been developed. Their role has not been established and they probably will not be applicable to the general population. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24362?source=see_link&amp;anchor=H29#H29\">",
"     \"General principles of the implantable cardioverter-defibrillator\", section on 'Wearable cardioverter-defibrillator'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some advocates of widespread AED dissemination have considered them as compulsory safety equipment along the lines of smoke alarms and fire extinguishers [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25208/abstract/80\">",
"     80",
"    </a>",
"    ]. Such an approach has not yet demonstrated a survival benefit and it is cost prohibitive at this point.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sudden cardiac arrest (SCA), most often due to ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT), is a major public health challenge traditionally associated with survival rates of less than 10 percent when occurring outside of the hospital. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Definitive treatment of out-of-hospital SCA with early defibrillation was limited by the small number of qualified rescuers who could interpret cardiac rhythms. Since AEDs analyze cardiac rhythms and directly inform rescuers whether a shock is indicated, their advent has allowed lay rescuers to provide early defibrillation. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Development of the AED'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'AED operation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Successful early defibrillation using an AED, when appropriate, has been shown to significantly improve survival and survival with intact neurologic function following out-of-hospital SCA. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Public access defibrillation programs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Compared to usual resuscitative measures (including external defibrillation when indicated), AED use in hospitalized patients with cardiac arrest did",
"      <strong>",
"       not",
"      </strong>",
"      improve survival in a large, multi-center observational study. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'In-hospital AED allocation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While AEDs can be highly effective, appropriate use does require interruptions in cardiopulmonary resuscitation to assess the cardiac rhythm. The increase in \"hands-off\" time may reduce the chances of successful resuscitation, particularly in patients without a shockable rhythm. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'AED challenges and opportunities'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=see_link&amp;anchor=H4#H4\">",
"       \"Advanced cardiac life support (ACLS) in adults\", section on 'Excellent basic life support and its importance'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/1\">",
"      Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104:2158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/2\">",
"      Rea TD, Pearce RM, Raghunathan TE, et al. Incidence of out-of-hospital cardiac arrest. Am J Cardiol 2004; 93:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/3\">",
"      Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/4\">",
"      Peberdy MA, Kaye W, Ornato JP, et al. Cardiopulmonary resuscitation of adults in the hospital: a report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation. Resuscitation 2003; 58:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/5\">",
"      Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008; 300:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/6\">",
"      Peberdy MA, Ornato JP, Larkin GL, et al. Survival from in-hospital cardiac arrest during nights and weekends. JAMA 2008; 299:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/7\">",
"      ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005; 112:IV1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/8\">",
"      Valenzuela TD, Roe DJ, Cretin S, et al. Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model. Circulation 1997; 96:3308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/9\">",
"      Beck C, Pritchard W, Feil H. Ventricular fibrillation of long duration abolished by electric shock. JAMA 1947; 136:985.",
"     </a>",
"    </li>",
"    <li>",
"     Eisenberg M. Defibrillation is the spark of life; Life in the balance: emergency medicine and the quest to reverse sudden death, Oxford University Press, New York 1997. p.178.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/11\">",
"      Janse MJ. A brief history of sudden cardiac death and its therapy. Pharmacol Ther 2003; 100:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/12\">",
"      ZOLL PM, LINENTHAL AJ, GIBSON W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med 1956; 254:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/13\">",
"      Hallstrom A, Eisenberg M, Bergner L. The potential use of automatic defibrillators in the home for management of cardiac arrest. Med Care 1984; 22:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/14\">",
"      Ecker R, Rea TD, Meischke H, et al. Dispatcher assistance and automated external defibrillator performance among elders. Acad Emerg Med 2001; 8:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/15\">",
"      Fromm RE Jr, Varon J. Automated external versus blind manual defibrillation by untrained lay rescuers. Resuscitation 1997; 33:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/16\">",
"      Harve H, Jokela J, Tissari A, et al. Can untrained laypersons use a defibrillator with dispatcher assistance? Acad Emerg Med 2007; 14:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/17\">",
"      Roppolo LP, Pepe PE, Campbell L, et al. Prospective, randomized trial of the effectiveness and retention of 30-min layperson training for cardiopulmonary resuscitation and automated external defibrillators: The American Airlines Study. Resuscitation 2007; 74:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/18\">",
"      Powell J, Van Ottingham L, Schron E. Public defibrillation: increased survival from a structured response system. J Cardiovasc Nurs 2004; 19:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/19\">",
"      Riegel B, Birnbaum A, Aufderheide TP, et al. Predictors of cardiopulmonary resuscitation and automated external defibrillator skill retention. Am Heart J 2005; 150:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/20\">",
"      Meischke HW, Rea TD, Eisenberg MS, Rowe SM. Intentions to use an automated external defibrillator during a cardiac emergency among a group of seniors trained in its operation. Heart Lung 2002; 31:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/21\">",
"      Riegel B, Nafziger SD, McBurnie MA, et al. How well are cardiopulmonary resuscitation and automated external defibrillator skills retained over time? Results from the Public Access Defibrillation (PAD) Trial. Acad Emerg Med 2006; 13:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/22\">",
"      Lynch B, Einspruch EL, Nichol G, et al. Effectiveness of a 30-min CPR self-instruction program for lay responders: a controlled randomized study. Resuscitation 2005; 67:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/23\">",
"      Meischke HW, Rea T, Eisenberg MS, et al. Training seniors in the operation of an automated external defibrillator: a randomized trial comparing two training methods. Ann Emerg Med 2001; 38:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/24\">",
"      Kerber RE, Becker LB, Bourland JD, et al. Automatic external defibrillators for public access defibrillation: recommendations for specifying and reporting arrhythmia analysis algorithm performance, incorporating new waveforms, and enhancing safety. A statement for health professionals from the American Heart Association Task Force on Automatic External Defibrillation, Subcommittee on AED Safety and Efficacy. Circulation 1997; 95:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/25\">",
"      Kramer-Johansen J, Edelson DP, Abella BS, et al. Pauses in chest compression and inappropriate shocks: a comparison of manual and semi-automatic defibrillation attempts. Resuscitation 2007; 73:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/26\">",
"      Carpenter J, Rea TD, Murray JA, et al. Defibrillation waveform and post-shock rhythm in out-of-hospital ventricular fibrillation cardiac arrest. Resuscitation 2003; 59:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/27\">",
"      van Alem AP, Sanou BT, Koster RW. Interruption of cardiopulmonary resuscitation with the use of the automated external defibrillator in out-of-hospital cardiac arrest. Ann Emerg Med 2003; 42:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/28\">",
"      Valenzuela TD, Kern KB, Clark LL, et al. Interruptions of chest compressions during emergency medical systems resuscitation. Circulation 2005; 112:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/29\">",
"      Pytte M, Pedersen TE, Ottem J, et al. Comparison of hands-off time during CPR with manual and semi-automatic defibrillation in a manikin model. Resuscitation 2007; 73:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/30\">",
"      Stults KR, Brown DD, Schug VL, Bean JA. Prehospital defibrillation performed by emergency medical technicians in rural communities. N Engl J Med 1984; 310:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/31\">",
"      Weaver WD, Hill D, Fahrenbruch CE, et al. Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest. N Engl J Med 1988; 319:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/32\">",
"      Sweeney TA, Runge JW, Gibbs MA, et al. EMT defibrillation does not increase survival from sudden cardiac death in a two-tiered urban-suburban EMS system. Ann Emerg Med 1998; 31:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/33\">",
"      Kellermann AL, Hackman BB, Somes G, et al. Impact of first-responder defibrillation in an urban emergency medical services system. JAMA 1993; 270:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/34\">",
"      Watts DD. Defibrillation by basic emergency medical technicians: effect on survival. Ann Emerg Med 1995; 26:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/35\">",
"      Auble TE, Menegazzi JJ, Paris PM. Effect of out-of-hospital defibrillation by basic life support providers on cardiac arrest mortality: a metaanalysis. Ann Emerg Med 1995; 25:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/36\">",
"      Cobb LA, Fahrenbruch CE, Walsh TR, et al. Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation. JAMA 1999; 281:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/37\">",
"      Rea TD, Helbock M, Perry S, et al. Increasing use of cardiopulmonary resuscitation during out-of-hospital ventricular fibrillation arrest: survival implications of guideline changes. Circulation 2006; 114:2760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/38\">",
"      Tang W, Snyder D, Wang J, et al. One-shock versus three-shock defibrillation protocol significantly improves outcome in a porcine model of prolonged ventricular fibrillation cardiac arrest. Circulation 2006; 113:2683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/39\">",
"      Berg MD, Clark LL, Valenzuela TD, et al. Post-shock chest compression delays with automated external defibrillator use. Resuscitation 2005; 64:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/40\">",
"      Berg RA, Hilwig RW, Kern KB, et al. Automated external defibrillation versus manual defibrillation for prolonged ventricular fibrillation: lethal delays of chest compressions before and after countershocks. Ann Emerg Med 2003; 42:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/41\">",
"      Berg RA, Hilwig RW, Berg MD, et al. Immediate post-shock chest compressions improve outcome from prolonged ventricular fibrillation. Resuscitation 2008; 78:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/42\">",
"      Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscitation by emergency medical services for out-of-hospital cardiac arrest. JAMA 2008; 299:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/43\">",
"      Waalewijn RA, de Vos R, Koster RW. Out-of-hospital cardiac arrests in Amsterdam and its surrounding areas: results from the Amsterdam resuscitation study (ARREST) in 'Utstein' style. Resuscitation 1998; 38:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/44\">",
"      White RD, Vukov LF, Bugliosi TF. Early defibrillation by police: initial experience with measurement of critical time intervals and patient outcome. Ann Emerg Med 1994; 23:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/45\">",
"      White RD, Bunch TJ, Hankins DG. Evolution of a community-wide early defibrillation programme experience over 13 years using police/fire personnel and paramedics as responders. Resuscitation 2005; 65:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/46\">",
"      Mosesso VN Jr, Davis EA, Auble TE, et al. Use of automated external defibrillators by police officers for treatment of out-of-hospital cardiac arrest. Ann Emerg Med 1998; 32:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/47\">",
"      Myerburg RJ, Fenster J, Velez M, et al. Impact of community-wide police car deployment of automated external defibrillators on survival from out-of-hospital cardiac arrest. Circulation 2002; 106:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/48\">",
"      Groh WJ, Newman MM, Beal PE, et al. Limited response to cardiac arrest by police equipped with automated external defibrillators: lack of survival benefit in suburban and rural Indiana--the police as responder automated defibrillation evaluation (PARADE). Acad Emerg Med 2001; 8:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/49\">",
"      Becker L, Eisenberg M, Fahrenbruch C, Cobb L. Public locations of cardiac arrest. Implications for public access defibrillation. Circulation 1998; 97:2106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/50\">",
"      Frank RL, Rausch MA, Menegazzi JJ, Rickens M. The locations of nonresidential out-of-hospital cardiac arrests in the City of Pittsburgh over a three-year period: implications for automated external defibrillator placement. Prehosp Emerg Care 2001; 5:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/51\">",
"      Reed DB, Birnbaum A, Brown LH, et al. Location of cardiac arrests in the public access defibrillation trial. Prehosp Emerg Care 2006; 10:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/52\">",
"      Davies CS, Colquhoun M, Graham S, et al. Defibrillators in public places: the introduction of a national scheme for public access defibrillation in England. Resuscitation 2002; 52:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/53\">",
"      Davis TR, Young BA, Eisenberg MS, et al. Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers. Kidney Int 2008; 73:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/54\">",
"      Caffrey SL, Willoughby PJ, Pepe PE, Becker LB. Public use of automated external defibrillators. N Engl J Med 2002; 347:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/55\">",
"      Page RL, Joglar JA, Kowal RC, et al. Use of automated external defibrillators by a U.S. airline. N Engl J Med 2000; 343:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/56\">",
"      Valenzuela TD, Roe DJ, Nichol G, et al. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med 2000; 343:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/57\">",
"      Culley LL, Rea TD, Murray JA, et al. Public access defibrillation in out-of-hospital cardiac arrest: a community-based study. Circulation 2004; 109:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/58\">",
"      Weisfeldt ML, Sitlani CM, Ornato JP, et al. Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million. J Am Coll Cardiol 2010; 55:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/59\">",
"      Hallstrom AP, Ornato JP, Weisfeldt M, et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 2004; 351:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/60\">",
"      Nichol G, Huszti E, Birnbaum A, et al. Cost-effectiveness of lay responder defibrillation for out-of-hospital cardiac arrest. Ann Emerg Med 2009; 54:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/61\">",
"      Nichol G, Valenzuela T, Roe D, et al. Cost effectiveness of defibrillation by targeted responders in public settings. Circulation 2003; 108:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/62\">",
"      Groeneveld PW, Kwong JL, Liu Y, et al. Cost-effectiveness of automated external defibrillators on airlines. JAMA 2001; 286:1482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/63\">",
"      Lee SJ, Anasetti C, Kuntz KM, et al. The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia. Blood 1998; 92:4047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/64\">",
"      Hornberger J, Best J, Geppert J, McClellan M. Risks and costs of end-stage renal disease after heart transplantation. Transplantation 1998; 66:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/65\">",
"      Berdowski J, Blom MT, Bardai A, et al. Impact of onsite or dispatched automated external defibrillator use on survival after out-of-hospital cardiac arrest. Circulation 2011; 124:2225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/66\">",
"      Kitamura T, Iwami T, Kawamura T, et al. Nationwide public-access defibrillation in Japan. N Engl J Med 2010; 362:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/67\">",
"      Hazinski MF, Markenson D, Neish S, et al. Response to cardiac arrest and selected life-threatening medical emergencies: the medical emergency response plan for schools: A statement for healthcare providers, policymakers, school administrators, and community leaders. Circulation 2004; 109:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/68\">",
"      Lotfi K, White L, Rea T, et al. Cardiac arrest in schools. Circulation 2007; 116:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/69\">",
"      Becker L, Gold LS, Eisenberg M, et al. Ventricular fibrillation in King County, Washington: a 30-year perspective. Resuscitation 2008; 79:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/70\">",
"      Bardy GH, Lee KL, Mark DB, et al. Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med 2008; 358:1793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/71\">",
"      Chan PS, Krumholz HM, Nichol G, et al. Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med 2008; 358:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/72\">",
"      Friedman FD, Dowler K, Link MS. A public access defibrillation programme in non-inpatient hospital areas. Resuscitation 2006; 69:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/73\">",
"      Gombotz H, Weh B, Mitterndorfer W, Rehak P. In-hospital cardiac resuscitation outside the ICU by nursing staff equipped with automated external defibrillators--the first 500 cases. Resuscitation 2006; 70:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/74\">",
"      Chan PS, Krumholz HM, Spertus JA, et al. Automated external defibrillators and survival after in-hospital cardiac arrest. JAMA 2010; 304:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/75\">",
"      Weil MH, Fries M. In-hospital cardiac arrest. Crit Care Med 2005; 33:2825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/76\">",
"      Li Y, Bisera J, Tang W, Weil MH. Automated detection of ventricular fibrillation to guide cardiopulmonary resuscitation. Crit Pathw Cardiol 2007; 6:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/77\">",
"      Berger RD, Palazzolo J, Halperin H. Rhythm discrimination during uninterrupted CPR using motion artifact reduction system. Resuscitation 2007; 75:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/78\">",
"      Callaway CW, Menegazzi JJ. Waveform analysis of ventricular fibrillation to predict defibrillation. Curr Opin Crit Care 2005; 11:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/79\">",
"      Eftest&oslash;l T, Wik L, Sunde K, Steen PA. Effects of cardiopulmonary resuscitation on predictors of ventricular fibrillation defibrillation success during out-of-hospital cardiac arrest. Circulation 2004; 110:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25208/abstract/80\">",
"      Eisenberg MS. Is it time for over-the-counter defibrillators? JAMA 2000; 284:1435.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1042 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-109.224.62.197-C12E3FDE9F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25208=[""].join("\n");
var outline_f24_39_25208=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      AED TECHNOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Development of the AED",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      AED training",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      AED operation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Pad placement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Other features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      AED ALLOCATION STRATEGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Emergency medical services AED programs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Police AED programs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Public access defibrillation programs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      AEDs for use in private homes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      In-hospital AED allocation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      AED CHALLENGES AND OPPORTUNITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1042\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1042|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/13/10448\" title=\"figure 1\">",
"      Anterior and lateral defib pad placement",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/25/36248?source=related_link\">",
"      Basic life support (BLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/35/17977?source=related_link\">",
"      Basic principles and technique of cardioversion and defibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11050?source=related_link\">",
"      Cardioversion for specific arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24362?source=related_link\">",
"      General principles of the implantable cardioverter-defibrillator",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30041?source=related_link\">",
"      Outcome of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/55/890?source=related_link\">",
"      Overview of sudden cardiac arrest and sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/24/8585?source=related_link\">",
"      Supportive data for advanced cardiac life support in adults with sudden cardiac arrest",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_39_25209="Criteria for the diagnosis of acute myocardial infarction";
var content_f24_39_25209=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Criteria for the diagnosis of acute myocardial infarction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25209/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25209/contributors\">",
"     Guy S Reeder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25209/contributors\">",
"     Harold L Kennedy, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25209/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25209/contributors\">",
"     Christopher P Cannon, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25209/contributors\">",
"     James Hoekstra, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25209/contributors\">",
"     Allan S Jaffe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25209/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25209/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/39/25209/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial infarction (MI) is defined as a clinical (or pathologic) event caused by myocardial ischemia in which there is evidence of myocardial injury or necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Criteria are met when there is a rise",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fall of cardiac biomarkers, along with supportive evidence in the form of typical symptoms, suggestive electrocardiographic changes, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormality.",
"   </p>",
"   <p>",
"    Initial care of the patient with suspected acute myocardial infarction (MI) should include the early and simultaneous achievement of four goals:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Confirmation of the diagnosis by electrocardiogram (ECG) and biomarker measurement",
"     </li>",
"     <li>",
"      Relief of ischemic pain",
"     </li>",
"     <li>",
"      Assessment of the hemodynamic state and correction of abnormalities that may be present",
"     </li>",
"     <li>",
"      Initiation of antithrombotic and reperfusion therapy if indicated",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The management of patients with an ST segment elevation (Q wave) MI or non-ST segment elevation acute coronary syndrome (ACS) is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=see_link\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A related issue is the evaluation of a patient who presents with chest pain suggestive of an ACS in whom the initial evaluation (ECG, cardiac enzymes) is not diagnostic. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H27#H27\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Observation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Acute coronary syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term acute coronary syndrome (ACS) is applied to patients in whom there is a suspicion of myocardial ischemia. There are three types of ACS: ST elevation (formerly Q-wave) MI (STEMI), non-ST elevation (formerly non-Q wave) MI (NSTEMI), and unstable angina (UA). The first two are characterized by a typical rise",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fall in biomarkers of myocyte injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two multicenter, international surveys published in 2002 - the Euro Heart Survey and the GRACE registry - determined the relative frequency of these disorders in approximately 22,000 patients admitted with an ACS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. STEMI occurred in 30 to 33 percent, NSTEMI in 25 percent, and UA in 38 to 42 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Acute MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;For many years, the diagnosis of acute MI relied on the revised criteria established by the World Health Organization (WHO) in 1979 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/6\">",
"     6",
"    </a>",
"    ]. These criteria were epidemiological and aimed at specificity. A joint European Society of Cardiology (ESC) and American College of Cardiology (ACC) committee proposed a more clinically based definition of an acute, evolving, or recent MI in 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/1\">",
"     1",
"    </a>",
"    ]. In 2007 the Joint Task Force of the European Society of Cardiology, American College of Cardiology Foundation, the American Heart Association, and the World Health Federation",
"    <span class=\"nowrap\">",
"     (ESC/ACCF/AHA/WHF)",
"    </span>",
"    refined the 2000 criteria and defined acute MI as a clinical event consequent to the death of cardiac myocytes (myocardial necrosis) that is caused by ischemia (as opposed to other etiologies such as myocarditis or trauma) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/2\">",
"     2",
"    </a>",
"    ]. This definition was not fundamentally changed in the third universal definition of MI released in 2012 by the",
"    <span class=\"nowrap\">",
"     ESC/ACCF/AHA/WHF",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    According to the third universal definition, any one of the following criteria meets the diagnosis of MI:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Detection of a rise",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      fall of cardiac biomarker values (preferably cTn with at least one value above the 99",
"      <sup>",
"       th",
"      </sup>",
"      percentile upper reference limit [URL]) and with at least one of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Symptoms of ischemia",
"     </li>",
"     <li>",
"      Development of pathologic Q waves in the ECG",
"     </li>",
"     <li>",
"      New or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB)",
"     </li>",
"     <li>",
"      Identification of an intracoronary thrombus by angiography or autopsy",
"     </li>",
"     <li>",
"      Imaging evidence of new loss of viable myocardium or a new regional wall motion abnormality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac death with symptoms suggestive of myocardial ischemia and presumed new ischemia ECG changes or new LBBB, but death occurred before cardiac biomarkers were obtained, or before cardiac biomarker values would be increased.",
"     </li>",
"     <li>",
"      PCI related MI was defined by elevation of biomarker values (cTn is preferred) &gt;5 x 99",
"      <sup>",
"       th",
"      </sup>",
"      percentile upper reference limit [URL]) in patients with normal baseline values (&lt;99",
"      <sup>",
"       th",
"      </sup>",
"      percentile URL) or a rise of values &gt;20 percent if the baseline values are elevated and are stable or falling. In addition, either (i) symptoms suggestive of myocardial ischemia, or (ii) new ischemic ECG changes or new LBBB, or (iii) angiographic loss of patency of a major coronary artery or a side branch or persistent slow- or no-flow or embolization, or (iv) imaging demonstration of new loss of viable myocardium or new regional wall motion abnormality are required.",
"     </li>",
"     <li>",
"      Stent thrombosis associated with MI when detected by coronary angiography or autopsy in the setting of myocardial ischemia and with a rise",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      fall of cardiac biomarkers with at least one value above the 99",
"      <sup>",
"       th",
"      </sup>",
"      percentile",
"     </li>",
"     <li>",
"      Coronary artery bypass graft surgery (CABG) associated MI was defined by elevation",
"      <sup>",
"      </sup>",
"      of cardiac biomarker values &gt;10 x 99",
"      <sup>",
"       th",
"      </sup>",
"      percentile URL in patients with normal baseline cTn values. In addition, either (i) new pathologic Q waves or new LBBB, or (ii) angiographic documented new graft of native coronary artery occlusion, or (iii) imaging evidence of new loss of viable myocardium or new regional wall motion abnormality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The joint task force further refined the definition of MI by developing a clinical classification according to the assumed proximate cause of the myocardial ischemia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type 1 (spontaneous MI): MI consequent to a pathologic process in the wall of the coronary artery (eg, plaque",
"      <span class=\"nowrap\">",
"       erosion/rupture,",
"      </span>",
"      fissuring, or dissection), resulting in intraluminal thrombus",
"     </li>",
"     <li>",
"      Type 2 (MI secondary to an ischemic imbalance): MI consequent to increased oxygen demand or decreased supply (eg, coronary endothelial dysfunction, coronary artery spasm, coronary artery embolus, anemia,",
"      <span class=\"nowrap\">",
"       tachy-/brady-arrhythmias,",
"      </span>",
"      anemia, respiratory failure, hypertension or hypotension)",
"     </li>",
"     <li>",
"      Type 3 (MI resulting in death when biomarker values are unavailable): Sudden unexpected cardiac death before blood samples for biomarkers could be drawn or before their appearance in the blood",
"     </li>",
"     <li>",
"      Type 4a (MI related to PCI): See criteria directly above.",
"     </li>",
"     <li>",
"      Type 4b (MI related to stent thrombosis): See criteria directly above.",
"     </li>",
"     <li>",
"      Type 5 (MI related to CABG): See criteria directly above.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Unstable angina",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unstable angina (UA) is considered to be present in patients with ischemic symptoms suggestive of an ACS without elevation in biomarkers with or without ECG changes indicative of ischemia. Due to the insensitivity of CK-MB compared to troponin, one must be circumspect if that is the only biomarker available. Elevations of troponin with contemporary assays probably take two to three hours, while elevations for CK-MB take longer. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Cardiac biomarkers'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    UA and NSTEMI are frequently indistinguishable at initial evaluation. ST segment",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    T wave changes are often persistent in NSTEMI while, if they occur in UA, they are usually transient. Regardless, of the category, ST segment change defines a higher-risk group [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107850186\">",
"    <span class=\"h2\">",
"     After revascularization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following revascularization with either coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention (PCI) cardiac biomarkers may rise. Transient elevations in troponins may represent necrosis, although the mechanism is unknown. Higher elevations are associated with worse prognosis after CABG. A discussion of MI following PCI is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39737?source=see_link\">",
"     \"Periprocedural myocardial infarction following percutaneous coronary intervention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Joint",
"    <span class=\"nowrap\">",
"     ESC/ACCF/AHA/WHF",
"    </span>",
"    Task Force for the Redefinition of Myocardial Infarction addressed the issue of biomarker rise after revascularization procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/7\">",
"     7",
"    </a>",
"    ]. They state that for patients undergoing PCI who have normal baseline troponin value (99",
"    <sup>",
"     th",
"    </sup>",
"    percentile URL) is mandatory in order to use the definition below. If the baseline value is elevated or rising, it is impossible to tell if elevations postprocedure are related to the initial insult or to additional injury. However, they also state that if the troponin values are stable or falling before revascularization, the use of the reinfarction criteria may be reasonable. We also believe it is reasonable to obtain a troponin prior and proximate (within six hours at the outside) to PCI (baseline value). (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Recommended approach'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    No criteria have been established to separate expected rises (such as needle trauma to the myocardium at CABG) from those that represent a complication of the procedure (such as unexpected coronary artery dissection due to wire trauma at PCI) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/9\">",
"     9",
"    </a>",
"    ]. In addition, the cut points given below are controversial.",
"   </p>",
"   <p>",
"    The specific criteria for meeting the definition of MI in the setting of PCI or CABG are presented above. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Acute MI'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Prior MI",
"    </span>",
"   </p>",
"   <p>",
"    According to the third universal definition of MI, any one of the following three criteria satisfies the diagnosis for a prior (established) MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pathologic Q waves (&ge;0.04 sec) with or without symptoms in the absence of non-ischemic causes.",
"     </li>",
"     <li>",
"      Pathologic findings of a healed or healing MI.",
"     </li>",
"     <li>",
"      Evidence from an imaging study of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a nonischemic cause. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=see_link&amp;anchor=H2#H2\">",
"       \"Role of echocardiography in acute myocardial infarction\", section on 'Diagnosis of MI'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;For a patient presenting with a suspected acute MI, the characteristics of the chest pain and the ECG findings permit initial risk stratification. An ECG and an abbreviated history and physical examination should be obtained within 10 minutes of patient arrival [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/10\">",
"     10",
"    </a>",
"    ]. Other steps in the immediate management of patients suspected of an acute MI are discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H3#H3\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Immediate ED interventions'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The history should be targeted toward pain duration, character, similarity to possible previous episodes, provoking factors, and past history of coronary disease risk factors. The physical examination (including auscultation of the heart and lungs, measurement of blood pressure in both arms, and assessment for heart failure or circulatory compromise, which are associated with a high early mortality).",
"   </p>",
"   <p>",
"    Patients with a strong clinical history and ST segment elevation or new left bundle branch block should be assumed to have an acute MI and undergo immediate reperfusion therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/31/37369?source=see_link\">",
"     \"Selecting a reperfusion strategy for acute ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    \"Ruling in\" an acute MI with newer troponin assays occurs in 80 percent of patients by two to three hours after presentation; \"ruling out\" may take longer (up to six hours) (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Cardiac biomarkers'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CHEST PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;While chest pain is not required for the diagnosis of MI, its presence, particularly if characteristic for myocardial ischemia, may influence decision making about the likelihood of the presence of MI (",
"    <a class=\"graphic graphic_table graphicRef59572 \" href=\"UTD.htm?14/52/15179\">",
"     table 1",
"    </a>",
"    ). A discussion of the characteristic of ischemic chest pain is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34042?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnostic approach to chest pain in adults\", section on 'Description of chest pain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Present",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with chest pain characteristic of myocardial ischemia (angina pectoris), there are three primary presentations that suggest a change in the anginal pattern as ACS as opposed to stable or exertional angina [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rest angina, which is usually more than 20 minutes in duration",
"     </li>",
"     <li>",
"      New onset angina that markedly limits physical activity",
"     </li>",
"     <li>",
"      Increasing angina that is more frequent, longer in duration, or occurs with less exertion than previous angina",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Absent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients without features of typical angina are more likely to have another cause of chest pain. Common causes include other cardiovascular, pulmonary, and gastrointestinal disorders (",
"    <a class=\"graphic graphic_table graphicRef53227 \" href=\"UTD.htm?12/43/12989\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34042?source=see_link\">",
"     \"Diagnostic approach to chest pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/0/26634?source=see_link\">",
"     \"Differential diagnosis of chest pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a review of over 430,000 patients with confirmed acute MI from the National Registry of Myocardial Infarction 2, one-third had no chest pain on presentation to the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/11\">",
"     11",
"    </a>",
"    ]. These patients may present with dyspnea alone, nausea",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vomiting, palpitations, syncope, or cardiac arrest. They are more likely to be older, diabetic, and women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/9/41113?source=see_link\">",
"     \"Clinical features and diagnosis of coronary heart disease in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The absence of chest pain has important implications for therapy and prognosis. In the Registry report, patients without chest pain were much less likely to be diagnosed with a confirmed MI on admission (22 versus 50 percent in those with chest pain) and were less likely to be treated with appropriate medical therapy and to receive fibrinolytic therapy or primary angioplasty (25 versus 74 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/11\">",
"     11",
"    </a>",
"    ]. Not surprisingly, these differences were associated with an increase in in-hospital mortality (23.3 versus 9.3 percent, adjusted odds ratio 2.21, 95 percent confidence interval 2.17 to 2.26).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ECG",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiogram (ECG) is a mainstay in the initial diagnosis of patients with suspected ACS. It allows initial categorization of the patient with a suspected MI into one of three groups based on the pattern:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      ST elevation MI (ST elevation or new left bundle branch block)",
"     </li>",
"     <li>",
"      non-ST elevation ACS, with either NSTEMI or UA (ST-depression, T wave inversions, or transient ST-elevation)",
"     </li>",
"     <li>",
"      Undifferentiated chest pain syndrome (nondiagnostic ECG)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2004",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guideline on ST myocardial infarction (and the 2007 focused update) concluded that it is reasonable for emergency medical service (EMS) personnel with advanced cardiac life support training to perform and evaluate a 12-lead ECG on a patient suspected of having an acute MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/10,12\">",
"     10,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     ST elevation MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with acute ST elevation MI, the electrocardiogram evolves through a typical sequence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9317?source=see_link\">",
"     \"ECG tutorial: Myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although not frequently seen, the earliest change in an STEMI is the development of a hyperacute or peaked T wave that reflects localized hyperkalemia. Thereafter, the ST segment elevates in the leads recording electrical activity of the involved region of the myocardium; it has the following appearance:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initially, there is elevation of the J point and the ST segment retains its concave configuration.",
"     </li>",
"     <li>",
"      Over time, the ST segment elevation becomes more pronounced and the ST segment becomes more convex or rounded upward.",
"     </li>",
"     <li>",
"      The ST segment may eventually become indistinguishable from the T wave; the QRS-T complex can actually resemble a monophasic action potential.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The joint",
"    <span class=\"nowrap\">",
"     ESC/ACCF/AHA/WHF",
"    </span>",
"    committee for the definition of MI established specific ECG criteria for the diagnosis of ST elevation MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/7,13\">",
"     7,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      New ST segment elevation at the J point in two contiguous leads with the cut-points: &gt;0.1 mV in all leads other than leads V2-V3;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For leads V2-V3, the following cut points apply: &ge;0.2 mV in men &ge;40 years, &ge;0.25 mV in men &lt;40 years, or &ge;0.15 mV in women.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Over time there is further evolution of these ECG changes; the ST segment gradually returns to the isoelectric baseline, the R wave amplitude becomes markedly reduced, and the Q wave deepens. In addition, the T wave becomes inverted. These changes generally occur within the first two weeks after the event, but may progress more rapidly, within several hours of presentation.",
"   </p>",
"   <p>",
"    In addition to patients with ST elevation on the ECG, two other groups of patients with an acute coronary syndrome are considered to have an STEMI: those with new or presumably new left bundle branch block and those with a true posterior MI. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Bundle branch block or paced rhythm'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link&amp;anchor=H11#H11\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\", section on 'Posterior wall MI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A separate issue, the assessment of patients with a suspected acute MI who have known left bundle branch block or a paced rhythm, is discussed below. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Bundle branch block or paced rhythm'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Absence of Q waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;A subset of patients who present with initial ST segment elevation, do not develop Q waves. These patients are treated for an ST elevation MI. Such patients have a better prognosis than those who develop Q waves because of more frequent reperfusion, a less severe infarction, and, at follow-up, better left ventricular function and improved survival. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/26/4521?source=see_link&amp;anchor=H10#H10\">",
"     \"Electrocardiogram in the prognosis of myocardial infarction or unstable angina\", section on 'Presence or absence of new Q waves'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Localization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiogram can be used to localize the MI, and at times, predict the infarct-related artery. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If there is electrocardiographic evidence of inferior wall ischemia (ST or T wave changes in leads II, III, and aVF), the right-sided leads V4R, V5R, and V6R should also be obtained to evaluate the possibility of right ventricular infarction. The recording of right-sided leads in this setting was given a class I recommendation by the 2004",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    task force [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/10\">",
"     10",
"    </a>",
"    ]. No changes to this approach were made in the 2007 focused update of the 2004",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines for the management of patients with ST-elevation MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/12\">",
"     12",
"    </a>",
"    ]. Posterior leads (V7-9) are also indicated for those who present with ST segment depression in the inferior leads to evaluate the possibility of posterior infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other causes of ST elevation and Q waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although ST segment elevation and Q waves are consistent with acute MI (particularly if new), each alone can be seen in other disorders (",
"    <a class=\"graphic graphic_table graphicRef81757 \" href=\"UTD.htm?38/35/39483\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef58569 \" href=\"UTD.htm?35/15/36091\">",
"     table 4",
"    </a>",
"    ). As examples, ST segment elevation can occur in myocarditis, acute pericarditis, patients with old MI and persistent ST segment elevation often associated with wall motion abnormalities, and with the early repolarization variant, and Q waves can be seen in hypertrophic cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/0/36868?source=see_link\">",
"     \"Pathogenesis and diagnosis of Q waves on the electrocardiogram\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Non-ST elevation ACS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A non-ST elevation ACS is manifested by ST depressions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    T wave inversions without ST segment elevations or pathologic Q waves. These ST-T wave abnormalities may be present diffusely in many leads; more commonly they are localized to the leads associated with the region of ischemic myocardium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, the two forms of non-ST elevation ACS (UA and NSTEMI) are frequently indistinguishable at initial evaluation (prior to biomarker elevation). In a patient with an NSTEMI, ST segment depressions usually evolve over the subsequent few days to result in residual ST segment depression and T wave inversions, but not to the formation of pathologic Q waves. In a patient with UA, ST segment and T wave changes usually resolve completely.",
"   </p>",
"   <p>",
"    The joint",
"    <span class=\"nowrap\">",
"     ESC/ACCF/AHA/WHF",
"    </span>",
"    committee for the definition of MI established specific ECG criteria for the diagnosis of non-ST elevation MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/7,13\">",
"     7,13",
"    </a>",
"    ]: new horizontal or down-sloping ST depression &ge;0.05 mV in two contiguous leads",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    T inversion &ge;0.1 mV in two contiguous leads with prominent R wave or",
"    <span class=\"nowrap\">",
"     R/S",
"    </span>",
"    ratio &gt;1.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Nondiagnostic initial ECG",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial ECG is often not diagnostic in patients with MI. In two series, for example, the initial ECG was not diagnostic in 45 percent and normal in 20 percent of patients subsequently shown to have an acute MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. In patients clinically suspected of having an acute MI in whom the ECG is nondiagnostic, it is recommended that the ECG should be repeated at 20 to 30 minute intervals for any patient with ongoing pain in whom the suspicion of ACS remains high. In some patients, initially nondiagnostic electrocardiographic changes will evolve into ST elevation or ST depression [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/15,17\">",
"     15,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of repeated ECGs was addressed in a study of 1000 patients presenting to the emergency department with chest pain in whom serial ECGs were obtained every 20 minutes for an average of two hours. Serial ECGs were equally specific (95 percent) but more sensitive than an initial single ECG for detecting an acute MI (68 versus 55 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Bundle branch block or paced rhythm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both left bundle branch block (LBBB), which is present in approximately 7 percent of patients with an acute MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/18\">",
"     18",
"    </a>",
"    ], and pacing can interfere with the electrocardiographic diagnosis of MI or coronary ischemia. Of note, approximately one-half of patients with LBBB and an acute MI do not have chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/19\">",
"     19",
"    </a>",
"    ]. New right bundle branch block, while generally not interfering with the electrocardiographic diagnosis of STEMI, connotes an adverse prognosis similar in degree to LBBB.",
"   </p>",
"   <p>",
"    Patients with LBBB, compared to those without bundle branch block, are much less likely to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , beta blockers, and reperfusion therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], particularly if they present without chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/19\">",
"     19",
"    </a>",
"    ]. Similar observations have been made in patients with a paced rhythm [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Careful evaluation of the ECG may show some evidence of coronary ischemia in patients with LBBB or a paced rhythm. However, the clinical history and cardiac enzymes are of primary importance in diagnosing MI in this setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9431?source=see_link\">",
"     \"Electrocardiographic diagnosis of myocardial infarction in the presence of bundle branch block or a paced rhythm\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     CARDIAC BIOMARKERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of biomarkers have been used to evaluate patients with a suspected acute MI. The cardiac troponins I and T as well as the MB isoenzyme of creatine kinase (CK-MB) are the most frequently used.",
"   </p>",
"   <p>",
"    The use of these tests is discussed in detail elsewhere, but the general principles will be briefly reviewed here. Values &ge;99 percentile of the upper reference limit (URL) should be considered abnormal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/2\">",
"     2",
"    </a>",
"    ]. This value for troponin and CK-MB will vary depending on the assay used. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following discussion will emphasize the diagnostic role of cardiac markers. These markers as well as many other factors are important for risk stratification. These issues for both ST elevation and non-ST elevation MI are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35658?source=see_link\">",
"     \"Risk stratification for cardiac events after acute ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/43/2746?source=see_link\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25754?source=see_link\">",
"     \"Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An elevation in the concentration of troponin or CK-MB is required for the diagnosis of acute MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. If both are measured and the troponin value is normal but the CK-MB is elevated, MB is likely due to release from noncardiac tissue. Follow-up on such individuals reveals that they do extremely well without subsequent events [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Troponin is the preferred marker for the diagnosis of myocardial injury for all diagnostic categories because of their increased specificity and better sensitivity compared to CK-MB [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/1,2,10\">",
"     1,2,10",
"    </a>",
"    ]. However, an elevation in cardiac troponins must be interpreted in the context of the clinical history and ECG findings since it can be seen in a variety of clinical settings and is therefore not specific for an acute coronary syndrome. The new guidelines endorse the concept that if there are elevations of cTn in a situation where ischemia is not present that term cardiac injury should be used. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Other causes of biomarker elevation'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/30/2537?source=see_link\">",
"     \"Elevated cardiac troponin concentration in the absence of an acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As there can be chronic elevations of troponin in patients who do not have acute events, the guidelines emphasize the need for a changing pattern of values [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/1,2,22\">",
"     1,2,22",
"    </a>",
"    ]. The magnitude of change needed to operationalize this recommendation varies from assay to assay, so it is optimal when the clinical laboratory helps to make these distinctions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three points should be kept in mind when using troponin to diagnose AMI:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With contemporary troponin assays, most patients can be diagnosed within two to three hours of presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A negative test at the time of presentation, especially if the patient presents early after the onset of symptoms, does not exclude myocardial injury.",
"     </li>",
"     <li>",
"      AMI can be excluded in most patients by six hours, but the guidelines suggest that, if there is a high degree of suspicion of an ACS, a 12-hour sample be obtained. [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/1,2,10\">",
"       1,2,10",
"      </a>",
"      ]. However, very few patients become positive after eight hours [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Other causes of biomarker elevation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevations of biochemical markers diagnose cardiac injury, not infarction due to coronary artery obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/26\">",
"     26",
"    </a>",
"    ]. If an ischemic mechanism of injury is present, for example, as indicated by ischemic ECG changes, then an ACS is diagnosed.",
"   </p>",
"   <p>",
"    Otherwise, other mechanisms for cardiac injury must be considered (eg, heart failure, rapid atrial fibrillation, myocarditis, anthracycline cardiotoxicity, subendocardial wall stress, myopericarditis, sepsis, etc). As an example, small amounts of cardiac injury can occur in critically ill patients, which may or may not represent an AMI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Troponin elevations also occur in chronic kidney disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/30/2537?source=see_link\">",
"     \"Elevated cardiac troponin concentration in the absence of an acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the emergency department setting, life-threatening causes of chest pain with troponin elevation not due to coronary artery disease are acute pulmonary embolism, in which troponin release may result from acute right heart overload, myocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/26\">",
"     26",
"    </a>",
"    ], and stress-induced cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"     \"Diagnosis of acute pulmonary embolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Absence of biomarker elevation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Using older assays, some patients with STEMI who were rapidly reperfused did not develop a cardiac biomarker elevation. These patients were called \"aborted MIs.\" With contemporary troponin assays, this does not occur or is extremely rare. For example, in an analysis of 767 patients with STEMI, the frequency of patients who had elevations of troponin above the 99th percent value was 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/29\">",
"     29",
"    </a>",
"    ]. For patients with ST elevation on the electrocardiogram and no biomarker elevation one of the other causes of ST elevation should be considered (",
"    <a class=\"graphic graphic_table graphicRef81757 \" href=\"UTD.htm?38/35/39483\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Other causes of ST elevation and Q waves'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/43/1721?source=see_link&amp;anchor=H1#H1\">",
"     \"Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Discordant cardiac enzymes biomarkers",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least one third of patients with an ACS have elevated troponins but normal CK-MB [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/21,30-32\">",
"     21,30-32",
"    </a>",
"    ]. The frequency and prognostic significance of discordant troponin and CK-MB were illustrated in a review of almost 30,000 such patients from the multicenter CRUSADE initiative in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/32\">",
"     32",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The results were discordant in 28 percent of patients despite the fact that many centers were still using either high cut-off values or inadequately sensitive troponin assays. Troponin was more sensitive, as 18 percent had elevated troponin but normal CK-MB values. In addition, 10 percent had false positive CK-MB elevations, as defined by normal troponin values.",
"     </li>",
"     <li>",
"      Compared to patients who were negative for both biomarkers, in-hospital mortality was not increased in patients who were Tn-negative and CK-MB-positive (ie, false positives; 3.0 versus 2.7 percent, adjusted odds ratio 1.02, 95% CI 0.75-1.38).",
"     </li>",
"     <li>",
"      Compared to patients who were negative for both biomarkers, there was a nonsignificant trend toward increased mortality in patients who were",
"      <span class=\"nowrap\">",
"       cTn-positive/CK-MB-negative",
"      </span>",
"      (4.5 versus 2.7 percent, adjusted odds ratio 1.15, 95 percent CI 0.86-1.54) and a significant increase in mortality in patients who were positive for both biomarkers (5.9 versus 2.7 percent, adjusted odds ratio 1.53, 95 percent CI 1.18-1.98). The latter finding reflects the fact that patients with larger insults do worse [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/33\">",
"       33",
"      </a>",
"      ]. The two discordant groups were treated similarly with antithrombotic agents and percutaneous coronary intervention so differences in outcomes are less likely to be explained by differences in therapy. Thus, an isolated CK-MB elevation has limited prognostic value in patients with a non-ST elevation ACS. Several meta-analyses suggest that patients with isolated troponin elevations do much worse than those without elevations [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. If high cut-off values are used, these effects are obfuscated by the admixture of patients with and without real troponin elevations.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar findings were noted among 1825 patients with a non-ST elevation ACS in the TACTICS-TIMI 18 trial in whom troponin T was measured; 668 (37 percent) had elevated CK-MB, almost all of whom had elevated troponin T, while 361 patients (20 percent) had an elevated troponin T with normal CK-MB [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/31\">",
"     31",
"    </a>",
"    ]. The latter patients the greatest benefit from an early invasive strategy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=see_link\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Recommended approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following general statements apply to the biochemical diagnosis of an acute MI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Troponins are the markers of choice and should be used instead of CK-MB except when post-procedural MI, where CK-MB may be more useful [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link&amp;anchor=H8#H8\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\", section on 'Late diagnosis and reinfarction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We recommend the following approach [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measure serum troponin-I or troponin-T at first presentation.",
"     </li>",
"     <li>",
"      If the troponin is not elevated, repeat at six to nine hours. It is not uncommon to measure a second troponin earlier than six hours in patients who are highly suspected of having ongoing NSTEMI, since 80 percent of patients who rule in will do so in two to three hours [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/24\">",
"       24",
"      </a>",
"      ]. In an occasional patient in whom the index of suspicion for acute MI is high, but the first two troponin measurements are not elevated, a repeat measurement at 12 to 24 hours may be necessary.",
"     </li>",
"     <li>",
"      CK-MB is measured when a troponin assay is not available. Previously, CK-MB was advocated to help diagnose reinfarction, but now troponin has subsumed that role [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/2\">",
"       2",
"      </a>",
"      ]. Reinfarction is diagnosed if there is a &ge;20 percent increase of the value in the second sample [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Troponin elevations persist for one to two weeks after AMI, but values are usually not rising or falling rapidly at this time, allowing one to distinguish acute from more chronic events [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25209/abstract/2,22\">",
"       2,22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/16/40195?source=see_link\">",
"       \"Patient information: Heart attack (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial infarction (MI) is defined as a clinical (or pathologic) event caused by myocardial ischemia in which there is evidence of myocardial injury or necrosis. Criteria are met when there is a rise",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fall of cardiac biomarkers, along with supportive evidence in the form of typical symptoms, suggestive electrocardiographic changes, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The criteria used to define MI differ somewhat depending upon the particular clinical circumstance of the patient: those suspected of acute MI based upon their presentation; those undergoing either coronary artery bypass graft surgery or percutaneous intervention; or those who have sustained sudden, unexpected cardiac arrest with or without death. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Definitions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We recommend the following approach to diagnose an acute MI (excluding patients who have just undergone revascularization):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An ECG, an abbreviated history (which focuses on the chest pain), and physical examination should be obtained within 10 minutes of patient arrival. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'ECG'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Chest pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measure serum troponin-I or troponin-T at first presentation. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Cardiac biomarkers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the serum troponin is not elevated, repeat at six to nine hours. It is not uncommon to measure a second troponin earlier than six hours in patients who are highly suspected of having ongoing NSTEMI. In an occasional patient in whom the index of suspicion for acute MI is high but the first two troponin measurements are not elevated, a repeat measurement at 12 to 24 hours may be necessary. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Cardiac biomarkers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measure serum creatine kinase-MB (CK-MB) when a troponin assay is not available. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Cardiac biomarkers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who have undergone recent revascularization with either percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG), we suggest measurement of troponin after the procedure. In order to diagnose myocardial infarction resulting from either PCI or CABG, the baseline troponin has to have been normal, and thus a troponin should be ordered prior to all revascularization procedures. (See",
"      <a class=\"local\" href=\"#H107850186\">",
"       'After revascularization'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/1\">",
"      Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/2\">",
"      Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28:2525.",
"     </a>",
"    </li>",
"    <li>",
"     Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College or Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:e1 www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/4\">",
"      Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/5\">",
"      Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002; 23:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/6\">",
"      Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979; 59:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/7\">",
"      Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012; 126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/8\">",
"      Cannon CP, McCabe CH, Stone PH, et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 1997; 30:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/9\">",
"      Pierpont GL, McFalls EO. Interpreting troponin elevations: do we need multiple diagnoses? Eur Heart J 2009; 30:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/10\">",
"      Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110:e82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/11\">",
"      Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000; 283:3223.",
"     </a>",
"    </li>",
"    <li>",
"     www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007). www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/13\">",
"      Colaco R, Reay P, Beckett C, et al. False positive ECG reports of anterior myocardial infarction in women. J Electrocardiol 2000; 33 Suppl:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/14\">",
"      Kulkarni AU, Brown R, Ayoubi M, Banka VS. Clinical use of posterior electrocardiographic leads: a prospective electrocardiographic analysis during coronary occlusion. Am Heart J 1996; 131:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/15\">",
"      Fesmire FM, Percy RF, Bardoner JB, et al. Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain. Ann Emerg Med 1998; 31:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/16\">",
"      Pope JH, Ruthazer R, Beshansky JR, et al. Clinical Features of Emergency Department Patients Presenting with Symptoms Suggestive of Acute Cardiac Ischemia: A Multicenter Study. J Thromb Thrombolysis 1998; 6:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/17\">",
"      Kudenchuk PJ, Maynard C, Cobb LA, et al. Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) Project. J Am Coll Cardiol 1998; 32:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/18\">",
"      Go AS, Barron HV, Rundle AC, et al. Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. Ann Intern Med 1998; 129:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/19\">",
"      Shlipak MG, Go AS, Frederick PD, et al. Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators. J Am Coll Cardiol 2000; 36:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/20\">",
"      Rathore SS, Weinfurt KP, Gersh BJ, et al. Treatment of patients with myocardial infarction who present with a paced rhythm. Ann Intern Med 2001; 134:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/21\">",
"      Goodman SG, Steg PG, Eagle KA, et al. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006; 151:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/22\">",
"      Jaffe AS. Chasing troponin: how low can you go if you can see the rise? J Am Coll Cardiol 2006; 48:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/23\">",
"      Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010; 31:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/24\">",
"      Macrae AR, Kavsak PA, Lustig V, et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clin Chem 2006; 52:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/25\">",
"      Newby LK, Christenson RH, Ohman EM, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 1998; 98:1853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/26\">",
"      Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006; 48:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/27\">",
"      Guest TM, Ramanathan AV, Tuteur PG, et al. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 1995; 273:1945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/28\">",
"      Babuin L, Vasile VC, Rio Perez JA, et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med 2008; 36:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/29\">",
"      Vasile VC, Babuin L, Ting HH, et al. Aborted myocardial infarction: is it real in the troponin era? Am Heart J 2009; 157:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/30\">",
"      Meier MA, Al-Badr WH, Cooper JV, et al. The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med 2002; 162:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/31\">",
"      Kleiman NS, Lakkis N, Cannon CP, et al. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 2002; 40:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/32\">",
"      Newby LK, Roe MT, Chen AY, et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol 2006; 47:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/33\">",
"      Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/34\">",
"      Ottani F, Galvani M, Nicolini FA, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000; 140:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25209/abstract/35\">",
"      Heidenreich PA, Alloggiamento T, Melsop K, et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001; 38:478.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 52 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-B2700F0D78-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25209=[""].join("\n");
var outline_f24_39_25209=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Acute MI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Unstable angina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H107850186\">",
"      After revascularization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Prior MI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CHEST PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Present",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Absent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ST elevation MI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Absence of Q waves",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Localization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other causes of ST elevation and Q waves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Non-ST elevation ACS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Nondiagnostic initial ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Bundle branch block or paced rhythm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      CARDIAC BIOMARKERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Other causes of biomarker elevation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Absence of biomarker elevation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Discordant cardiac enzymes biomarkers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Recommended approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/52\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/52|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/52/15179\" title=\"table 1\">",
"      Definitions angina CASS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/43/12989\" title=\"table 2\">",
"      Other diagnoses chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/35/39483\" title=\"table 3\">",
"      Causes of ST segment elevation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/15/36091\" title=\"table 4\">",
"      Causes of Q waves on the electrocardiogram",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/9/41113?source=related_link\">",
"      Clinical features and diagnosis of coronary heart disease in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=related_link\">",
"      Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34042?source=related_link\">",
"      Diagnostic approach to chest pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/0/26634?source=related_link\">",
"      Differential diagnosis of chest pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9317?source=related_link\">",
"      ECG tutorial: Myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=related_link\">",
"      Electrocardiogram in the diagnosis of myocardial ischemia and infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/26/4521?source=related_link\">",
"      Electrocardiogram in the prognosis of myocardial infarction or unstable angina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9431?source=related_link\">",
"      Electrocardiographic diagnosis of myocardial infarction in the presence of bundle branch block or a paced rhythm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/30/2537?source=related_link\">",
"      Elevated cardiac troponin concentration in the absence of an acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/43/1721?source=related_link\">",
"      Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=related_link\">",
"      Initial evaluation and management of suspected acute coronary syndrome in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=related_link\">",
"      Overview of the acute management of ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=related_link\">",
"      Overview of the acute management of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/0/36868?source=related_link\">",
"      Pathogenesis and diagnosis of Q waves on the electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/16/40195?source=related_link\">",
"      Patient information: Heart attack (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39737?source=related_link\">",
"      Periprocedural myocardial infarction following percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25754?source=related_link\">",
"      Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/43/2746?source=related_link\">",
"      Risk stratification after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35658?source=related_link\">",
"      Risk stratification for cardiac events after acute ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=related_link\">",
"      Role of echocardiography in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/31/37369?source=related_link\">",
"      Selecting a reperfusion strategy for acute ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=related_link\">",
"      Troponins and creatine kinase as biomarkers of cardiac injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_39_25210="Radiologic evaluation of the painful hip in adults";
var content_f24_39_25210=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiologic evaluation of the painful hip in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25210/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25210/contributors\">",
"     Cecilia M Jude, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25210/contributors\">",
"     Shahla Modarresi, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25210/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25210/contributors\">",
"     Robert H Shmerling, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25210/contributors\">",
"     Karl B Fields, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/39/25210/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/39/25210/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/39/25210/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hip is a stable, major weight-bearing joint with significant mobility. Hip pain has different etiologies in adults and children. In adults, hip pain may be caused by intraarticular disorders such as avascular necrosis, arthritis, loose bodies, labral tears; periarticular pathology such as tendinitis and bursitis; or extraarticular conditions such as referred pain from lumbar spine, as well as sacroiliac joint and nerve entrapment syndromes.",
"   </p>",
"   <p>",
"    Imaging modalities used to evaluate adults with hip pain and the appropriateness of particular studies in different clinical scenarios will be reviewed here. The history and physical examination, which are necessary to develop a differential diagnosis prior to the selection of imaging tests, a general review of imaging tests that are used in the evaluation of bone and joint pain, and imaging modalities used to evaluate the hip in children are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=see_link\">",
"     \"Evaluation of the adult with hip pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/7/3193?source=see_link\">",
"     \"Diagnostic imaging of joint pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25097?source=see_link\">",
"     \"Radiologic evaluation of the hip in infants, children, and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TYPES OF IMAGING STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The modalities available for evaluation of the hip include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Plain film radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain film radiography is used in the initial evaluation of any cause of hip pain, including trauma and sports injuries, suspected avascular necrosis, arthritis, hip arthroplasty, infection, dysplasia, and tumor. Plain film can also identify causes of referred hip pain, such as sacroiliitis. Plain film may not detect or accurately characterize some hip fractures and bone marrow edema associated with early avascular necrosis (AVN) or early osteomyelitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Computerized tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computerized tomography (CT) is most useful in the setting of trauma, for preoperative planning, and for evaluation and guiding percutaneous biopsy of tumors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In traumatic injuries, CT is used to detect intraarticular extension of a fracture, acetabular fracture, pelvic ring and sacral fractures, and intraarticular loose bodies.",
"     </li>",
"     <li>",
"      CT is also used for preoperative evaluation of hip fractures, pre- and postoperative evaluation of hip dysplasia, and hip arthroplasty.",
"     </li>",
"     <li>",
"      In the setting of tumor, CT is useful for evaluation of tumor matrix and for detection of cortical thinning or cortical destruction. CT is valuable in guidance for biopsy or ablation of certain tumors such as osteoid osteoma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CT may not detect trabecular bone injuries, which may be present in femoral neck insufficiency fractures in osteoporotic patients, and will not demonstrate the bone marrow edema of early AVN and early osteomyelitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) accurately evaluates the bone marrow, joint space, neurovascular structures, and soft tissues. MRI is the modality of choice for suspected femoral fracture not demonstrated radiographically, osteochondral injuries, muscle injuries, joint effusion, early diagnosis and staging of avascular necrosis, iliopsoas and intertrochanteric bursitis, evaluation of infection, and tumor. More unusual disease entities such as pigmented villonodular synovitis and synovial osteochondromatosis can be diagnosed with MRI. Administration of gadolinium-containing MRI contrast agents should be avoided in patients with severely impaired renal function (eg, estimated glomerular filtration rate &lt;15-30",
"    <span class=\"nowrap\">",
"     mL/min).",
"    </span>",
"   </p>",
"   <p>",
"    If",
"    gadolinium-based imaging must be performed in a patient with moderately to severely impaired renal function, there may be a role for dialysis to reduce the risk of development of nephrogenic systemic fibrosis (NFS). Approaches to prevention of NFS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=see_link&amp;anchor=H24#H24\">",
"     \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\", section on 'If gadolinium must be given'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Radionuclide bone scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radionuclide bone scan is reserved for suspected fracture or avascular necrosis not demonstrated by plain film radiography when MRI is not available or is contraindicated (eg, pacemaker, aneurysm clip). Bone scan is also indicated in the evaluation of metastatic disease, as well as prosthetic device loosening or infection. Radionuclide bone scan surveys a large area; however, it is often nonspecific.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound (US) has low cost, is readily available, allows dynamic evaluation of the tendons and muscles, and does not involve ionizing radiation; however, it is highly operator-dependent. Hip effusions and bursal or periarticular fluid collections are readily identified. US may also be useful for guiding hip aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/1\">",
"     1",
"    </a>",
"    ] and injection of anesthetics and steroids into the hip joint or bursae. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4392?source=see_link\">",
"     \"Musculoskeletal ultrasonography: Clinical applications\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H9\">",
"     'Image-guided injection with anesthetic and/or steroid'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In the appropriate clinical setting, US can be used to identify soft tissue hematoma and partial or complete muscle tears. Another indication for US is dynamic evaluation of the snapping iliopsoas syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Conventional arthrography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The imaging indications for conventional hip arthrography are now limited due to the increased use of magnetic resonance arthrography (MR arthrography), which visualizes joint anatomy, as well as bone and surrounding soft tissues. However, limited conventional arthrography is useful to confirm intraarticular needle placement when hip aspiration is indicated for joint fluid analysis (eg, when septic arthritis or crystal induced synovitis is suspected). Aspiration and arthrography are also warranted when there is clinical suspicion of a prosthetic hip infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Image-guided injection with anesthetic and/or steroid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injection with anesthetic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    steroid under fluoroscopic guidance is reserved for cases when imaging is inconclusive or demonstrates mild osteoarthritis and when referred pain is clinically suspected. Persistent pain, despite the injection of a local anesthetic, reduces the likelihood that hip pathology is the cause of pain and may obviate the need for further diagnostic imaging of the hip [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/3\">",
"     3",
"    </a>",
"    ]. Such injections are usually performed in addition to conventional hip arthrography and aspiration. Therapeutic injection of glucocorticoids into the hip joint can be done for acute and chronic inflammation associated with various arthritides [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Magnetic resonance arthrography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance arthrography (MR arthrography) with intraarticular gadolinium administration best delineates the joint anatomy, including the acetabular labrum, articular cartilage, and ligamentum teres, and detects loose bodies. MR arthrography is used in cases of hip pain that may involve any of the above mentioned structures. Administration of gadolinium-containing MRI contrast agents should be avoided in patients with severely impaired renal function (eg, estimated glomerular filtration rate less than 15 to 30",
"    <span class=\"nowrap\">",
"     mL/min).",
"    </span>",
"    (See",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/15/4341?source=see_link\">",
"     \"Gadoteridol: Drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Computerized tomography arthrography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computerized tomography arthrography (CT arthrography) with intraarticular iodinated contrast is used in cases where the use of MR arthrography is contraindicated (eg pacemaker, aneurysm clip).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     IMAGING STUDIES FOR SPECIFIC CLINICAL SETTINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted in the introduction, radiological evaluation of the hip is directed by the history and physical examination findings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=see_link\">",
"     \"Evaluation of the adult with hip pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16729?source=see_link\">",
"     \"Overview of hip pain in childhood\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Major categories of hip pathology include trauma, sports-related injuries, the bone marrow edema syndrome, osteonecrosis (avascular necrosis), arthritis, the greater trochanteric pain syndrome, infection, tumor, and hip arthroplasty. Less common entities such as femoroacetabular impingement syndrome, nerve entrapment syndromes, and snapping hip syndrome are briefly addressed. Imaging in the evaluation of pediatric hip pain is presented in the context of individual disorders. A list of some entities that affect the hip in children of various ages is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25097?source=see_link\">",
"     \"Radiologic evaluation of the hip in infants, children, and adolescents\"",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Acute hip trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute hip trauma is initially evaluated with plain film radiographs. Patients with a history of trauma for whom there is a high clinical index of suspicion of fracture, which is not apparent on plain radiographs, should be assessed further with MRI (or CT if there is a contraindication to MRI).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is the initial study obtained for trauma or suspected fracture involving the hip and pelvis. Most fractures of the pelvis and hip joint, avulsion injuries, and dislocations will be identified on plain film. However, fractures involving the acetabulum, pelvic ring, or sacrum are occasionally difficult to detect on plain film radiography, and CT is recommended. Likewise, nondisplaced fractures, insufficiency fractures, or",
"      <span class=\"nowrap\">",
"       stress/incomplete",
"      </span>",
"      fractures of the femoral neck may not be seen on plain film, and MRI is recommended (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75625 \" href=\"UTD.htm?33/32/34319\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78263 \" href=\"UTD.htm?14/39/14964\">",
"       image 2",
"      </a>",
"      ). These advanced imaging modalities are indicated if the clinical suspicion remains high despite negative plain film radiography.",
"     </li>",
"     <li>",
"      CT &mdash; CT has several indications in the evaluation of hip fractures and dislocation. CT is indicated in clinically suspected acetabular, pelvic ring, and sacral fractures not seen on plain radiographs. CT can demonstrate the cortical break, intraarticular loose bodies, fracture alignment, and underlying pathological bone. CT with multiplanar reconstruction is used for preoperative planning of hip fractures and assessment of nonunion femoral fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/5\">",
"       5",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      CT is valuable in assessing the direction of the hip dislocation when plain film is not conclusive, evaluating the extent of injury, and in treatment planning. In posterior hip dislocation, CT shows the associated posterior acetabular wall fractures, intraarticular loose bodies, or other mechanical blocks, which may interfere with closed reduction or result in instability after reduction [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/6\">",
"       6",
"      </a>",
"      ]. CT is also indicated after closed reduction of all hip dislocations to assess for associated fractures, residual subluxation, and osteochondral fragments [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/7\">",
"       7",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      CT may not detect trabecular bone injuries seen in insufficiency fractures of the femoral neck; these are best detected by MRI.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is indicated for detection of radiographically occult fractures, such as stress and insufficiency fractures of the femoral neck, intertrochanteric fractures, and subtrochanteric fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75625 \" href=\"UTD.htm?33/32/34319\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78263 \" href=\"UTD.htm?14/39/14964\">",
"       image 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. Pelvic MRI evaluation will show any additional pelvic insufficiency (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef54969 \" href=\"UTD.htm?20/57/21398\">",
"       image 3",
"      </a>",
"      ), avulsion fractures, bone contusions, and muscle and sciatic nerve injury [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. MRI will demonstrate the full extent of a fracture, such as a greater trochanteric fracture, which may appear simple on plain radiography, to determine if surgical intervention is needed [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/13,14\">",
"       13,14",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Accuracy of MRI for detecting occult hip fracture is reported to be 100 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/12\">",
"       12",
"      </a>",
"      ], which can be achieved using T1-weighted coronal sequence alone [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/15\">",
"       15",
"      </a>",
"      ]. However, for early detection of associated edema and soft tissue injury, a fluid sensitive sequence is required.",
"      <br/>",
"      <br/>",
"      In the follow-up of femoral neck fracture and dislocation, MRI performed at three months is useful in detecting AVN, which is a potential complication from damage to the circumflex femoral artery [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Radionuclide scan &mdash; Radionuclide bone scan is indicated in cases with suspected fracture and negative radiographs when MRI or CT is not available. The bone scan usually becomes positive within six hours; however, in older or osteopenic patients, there may be a delay of 48 hours after injury [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/17\">",
"       17",
"      </a>",
"      ]. Sacral fractures have a characteristic appearance on bone scan and can be accurately diagnosed.",
"     </li>",
"     <li>",
"      MR arthrography &mdash; MR arthrography is indicated in the setting of persistent pain and clinical suspicion of acetabular labral tear, ligamentous or capsular injury, intraarticular loose bodies, and chondral injuries. MR arthrography can detect stability of an osteochondral lesion, which can affect management.",
"     </li>",
"     <li>",
"      Ultrasound &mdash; In the appropriate clinical setting, ultrasound can identify soft tissue hematoma, as well as partial or complete muscle tear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14698633\">",
"    <span class=\"h3\">",
"     Hip imaging in sports medicine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain film radiographs are used initially to evaluate patients with subacute or chronic hip pain. Radionuclide scanning, CT, and MRI are all more sensitive than plain radiographs for the detection of stress fractures of the hip or pelvis, particularly during the first few weeks following the onset of pain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography detects fracture, dislocation, avulsion injuries of the ischium, iliac spines, and iliac crest, as well as greater and lesser trochanters.",
"      <br/>",
"      <br/>",
"      Premature osteoarthritis of the symphysis pubis and sacroiliac joints, which is encountered in marathon runners, skiers, and soccer players, is detected.",
"      <br/>",
"      <br/>",
"      Stress fractures of the femoral neck are often not visualized in the first two weeks on plain radiographs [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/18\">",
"       18",
"      </a>",
"      ] and, when clinically suspected, should be further evaluated with MRI.",
"     </li>",
"     <li>",
"      Radionuclide bone scan &mdash; Radionuclide bone scan with single photon emission computed tomography (SPECT) is 100 percent sensitive for detecting stress fracture; however, it is not specific since it is also positive in stress reaction [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT &mdash; CT demonstrates small avulsion injuries, which may not be visualized on plain film, and the presence of intraarticular extension of fracture. CT is used for preoperative planning of hip fractures.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI detects stress fractures, subtle avulsion injuries, osteochondral injuries, periarticular soft tissue injuries such as muscle strains and contusions (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68007 \" href=\"UTD.htm?30/17/30993\">",
"       image 4",
"      </a>",
"      ), tendon tears, and sciatic nerve injury. MRI is the modality of choice for early detection of stress fractures, which, in turn, prevents complications such as displacement of tensile fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/18\">",
"       18",
"      </a>",
"      ]. MRI of muscle injury may affect the decision for surgical repair and predict time to recovery [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/20-22\">",
"       20-22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MR arthrography &mdash; MR arthrography is indicated in evaluation of suspected injuries to the acetabular labrum, ligamentum teres, detection of intraarticular loose bodies, and chondral defects. MR arthrography has 90 percent sensitivity and 91 percent accuracy for the detection of labral tears [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Acetabular labral tears",
"    </span>",
"    &nbsp;&mdash;&nbsp;Labral tears are most often posttraumatic in young adults and degenerative in the older population. Plain film radiographs cannot detect damage to the fibrocartilagenous labrum but may reveal osteoarthritic changes resulting from a prior injury. Lower field strength MRI is not useful, but equipment utilizing higher field (eg, 3 Tesla) may avoid the need for MR arthrography which is sensitive but invasive.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Radiographs have a low diagnostic yield for labral tears. Plain film findings that indicate sequela of labral tear are premature or rapidly progressing osteoarthritis.",
"     </li>",
"     <li>",
"      MRI &mdash; Current 1.5 T MRI is not sensitive for evaluation of the acetabular labrum. Preliminary studies using newer 3.0 T MRI scanners demonstrate that MRI can be as accurate as magnetic resonance arthrography for evaluation of labral tears and articular cartilage defects [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MR arthrography &mdash; MR arthrography is the modality of choice for evaluation of acetabular labral tear. MR arthrography defines the presence, morphology, and articular surface contour of the labrum. MR arthrography shows articular cartilage defects, labral tears (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82814 \" href=\"UTD.htm?10/33/10770\">",
"       image 5",
"      </a>",
"      ), intraarticular loose bodies, and major abnormalities of the ligamentum teres.",
"      <br/>",
"      <br/>",
"      Sensitivity of MR arthrography for detecting labral injuries is over 90 percent, and accuracy is between 88 and 91 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/23,25-27\">",
"       23,25-27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT arthrography &mdash; CT arthrography (CT arthrography) with intraarticular iodine can replace magnetic resonance arthrography when there is contraindication for MRI (eg aneurysm clips, certain pacemakers) or when MRI is not available.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Femoroacetabular impingement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Femoroacetabular impingement (FAI) is an important cause of hip pain, and its presence may lead to early osteoarthritis, particularly in those under age 40. The estimated prevalence is 10 to 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. FAI can be caused by a non-spherical femoral head (cam type) or by excessive acetabular covering (pincer type) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/30\">",
"     30",
"    </a>",
"    ]. Clinical manifestations of FAI are chronic pain, reduced range of motion, and early osteoarthritis.",
"   </p>",
"   <p>",
"    Early detection can be made by plain film, three dimensional CT, MRI, or MR arthrography [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]. MR arthrography also demonstrates the manifestations of untreated FAI, which include articular cartilage damage and acetabular labral tear. Treatment of FAI, when indicated, is by open surgical approach or by arthroscopic repair [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Bone marrow edema syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow edema syndrome, also referred to as the \"transient bone marrow edema syndrome\" or as \"transient osteoporosis of the hip,\" was initially described in pregnant women. This disorder of unknown etiology is most commonly seen in middle aged men presenting with hip pain. Osteopenia may be apparent on plain radiographs, while increased T2 signal in the bone marrow of the femoral head and neck is apparent on MRI. Diffuse rather than focal involvement of the femoral head may help to distinguish this entity from osteonecrosis. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Avascular necrosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Pain and osteopenia resolve spontaneously. Diagnostic imaging is useful primarily to exclude other causes of hip pain [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is often negative or may demonstrate osteopenia within four to eight weeks after the onset of hip pain [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/36\">",
"       36",
"      </a>",
"      ]. Osteopenia typically resolves within nine months of symptom onset.",
"     </li>",
"     <li>",
"      Radionuclide bone scan &mdash; Bone scan is more sensitive than plain film for detection of bone marrow edema syndrome. Scintigraphy reveals diffuse and homogeneously increased uptake that involves the femoral head and neck [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/37\">",
"       37",
"      </a>",
"      ]. However, this modality is no longer used since the advent of MRI.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI demonstrates bone marrow edema involving the entire femoral head and neck, with possible extension into the subtrochanteric region and commonly associated joint effusion. This entity can be differentiated from AVN by lack of focal changes of the femoral head on MRI [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/38,39\">",
"       38,39",
"      </a>",
"      ]. The MRI abnormalities are reversible as early as six weeks after onset of symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Avascular necrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The femoral head is the most common location for avascular necrosis of bone (AVN, also referred to as osteonecrosis), with trauma being the leading cause. Other risk factors include use of glucocorticoids, alcohol abuse, radiation, pancreatitis, and hemoglobinopathies. Non-traumatic cases of AVN are often bilateral. Patients on steroids may have asymptomatic AVN. The clinical and laboratory data are not specific for the diagnosis, and confirmation can be done only by imaging. Early detection and surgical intervention by core decompression can prevent progression to femoral head collapse and the need for total hip arthroplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is the first imaging study recommended for evaluation of suspected AVN. Plain film excludes other causes of hip pain and detects advanced stages of AVN, eliminating the need for further imaging. In addition to the frontal view, the frog leg view is necessary to evaluate the anterosuperior aspect of the femoral head [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/43\">",
"       43",
"      </a>",
"      ]. The sensitivity of plain film radiography for the early stages of AVN is low. Findings seen in later stages of AVN are subchondral sclerosis, progressing to subchondral fracture (\"crescent sign\") and collapse of the femoral head with secondary osteoarthritis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67706 \" href=\"UTD.htm?30/10/30882\">",
"       image 6",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      MRI &mdash; MR is the most sensitive and specific method for diagnosing and staging AVN (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60101 \" href=\"UTD.htm?36/48/37635\">",
"       image 7",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. MRI is recommended when there is a clinical suspicion of AVN but when the plain films are negative or equivocal. When the plain films are positive for AVN in one hip, MRI is indicated for evaluation of the contralateral hip for occult AVN. Limited MRI has the potential of becoming a screening procedure for selected groups of patients at high risk for developing AVN [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/46-48\">",
"       46-48",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The sensitivity and specificity of MRI for diagnosing early AVN range from 97 to 100 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]. MRI is less sensitive in detection of subchondral fracture seen in later stage of AVN, which is better detected by computerized tomography [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/51\">",
"       51",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The classic MRI finding is the \"double line sign\" at the necrotic-viable bone interface that is present in up to 80 percent of the cases [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/52\">",
"       52",
"      </a>",
"      ]. Associated bone marrow edema is frequently limited to the femoral head, as compared with the bone marrow edema syndrome which shows more extensive involvement. Bone marrow edema syndrome should be considered a marker for potential progression to advanced AVN, and careful follow-up is necessary [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/53,54\">",
"       53,54",
"      </a>",
"      ]. The signal characteristic of the lesion determines the bone viability and, therefore, the stage of the disease [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/55\">",
"       55",
"      </a>",
"      ]. A small percentage of AVN cases may have associated acetabular osteonecrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/56\">",
"       56",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In addition to being useful in diagnosis, MRI is valuable in assessing prognosis and postoperative follow-up. The extent of involvement of the weight bearing area of the femoral head by osteonecrosis and the location of the lesion correlate with progression to collapse [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/57-59\">",
"       57-59",
"      </a>",
"      ]. Laterally located lesions have a higher rate of femoral head collapse than centrally or medially located lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/58\">",
"       58",
"      </a>",
"      ]. The extent of involvement of the femoral head also correlates with the likelihood of success of early surgical interventions, such as core decompression. As an example, early stage AVN involving less than 25 percent of the weight bearing portion of the femoral head treated by core decompression did not progress to collapse, whereas 87 percent of the cases involving more than 50 percent of the femoral head proceeded to collapse [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/60\">",
"       60",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=see_link\">",
"       \"Osteonecrosis (avascular necrosis of bone)\"",
"      </a>",
"      .) In addition, MRI is important in postoperative follow-up of core decompression, by assessing the return of bone viability [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/61\">",
"       61",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Entities that mimic AVN on MRI are subchondral insufficiency fracture and femoral head osteochondral lesion. Subchondral insufficiency fracture is a non-traumatic lesion that occurs in older osteoporotic patients and is typically seen in the superior lateral aspect of the femoral head [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/62\">",
"       62",
"      </a>",
"      ]. Femoral head osteochondral lesion is a posttraumatic lesion that occurs in young athletes in the medial aspect of the femoral head. The history and location helps in differentiating these lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Radionuclide scan &mdash; Radionuclide bone scan is sensitive for detection of early AVN when MRI is not available or is contraindicated. The changes are apparent before the plain film radiography becomes positive. The sensitivity of radionuclide bone scan with SPECT for detecting AVN is approximately 88 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT &mdash; CT is not sensitive for detection of early AVN. CT may show the classic \"asterisk sign\" secondary to condensation of bony trabeculae and sclerosis. CT is more sensitive than MRI in detection of advanced changes of AVN manifested by subchondral fracture and articular collapse [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/65\">",
"       65",
"      </a>",
"      ]. CT is useful in anatomic localization of osteonecrosis, as well as evaluation of secondary osteoarthritis and the extent of bone deformity, if osteotomy or arthroplasty is planned [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Arthritides",
"    </span>",
"    &nbsp;&mdash;&nbsp;This section addresses the major arthritides involving the hip joint, including osteoarthritis, inflammatory arthritis such as rheumatoid arthritis and ankylosing spondylitis, and calcium pyrophosphate deposition disease. We will briefly discuss pigmented villonodular synovitis and synovial osteochondromatosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Osteoarthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoarthritis (OA) is the most common arthritis seen in practice. Primary OA has a variety of risk factors, while secondary OA follows an identifiable joint injury or may result from repeated microtrauma, a prior infection, osteonecrosis, crystal disease, or metabolic disorders such as hemochromatosis and ochronosis. Plain film radiography is the initial and is often the only imaging modality needed to diagnose OA and to exclude other causes of hip pain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is the initial imaging modality of choice for evaluation of all arthritides. Hallmarks of OA of the hip seen in plain film include superolateral joint space narrowing, osteophyte formation, subchondral sclerosis, and cyst formation (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74691 \" href=\"UTD.htm?7/6/7266\">",
"       image 8",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      CT &mdash; CT is valuable in the setting of premature OA to detect anatomical abnormalities such as acetabular or femoral dysplasia or femoroacetabular impingement. In advanced OA, CT is used for preoperative planning and prosthesis fitting for total hip arthroplasty. CT can also help in localization of paraarticular calcifications or ossification and detection of loose bodies.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI does not have an established indication in the diagnosis and management of OA [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Rheumatoid arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common inflammatory arthritis of the hip is rheumatoid arthritis (RA).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Characteristic findings of RA on plain film are bilaterally symmetric and uniform (concentric) joint space narrowing with axial migration, osteoporosis, varying degrees of erosion, and synovial cyst formation, without sclerosis and osteophytes (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53803 \" href=\"UTD.htm?6/58/7072\">",
"       image 9",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      CT &mdash; CT demonstrates erosions earlier than plain film; however, CT is not routinely used for evaluation of RA.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI demonstrates the hypertrophied synovium and erosions. Use of MRI has been advocated for early diagnosis of RA in the hands [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/67\">",
"       67",
"      </a>",
"      ], but the usefulness of MRI of the hip in early disease is uncertain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Ankylosing spondylitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the axial skeleton (spine and sacroiliac joints). The most common nonaxial joint to be involved is the hip.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film is the single most important technique for detection, diagnosis, and follow-up of AS affecting the hip. Characteristic findings of AS are bilateral symmetrical loss of joint space with axial migration of the femoral head. Ankylosis (fusion) of the joint may ensue.",
"     </li>",
"     <li>",
"      CT &mdash; CT has limited use for the diagnosis of hip involvement by AS.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is useful in assessing early cartilage abnormalities and bone marrow edema; however, it is not necessary for diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Calcium pyrophosphate deposition disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcium pyrophosphate deposition disease (CPPD) is the most common crystal arthropathy, caused by deposition of calcium pyrophosphate dihydrate crystal in and around the joints that may be apparent on plain film radiographs. The knees, wrists, and hips are the joints most commonly affected by CPPD disease. Fluoroscopically guided joint aspiration may be necessary to obtain synovial fluid to confirm the presence of CPPD crystals and to exclude infection.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is the gold standard in the diagnosis of CPPD. Calcification is seen in the acetabular labrum",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the cartilage (chondrocalcinosis). Uniform loss of cartilage resulting in axial migration and prominent subchondral cyst formation are seen in later stages.",
"     </li>",
"     <li>",
"      CT and MRI &mdash; Ct and MRI are not necessary for diagnosis.",
"     </li>",
"     <li>",
"      Fluoroscopically guided joint aspiration (arthrocentesis) &mdash; Fluoroscopically guided hip aspiration is valuable in the detection of CPPD crystals when the clinical manifestation of pseudogout (acute arthritis) is present and when the plain film is normal. Gram stain and culture of joint fluid is useful in excluding a concomitant joint infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Pigmented villonodular synovitis and synovial osteochondromatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pigmented villonodular synovitis (PVNS) and synovial osteochondromatosis are benign proliferative disorders of the synovial lining. PVNS and synovial osteochondromatosis are rare causes of hip pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/10/42150?source=see_link&amp;anchor=H5#H5\">",
"     \"Antineoplastic therapy for miscellaneous benign diseases affecting soft tissue and bone\", section on 'Pigmented villonodular synovitis/tenosynovial giant cell tumor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Plain film radiography is the initial study of choice when either of these disorders is suspected. MRI is the imaging modality of choice for the diagnosis of PVNS and for synovial chondromatosis (in which calcification of the cartilaginous loose bodies is absent).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography demonstrates well-defined erosions with a normal joint space [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/68\">",
"       68",
"      </a>",
"      ]. In synovial osteochondromatosis, multiple intraarticular loose bodies are seen [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/69\">",
"       69",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Uncalcified cartilagenous loose bodies (synovial chondromatosis) are not visible on plain films but can be detected by CT or MRI.",
"     </li>",
"     <li>",
"      CT &mdash; CT of PVNS demonstrates hyperdense, hemosiderin-laden masses and delineates bone cysts and erosions. CT is also valuable for needle biopsy guidance, when needed, and for preoperative planning. In synovial chondromatosis, CT will show non-calcified intraarticular loose bodies.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is the study of choice for PVNS and for synovial chondromatosis with normal plain film (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82817 \" href=\"UTD.htm?7/47/7922\">",
"       image 10",
"      </a>",
"      ). MRI findings of PVNS are low signal, nodular intraarticular masses in all sequences from hemosiderin deposition [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/70\">",
"       70",
"      </a>",
"      ]. Bony erosions, when present, and extraarticular extension of the lesion are well-demonstrated on MRI. In synovial chondromatosis, MRI shows non-calcified loose bodies and helps in preoperative planning [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT arthrography or MR arthrography &mdash; Hip arthrography, utilizing either CT or MRI, can be used for better delineation of intraarticular masses.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Greater trochanteric pain syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Greater trochanteric pain syndrome can be due to bursitis or abductor muscle (gluteus medius and gluteus minimus) tendinopathy and tear. Greater trochanteric, ischiogluteal, and iliopsoas bursitis are well-recognized causes of pain in the region of the hip. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/45/14041?source=see_link\">",
"     \"Bursitis: An overview of clinical manifestations, diagnosis, and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is usually not helpful in the diagnosis of greater trochanteric pain syndrome but may help to exclude other pathologies such as fractures. Calcifications may be seen in the bursa or adjacent soft tissues.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI demonstrates fluid collection within the affected bursa in the case of bursitis, as well as abnormal signal or discontinuity within the abductor muscle tendons in the case of tendinitis and tear (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79312 \" href=\"UTD.htm?43/4/44101\">",
"       image 11",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Ultrasound &mdash; Ultrasound in trochanteric bursitis shows a distended, fluid-filled bursa. Ultrasound helps in guidance for fluid aspiration and analysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Hip infection and inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hip infection may present as a radiologic and orthopedic emergency. In the absence of immunosuppression, infection affecting the hip is likely due to bacterial organism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11049?source=see_link\">",
"     \"Septic arthritis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link\">",
"     \"Disseminated gonococcal infection\"",
"    </a>",
"    .) Infection around the hip can involve the surrounding soft tissues (cellulitis, abscess, and septic bursitis), the joint (septic arthritis), and the bone (osteomyelitis), which can coexist in advanced cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Soft tissue infection",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cellulitis &mdash; Cellulitis rarely requires imaging for diagnosis. MRI can be useful to exclude associated conditions, such as myositis, abscess, sinus tract, fasciitis, or osteomyelitis. Contrast administration is valuable and highly recommended [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Infectious fasciitis &mdash; MRI is very sensitive for evaluation of fascial inflammation, evaluating the extent of infection and the presence of abscess or osteomyelitis, but is not specific for necrotizing fasciitis since it does not easily detect a small amount of fascial air. CT may be more useful because of high sensitivity for fascial gas [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Abscess &mdash; Abscesses can be easily detected with CT or MRI, particularly with the use of intravenous contrast.",
"     </li>",
"     <li>",
"      Pyomyositis &mdash; MRI is highly sensitive for detection of muscle edema and disease progression to abscess, septic arthritis, or osteomyelitis.",
"     </li>",
"     <li>",
"      Septic bursitis &mdash; The greater trochanteric bursa is most frequently involved, followed by iliopsoas bursa. MRI is most sensitive, showing focal fluid signal in the bursal location with thick rim enhancement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Septic arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoroscopically or ultrasonographically guided needle aspiration of the hip is the most important study in patients with suspected septic arthritis. Plain film radiography may not reveal any specific abnormalities in early disease but may be helpful in excluding other causes of hip pain. Patients with subacute or chronic infection may warrant MRI evaluation, which can assess for the presence of a joint effusion and juxtaarticular bone involvement.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Radiographs are normal initially but may show joint space widening secondary to effusion and osteoporosis on both sides of the joint. In the advanced stages, joint destruction with erosive changes and joint space narrowing are seen.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is very sensitive for detecting joint effusion, destruction of the articular cartilage, and bone marrow edema. Subchondral edema is common due to hyperemia; however, the extension of bone marrow edema into the medullary cavity and the degree of change in bone marrow signal intensity are helpful to detect osteomyelitis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT &mdash; CT is indicated when MRI is not available or is contraindicated for evaluation of large joint effusion and femoral head and neck erosion. CT is not sensitive for detecting cartilage destruction in early stage of septic arthritis.",
"     </li>",
"     <li>",
"      Radionuclide scan &mdash; Radionuclide bone scan is used when MRI is not available. Bone scan demonstrates increased uptake in both sides of the joint but is nonspecific.",
"     </li>",
"     <li>",
"      Fluoroscopically guided joint aspiration &mdash; Joint aspiration under fluoroscopic guidance is indicated for diagnostic evaluation and therapeutic drainage of large septic joint effusion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common etiology of osteomyelitis is bacterial infection. Less frequent causes are mycobacterial and fungal organisms such as Candida, Coccidioides, Histoplasma, and Blastomyces species, which are more likely to occur in patients who are immunocompromised or who live in or have traveled to endemic areas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4649?source=see_link\">",
"     \"Overview of osteomyelitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12071?source=see_link\">",
"     \"Approach to imaging modalities in the setting of suspected osteomyelitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=see_link\">",
"     \"Skeletal tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Plain film radiographs may not reveal any abnormality in the first two weeks of bone infection. Early diagnosis is enhanced by use of MRI. Radionuclide bone scanning is an alternative for those with contraindications to MRI.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography may take two weeks to demonstrate any abnormality. Findings suspicious of acute osteomyelitis include soft tissue swelling, joint effusion, periarticular osteoporosis, and bone erosion. Periosteal reaction is not commonly seen in infection around the hip, unless the proximal femoral shaft is involved. Chronic osteomyelitis presents with a mixed pattern of lysis, sclerosis, and cortical thickening. Sequestrum formation (necrotic bone), involucrum (thick, irregular periosteal reaction), cloacae (cortical defect), and sinus tract can also be present [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Radionuclide scan &mdash; Radionuclide bone scan is highly sensitive but nonspecific in preexisting bone pathology, joint prostheses, and recent surgery or trauma. In patients without prior bone changes, the 3-phase radionuclide bone scan is 94 percent sensitive and 95 percent specific for osteomyelitis. Normalization of the bone scan after infection may take months, making the diagnosis of chronic osteomyelitis difficult. Imaging with In-111 labeled leukocytes is advocated for detection of osteomyelitis in patients with underlying bone pathology or prosthesis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/73\">",
"       73",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT &mdash; CT is indicated in chronic osteomyelitis to evaluate the extent of the disease such as sequestrum, involucrum, cloacae, and sinus tract and soft tissue swelling. CT cannot assess activity of disease.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is the most sensitive and specific modality in the diagnosis of early osteomyelitis by showing bone marrow edema (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80599 \" href=\"UTD.htm?10/48/11013\">",
"       image 12",
"      </a>",
"      ), with values over 90 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/74\">",
"       74",
"      </a>",
"      ]. MRI can distinguish between paraarticular soft tissue infection and osteomyelitis. MRI is more valuable than CT in chronic osteomyelitis because it demonstrates activity of the disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Bone or soft tissue tumor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain film radiography is the first imaging modality employed in patients who present with suspected mass lesions in the region of the hip. Further evaluation of bone tumors is facilitated by CT scanning, while MRI is the modality of choice for evaluation of soft tissue tumors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film is the initial modality of choice for detection and assessment of the general features of bone tumor. Accuracy of plain film for detection of soft tissue tumors is limited. Plain film is the most valuable method to evaluate the margin characteristic of bone tumor (zone of transition), which is the important distinguishing feature between benign and malignant bone lesions. Plain film radiography also demonstrates the extent of cortical destruction, periosteal reaction, matrix calcifications, and pathological fractures. Certain radiographic patterns, combined with the age of the patient, can be very suggestive of specific tumors.",
"     </li>",
"     <li>",
"      CT &mdash; CT is the best method for detection of lesions not optimally seen by plain film. CT provides better assessment of cortical invasion, pathological fracture, periosteal reaction, matrix mineralization, and detection of cystic or fatty nature of tumor (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67177 \" href=\"UTD.htm?36/62/37857\">",
"       image 13",
"      </a>",
"      ). CT is used for biopsy guidance and preoperative evaluation. CT is the best imaging technique for identification and localization of the nidus of the osteoid osteoma [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/75\">",
"       75",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is nonspecific for differentiation of most tumors. MRI is the modality of choice for local staging, for definition of medullary and extracortical spread, and for the delineation of tumor in relation to critical neurovascular structures. The zone of transition, an important feature in plain film imaging, as discussed above, is not valid on MRI. Gadolinium administration is useful to differentiate solid from cystic or necrotic tumor, to evaluate responses to nonsurgical therapy, and to detect tumor recurrence. As noted earlier, administration of gadolinium-containing MRI contrast agents should be avoided in patients with moderately to severely impaired renal function (eg, estimated glomerular filtration rate &lt;15 to 30",
"      <span class=\"nowrap\">",
"       mL/min).",
"       <br/>",
"       <br/>",
"       If",
"      </span>",
"      gadolinium-based imaging must be performed in a patient with moderately to severely impaired renal function, there may be a role for dialysis to reduce the risk of development of nephrogenic systemic fibrosis (NFS). Causes and approaches to prevention of NFS are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=see_link&amp;anchor=H24#H24\">",
"       \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\", section on 'If gadolinium must be given'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Radionuclide scan &mdash; The use of radionuclide bone scan for tumor is limited to evaluation of metastatic skeletal involvement (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80098 \" href=\"UTD.htm?41/53/42847\">",
"       image 14",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Hip arthroplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hip is the most commonly replaced joint. Plain film is the first method in the evaluation of hip arthroplasty; however, CT, MRI, scintigraphy, sonography, aspiration, and arthrography all have different roles in the assessment of the painful hip prosthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1658?source=see_link\">",
"     \"Complications of total hip arthroplasty\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complications of total hip arthroplasty can be grouped into aseptic loosening and osteolysis, dislocation, infection, periprosthetic fracture, hardware failure, and heterotopic ossification. Heterotopic ossification that occurs in muscle is also known as myositis ossificans. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1658?source=see_link\">",
"     \"Complications of total hip arthroplasty\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serial radiographs are the most important modality in assessing the hip prosthesis. Most management decisions can be made based on serial plain film findings without resorting to more complex imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Aseptic loosening and osteolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Loosening of hip prosthesis due to mechanical factors (aseptic loosening) is the most common complication leading to revision surgery. Osteolysis is caused by particle disease resulting from wear of the polyethylene (PE) liner of the acetabulum. The polyethylene debris incites a granulomatous reaction in the adjacent bone, resulting in erosion and cyst-like changes in the periprosthetic bone, leading to loosening. In addition, patients can develop cyst-like regions of fluid or soft tissue density material that protrude into the periacetabular region and communicate with the hip joint (pseudomembrane or pseudobursae formation).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is indicated in routine evaluation of the prosthetic hip and for assessing complications of hip arthroplasty. Postoperative radiographic follow-up in asymptomatic patients is routinely recommended at one, three and five years, and every five years thereafter. In symptomatic patients in whom loosening is suspected, the initial study should be a plain radiograph. Comparison with prior studies is of utmost importance. Radiolucent areas greater than 2 mm adjacent to the prosthesis and progressive changes in follow-up radiographs are highly suspicious for loosening (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56858 \" href=\"UTD.htm?37/58/38817\">",
"       image 15",
"      </a>",
"      ). Other signs of loosening include development of bony sclerosis adjacent to the distal tip of prosthesis (pedestal formation) and evidence of prosthesis movement. Osteolysis related to particle disease is seen as focal, well-defined radiolucencies and smooth endosteal scalloping around the acetabular or femoral component.",
"     </li>",
"     <li>",
"      CT &mdash; Multidetector computed tomography (MDCT) with a special technique to reduce metallic artifact is more sensitive than plain film radiographs for evaluation of the prosthesis. For a cemented acetabular component, the presence of linear radiolucencies more than a few millimeters in width is suggestive of loosening. In a non-cemented acetabular component, large cysts surrounding the acetabular component may indicate particle-induced osteolysis. CT can also visualize the associated pseudomembrane formation and the amount of remaining trabecular bone at the rim of the acetabular component. For the femoral component, CT can visualize subsidence (inferior migration of the femoral stem relative to the shaft) and \"bead shedding\" [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/78\">",
"       78",
"      </a>",
"      ]. CT can be helpful in evaluating the femoral and acetabular bone stock prior to revision surgery.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI with optimization of image quality for correction of metallic hardware artifact is valuable in differentiating the soft tissue masses surrounding the prosthesis, which can be related to histiocytic osteolysis (particle disease) or infected fluid collections, by demonstrating different signal intensities [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/79\">",
"       79",
"      </a>",
"      ]. MRI is more accurate than plain radiography in demonstrating the location and extent of osteolysis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/80\">",
"       80",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Conventional arthrography &mdash; Arthrography is occasionally performed to evaluate suspected loosening of arthroplasty; however, its accuracy is limited by many false-negatives and false-positives [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/76\">",
"       76",
"      </a>",
"      ]. Arthrography can detect painful pseudobursae formation and can be used for aspiration and injection of local anesthetic or steroid for symptomatic relief.",
"     </li>",
"     <li>",
"      Ultrasonography &mdash; Ultrasonography can detect pseudobursae formation; however, it is not routinely used due to inadequate evaluation of the bony structures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12209584\">",
"    <span class=\"h2\">",
"     Pseudotumors and metal-on-metal resurfacing arthroplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;In younger patients, hip resurfacing arthroplasty has been utilized as an alternative to conventional arthroplasty. These implants consist of metal-on-metal articulations, leading to small wear particles being released. These particles cause lymphocyte and plasma cell infiltrates, termed aseptic lymphocytic vasculitis-associated lesions. These infiltrates may be associated with periarticular fluid collections or masses, also termed \"pseudotumors.\" Although pseudotumors have been reported most frequently in association with metal-on-metal hip implants, these pseudotumors are simply an additional manifestation of particle disease, and, therefore, they may be seen in hip arthroplasties of any type, including metal-on-polyethylene implants [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MRI &mdash; Pseudotumors are most commonly located at the posterolateral aspect of the joint, often in continuity with the greater trochanter, and are usually cystic. Anterior lesions may also be seen and are more likely to have solid components. Pseudotumors are contiguous with the joint capsule.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Dislocation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dislocation is the second most common reason for revision surgery. Dislocation is diagnosed on plain film radiography. CT can better assess the integrity of the acetabular component.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoroscopically guided joint aspiration is used to assess possible infection of a prosthetic hip. Plain film radiography may reveal osteolysis or periosteal reaction. Radionuclide scanning may help differentiate aseptic loosening from infection; the combination of radionuclide-labeled white blood cells and a technetium-labeled sulfur colloid scanning is the most accurate noninvasive method of differentiating aseptic loosening from prosthetic joint infection.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Radiographic findings of wide irregular radiolucency around the prosthesis and more rapid progression of bone resorption are consistent with infection. Periosteal reaction is also highly suggestive of infection. More advanced cases demonstrate frank bone destruction. However, infection can also be indolent and can mimic aseptic loosening or small particle osteolysis.",
"     </li>",
"     <li>",
"      Conventional arthrography and aspiration &mdash; Joint aspiration is the gold standard for evaluation of suspected prosthesis infection [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/82\">",
"       82",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42680?source=see_link\">",
"       \"Clinical manifestations and diagnosis of prosthetic joint infections\"",
"      </a>",
"      .) Synovial biopsy may be performed if the joint aspiration is negative or nondiagnostic for infection and if the clinical suspicion is high.",
"     </li>",
"     <li>",
"      Radionuclide scan &mdash; Various scintigraphic methods can be used to evaluate prosthetic loosening or infection. A normal bone scan excludes the diagnosis of infection. Adding a gallium scan to the standard technetium bone scan improves the accuracy for differentiating between infection and aseptic loosening. The combination of technetium or indium-labeled white cells and technetium-labeled sulfur colloid is currently the combination of choice for evaluating infection, with an accuracy of over 90 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/83,84\">",
"       83,84",
"      </a>",
"      ]. Positron emission tomography (PET scan) has variable accuracy and is not used routinely for prosthetic infection or loosening.",
"     </li>",
"     <li>",
"      CT &mdash; Periosteal reaction, joint effusion, or periprosthetic fluid collections seen on CT are highly predictive of early infection [",
"      <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/85\">",
"       85",
"      </a>",
"      ]. More advanced cases demonstrate frank bone destruction.",
"     </li>",
"     <li>",
"      Ultrasonography &mdash; &mdash; Ultrasonography can detect joint effusions or periarticular fluid collections which are associated with an infected prosthesis. The absence of joint effusion excludes a septic joint. Ultrasonography can also detect immediate postoperative complications of total hip replacement, such as hematoma or seroma, and can be used as image guidance for aspiration.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI with optimization of image quality for correction of metallic hardware artifact is valuable in differentiating soft tissue masses surrounding the prosthesis (which can be related to histiocytic osteolysis or \"particle disease\") from infected fluid collections, by demonstrating different signal intensities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Periprosthetic fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periprosthetic fracture is more common in the femoral component than the acetabular component and is more common in revision hip than in primary arthroplasty. Periprosthetic fracture can occur during placement of the femoral stem or any time after hip replacement, typically at the level of the tip of the femoral stem. Diagnosis is made by plain film radiography. MRI can also identify associated soft tissue injuries such as avulsion of the abductor muscles from the greater trochanter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h3\">",
"     Hardware failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hardware failure can affect both the femoral and acetabular components. The stem of the femoral component can break, representing a metal fatigue stress fracture. \"Bead shedding\" in non cemented hip prosthesis (dislodgement of the metal spheres sintered to the femoral metal stem) can be visualized as aggregate clumps of beads on CT, indicating hardware failure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/78\">",
"     78",
"    </a>",
"    ]. The superior aspect of the polyethylene (PE) liner of the acetabulum can gradually wear down, resulting in asymmetric superior location of the femoral head within the acetabulum. In addition to gradual wear, the PE liner can break and separate from the metal acetabular shell, resulting in direct contact between the femoral head and acetabular metal component. Antero-posterior radiograph is diagnostic for evaluation of PE liner wear in 95 percent of cases. Arthrography can also show displaced intraarticular pieces of broken PE liner.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Heterotopic calcification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heterotopic calcification within the soft tissues surrounding the arthroplasty is a more common but less significant complication of total hip replacement, which can be easily diagnosed with plain film radiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Nerve entrapment syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The piriformis syndrome usually is caused by a neuritis of the proximal sciatic nerve. Spasm or contracture of the piriformis muscle can either irritate or compress the proximal sciatic nerve and can mimic discogenic sciatica (pseudosciatica) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/86\">",
"     86",
"    </a>",
"    ]. Hamstring syndrome is caused by tight tendinous structures of the hamstring muscle at its insertion on the ischial tuberosity, causing pain in this area radiating down the back of the thigh. Hip arthroplasty is one of the causes of nerve entrapment syndromes. These syndromes are evaluated by MRI. MRI will often show sciatic nerve inflammation in the area of piriformis muscle in the piriformis syndrome and between the semitendinosus and biceps femoris muscles in hamstring syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Snapping hip syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Snapping hip syndrome is a benign condition that results from slippage of the iliotibial band or gluteus maximus muscle over the greater trochanter (external snapping hip syndrome) or slippage of the iliopsoas tendon over the iliopectineal eminence or the femoral head (internal snapping hip syndrome). Evaluation of the snapping hip syndrome is performed with a combination of plain radiography and ultrasonography [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/2\">",
"     2",
"    </a>",
"    ]. MRI should be reserved for difficult cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/39/25210/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7186765\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATION",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography is used in the initial evaluation of any cause of hip pain. Plain films can also identify causes of referred hip pain, such as sacroiliitis, but may not detect or accurately characterize some hip fractures and bone marrow edema associated with early avascular necrosis or early osteomyelitis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Plain film radiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Computerized tomography (CT) is most useful in the setting of trauma, for preoperative planning, and for evaluation and guiding percutaneous biopsy of tumors. CT can detect the intraarticular extension of fractures. CT may not detect trabecular bone injuries, which may be present in femoral neck insufficiency fractures in osteoporotic patients, and will not demonstrate the bone marrow edema of early osteonecrosis and early osteomyelitis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Computerized tomography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Magnetic resonance imaging (MRI) accurately evaluates the bone marrow, joint space, neurovascular structures, and soft tissues. MRI is the modality of choice for suspected femoral fracture not demonstrated radiographically, osteochondral injuries, muscle injuries, joint effusion, early diagnosis and staging of avascular necrosis, iliopsoas and intertrochanteric bursitis, evaluation of infection, and tumor. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radionuclide bone scan surveys a large area; however, it is often nonspecific. Radionuclide bone scan is reserved for suspected fracture or avascular necrosis not demonstrated by plain film radiography when MRI is not available or is contraindicated and in the evaluation of metastatic disease and prosthetic device loosening or infection. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Radionuclide bone scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ultrasound (US) has low cost, is readily available, allows dynamic evaluation of the tendons and muscles, and does not involve ionizing radiation; however, it is highly operator-dependent. Hip effusions and bursal or periarticular fluid collections are readily identified. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ultrasound'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The imaging indications for conventional hip arthrography are now limited due to the increased use of magnetic resonance arthrography (MR arthrography), which visualizes joint anatomy, as well as bone and surrounding soft tissues, but may be useful to confirm intraarticular needle placement when hip aspiration is indicated for joint fluid analysis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Conventional arthrography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Injection with anesthetic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      steroid under fluoroscopic guidance is reserved for cases when imaging is inconclusive or demonstrates mild osteoarthritis and when referred pain is clinically suspected. Persistent pain despite the injection of a local anesthetic reduces the likelihood that hip pathology is the cause of pain and may obviate the need for further diagnostic imaging of the hip. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Image-guided injection with anesthetic and/or steroid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Magnetic resonance arthrography (MR arthrography) with intraarticular gadolinium administration best delineates the joint anatomy, including the acetabular labrum, articular cartilage, and ligamentum teres, and detects loose bodies. Administration of gadolinium-containing MRI contrast agents should be avoided in patients with severely impaired renal function. Computerized tomography arthrography (CT arthrography) with intraarticular iodinated contrast is used in cases where the use of MR arthrography is contraindicated. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Computerized tomography arthrography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Magnetic resonance arthrography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The imaging modality used in a given patient depends upon the differential diagnosis that has been developed based upon the history and physical examination. The conditions for which the choice of imaging study is reviewed here include trauma, sports-related injuries, the bone marrow edema syndrome, osteonecrosis, arthritis, the greater trochanteric pain syndrome, infection, tumor, hip arthroplasty, femoroacetabular impingement syndrome, nerve entrapment syndromes, and snapping hip syndrome. (See appropriate section headings in this topic and appropriate topic reviews).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/1\">",
"      Cavalier R, Herman MJ, Pizzutillo PD, Geller E. Ultrasound-guided aspiration of the hip in children: a new technique. Clin Orthop Relat Res 2003; :244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/2\">",
"      Cardinal E, Buckwalter KA, Capello WN, Duval N. US of the snapping iliopsoas tendon. Radiology 1996; 198:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/3\">",
"      Berquist TH. Diagnostic and therapeutic injections as an aid to musculoskeletal diagnosis. Semin Intervent Radiol 1993; 10:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/4\">",
"      Cardone DA, Tallia AF. Diagnostic and therapeutic injection of the hip and knee. Am Fam Physician 2003; 67:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/5\">",
"      Savolaine ER, Ebraheim N. Assessment of femoral neck nonunion with multiplanar computed tomography reconstruction. Orthopedics 2000; 23:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/6\">",
"      Calkins MS, Zych G, Latta L, et al. Computed tomography evaluation of stability in posterior fracture dislocation of the hip. Clin Orthop Relat Res 1988; 227:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/7\">",
"      Hougaard K, Lindequist S, Nielsen LB. Computerised tomography after posterior dislocation of the hip. J Bone Joint Surg Br 1987; 69:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/8\">",
"      May DA, Purins JL, Smith DK. MR imaging of occult traumatic fractures and muscular injuries of the hip and pelvis in elderly patients. AJR Am J Roentgenol 1996; 166:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/9\">",
"      Schultz E, Miller TT, Boruchov SD, et al. Incomplete intertrochanteric fractures: imaging features and clinical management. Radiology 1999; 211:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/10\">",
"      Bogost GA, Lizerbram EK, Crues JV 3rd. MR imaging in evaluation of suspected hip fracture: frequency of unsuspected bone and soft-tissue injury. Radiology 1995; 197:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/11\">",
"      Chung CB, Robertson JE, Cho GJ, et al. Gluteus medius tendon tears and avulsive injuries in elderly women: imaging findings in six patients. AJR Am J Roentgenol 1999; 173:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/12\">",
"      Verbeeten KM, Hermann KL, Hasselqvist M, et al. The advantages of MRI in the detection of occult hip fractures. Eur Radiol 2005; 15:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/13\">",
"      Craig JG, Moed BR, Eyler WR, van Holsbeeck M. Fractures of the greater trochanter: intertrochanteric extension shown by MR imaging. Skeletal Radiol 2000; 29:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/14\">",
"      Feldman F, Staron RB. MRI of seemingly isolated greater trochanteric fractures. AJR Am J Roentgenol 2004; 183:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/15\">",
"      Quinn SF, McCarthy JL. Prospective evaluation of patients with suspected hip fracture and indeterminate radiographs: use of T1-weighted MR images. Radiology 1993; 187:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/16\">",
"      Poggi JJ, Callaghan JJ, Spritzer CE, et al. Changes on magnetic resonance images after traumatic hip dislocation. Clin Orthop Relat Res 1995; :249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/17\">",
"      Evans PD, Wilson C, Lyons K. Comparison of MRI with bone scanning for suspected hip fracture in elderly patients. J Bone Joint Surg Br 1994; 76:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/18\">",
"      DeAngelis NA, Busconi BD. Assessment and differential diagnosis of the painful hip. Clin Orthop Relat Res 2003; :11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/19\">",
"      Matin P. Basic principles of nuclear medicine techniques for detection and evaluation of trauma and sports medicine injuries. Semin Nucl Med 1988; 18:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/20\">",
"      Meislin R, Abeles A. Role of hip MR imaging in the management of sports-related injuries. Magn Reson Imaging Clin N Am 2005; 13:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/21\">",
"      Gibbs NJ, Cross TM, Cameron M, Houang MT. The accuracy of MRI in predicting recovery and recurrence of acute grade one hamstring muscle strains within the same season in Australian Rules football players. J Sci Med Sport 2004; 7:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/22\">",
"      Cross TM, Gibbs N, Houang MT, Cameron M. Acute quadriceps muscle strains: magnetic resonance imaging features and prognosis. Am J Sports Med 2004; 32:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/23\">",
"      Czerny C, Hofmann S, Neuhold A, et al. Lesions of the acetabular labrum: accuracy of MR imaging and MR arthrography in detection and staging. Radiology 1996; 200:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/24\">",
"      Sundberg TP, Toomayan GA, Major NM. Evaluation of the acetabular labrum at 3.0-T MR imaging compared with 1.5-T MR arthrography: preliminary experience. Radiology 2006; 238:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/25\">",
"      Czerny C, Hofmann S, Urban M, et al. MR arthrography of the adult acetabular capsular-labral complex: correlation with surgery and anatomy. AJR Am J Roentgenol 1999; 173:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/26\">",
"      Leunig M, Werlen S, Ungersb&ouml;ck A, et al. Evaluation of the acetabular labrum by MR arthrography. J Bone Joint Surg Br 1997; 79:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/27\">",
"      Toomayan GA, Holman WR, Major NM, et al. Sensitivity of MR arthrography in the evaluation of acetabular labral tears. AJR Am J Roentgenol 2006; 186:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/28\">",
"      Wettstein M, Dienst M. [Hip arthroscopy for femoroacetabular impingement]. Orthopade 2006; 35:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/29\">",
"      Leunig M, Beck M, Dora C, Ganz R. [Femoroacetabular impingement: trigger for the development of coxarthrosis]. Orthopade 2006; 35:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/30\">",
"      Beck M, Kalhor M, Leunig M, Ganz R. Hip morphology influences the pattern of damage to the acetabular cartilage: femoroacetabular impingement as a cause of early osteoarthritis of the hip. J Bone Joint Surg Br 2005; 87:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/31\">",
"      Beaul&eacute; PE, Zaragoza E, Motamedi K, et al. Three-dimensional computed tomography of the hip in the assessment of femoroacetabular impingement. J Orthop Res 2005; 23:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/32\">",
"      Bredella MA, Stoller DW. MR imaging of femoroacetabular impingement. Magn Reson Imaging Clin N Am 2005; 13:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/33\">",
"      Tannast M, Siebenrock KA, Anderson SE. Femoroacetabular impingement: radiographic diagnosis--what the radiologist should know. AJR Am J Roentgenol 2007; 188:1540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/34\">",
"      James SL, Ali K, Malara F, et al. MRI findings of femoroacetabular impingement. AJR Am J Roentgenol 2006; 187:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/35\">",
"      Schapira D. Transient osteoporosis of the hip. Semin Arthritis Rheum 1992; 22:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/36\">",
"      Hayes CW, Conway WF, Daniel WW. MR imaging of bone marrow edema pattern: transient osteoporosis, transient bone marrow edema syndrome, or osteonecrosis. Radiographics 1993; 13:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/37\">",
"      Kaplan SS, Stegman CJ. Transient osteoporosis of the hip. A case report and review of the literature. J Bone Joint Surg Am 1985; 67:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/38\">",
"      Balakrishnan A, Schemitsch EH, Pearce D, McKee MD. Distinguishing transient osteoporosis of the hip from avascular necrosis. Can J Surg 2003; 46:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/39\">",
"      Vande Berg BC, Malghem JJ, Lecouvet FE, et al. Idiopathic bone marrow edema lesions of the femoral head: predictive value of MR imaging findings. Radiology 1999; 212:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/40\">",
"      Watson RM, Roach NA, Dalinka MK. Avascular necrosis and bone marrow edema syndrome. Radiol Clin North Am 2004; 42:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/41\">",
"      Smith SW, Fehring TK, Griffin WL, Beaver WB. Core decompression of the osteonecrotic femoral head. J Bone Joint Surg Am 1995; 77:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/42\">",
"      Tooke SM, Nugent PJ, Bassett LW, et al. Results of core decompression for femoral head osteonecrosis. Clin Orthop Relat Res 1988; :99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/43\">",
"      Meyer SJ, Vahey TN. Imaging algorithm for avascular necrosis of the hip. Rheum Dis Clin North Am 1991; 17:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/44\">",
"      Shih TT, Su CT, Chiu LC, et al. Evaluation of hip disorders by radiography, radionuclide scanning and magnetic resonance imaging. J Formos Med Assoc 1993; 92:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/45\">",
"      Lee MJ, Corrigan J, Stack JP, Ennis JT. A comparison of modern imaging modalities in osteonecrosis of the femoral head. Clin Radiol 1990; 42:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/46\">",
"      Tervonen O, Mueller DM, Matteson EL, et al. Clinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk. Radiology 1992; 182:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/47\">",
"      Khanna AJ, Yoon TR, Mont MA, et al. Femoral head osteonecrosis: detection and grading by using a rapid MR imaging protocol. Radiology 2000; 217:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/48\">",
"      Kopecky KK, Braunstein EM, Brandt KD, et al. Apparent avascular necrosis of the hip: appearance and spontaneous resolution of MR findings in renal allograft recipients. Radiology 1991; 179:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/49\">",
"      Glickstein MF, Burk DL Jr, Schiebler ML, et al. Avascular necrosis versus other diseases of the hip: sensitivity of MR imaging. Radiology 1988; 169:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/50\">",
"      Beltran J, Burk JM, Herman LJ, et al. Avascular necrosis of the femoral head: early MRI detection and radiological correlation. Magn Reson Imaging 1987; 5:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/51\">",
"      Gardeniers J. A new international classification of osteonecrosis of the ARCO (Association Research Circulation Osseous) Committee. ARCO News 1992; 4:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/52\">",
"      Mitchell MD, Kundel HL, Steinberg ME, et al. Avascular necrosis of the hip: comparison of MR, CT, and scintigraphy. AJR Am J Roentgenol 1986; 147:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/53\">",
"      Iida S, Harada Y, Shimizu K, et al. Correlation between bone marrow edema and collapse of the femoral head in steroid-induced osteonecrosis. AJR Am J Roentgenol 2000; 174:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/54\">",
"      Radke S, Kirschner S, Seipel V, et al. Magnetic resonance imaging criteria of successful core decompression in avascular necrosis of the hip. Skeletal Radiol 2004; 33:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/55\">",
"      Mitchell DG, Steinberg ME, Dalinka MK, et al. Magnetic resonance imaging of the ischemic hip. Alterations within the osteonecrotic, viable, and reactive zones. Clin Orthop Relat Res 1989; :60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/56\">",
"      Fink B, Assheuer J, Enderle A, et al. Avascular osteonecrosis of the acetabulum. Skeletal Radiol 1997; 26:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/57\">",
"      Shimizu K, Moriya H, Akita T, et al. Prediction of collapse with magnetic resonance imaging of avascular necrosis of the femoral head. J Bone Joint Surg Am 1994; 76:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/58\">",
"      Ohzono K, Saito M, Takaoka K, et al. Natural history of nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg Br 1991; 73:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/59\">",
"      Nishii T, Sugano N, Ohzono K, et al. Significance of lesion size and location in the prediction of collapse of osteonecrosis of the femoral head: a new three-dimensional quantification using magnetic resonance imaging. J Orthop Res 2002; 20:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/60\">",
"      Beltran J, Knight CT, Zuelzer WA, et al. Core decompression for avascular necrosis of the femoral head: correlation between long-term results and preoperative MR staging. Radiology 1990; 175:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/61\">",
"      Imhof H, Breitenseher M, Trattnig S, et al. Imaging of avascular necrosis of bone. Eur Radiol 1997; 7:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/62\">",
"      Yamamoto T, Iwamoto Y, Schneider R, Bullough PG. Histopathological prevalence of subchondral insufficiency fracture of the femoral head. Ann Rheum Dis 2008; 67:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/63\">",
"      Jackson SM, Major NM. Pathologic conditions mimicking osteonecrosis. Orthop Clin North Am 2004; 35:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/64\">",
"      Kim KY, Lee SH, Moon DH, Nah HY. The diagnostic value of triple head single photon emission computed tomography (3H-SPECT) in avascular necrosis of the femoral head. Int Orthop 1993; 17:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/65\">",
"      Stevens K, Tao C, Lee SU, et al. Subchondral fractures in osteonecrosis of the femoral head: comparison of radiography, CT, and MR imaging. AJR Am J Roentgenol 2003; 180:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/66\">",
"      Conaghan P. Is MRI useful in osteoarthritis? Best Pract Res Clin Rheumatol 2006; 20:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/67\">",
"      Sugimoto H, Takeda A, Hyodoh K. Early-stage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis. Radiology 2000; 216:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/68\">",
"      Cotten A, Flipo RM, Chastanet P, et al. Pigmented villonodular synovitis of the hip: review of radiographic features in 58 patients. Skeletal Radiol 1995; 24:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/69\">",
"      Kim SH, Hong SJ, Park JS, et al. Idiopathic synovial osteochondromatosis of the hip: radiographic and MR appearances in 15 patients. Korean J Radiol 2002; 3:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/70\">",
"      Bhimani MA, Wenz JF, Frassica FJ. Pigmented villonodular synovitis: keys to early diagnosis. Clin Orthop Relat Res 2001; :197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/71\">",
"      Koulouris G, Morrison WB. MR imaging of hip infection and inflammation. Magn Reson Imaging Clin N Am 2005; 13:743.",
"     </a>",
"    </li>",
"    <li>",
"     Eisenberg RL, Margulis AR. Skeletal. In: What to order when: Pocket guide to diagnostic imaging, Lippincott Williams and Wilkens, Philadelphia 1999. p.288.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/73\">",
"      Schauwecker DS. The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol 1992; 158:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/74\">",
"      Morrison WB, Schweitzer ME, Bock GW, et al. Diagnosis of osteomyelitis: utility of fat-suppressed contrast-enhanced MR imaging. Radiology 1993; 189:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/75\">",
"      Assoun J, Richardi G, Railhac JJ, et al. Osteoid osteoma: MR imaging versus CT. Radiology 1994; 191:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/76\">",
"      Miller TT. Imaging of hip arthroplasty. Semin Musculoskelet Radiol 2006; 10:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/77\">",
"      Ostlere S, Soin S. Imaging of prosthetic joints. Imaging 2003; 15:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/78\">",
"      Buckwalter KA, Parr JA, Choplin RH, Capello WN. Multichannel CT Imaging of Orthopedic Hardware and Implants. Semin Musculoskelet Radiol 2006; 10:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/79\">",
"      White LM, Kim JK, Mehta M, et al. Complications of total hip arthroplasty: MR imaging-initial experience. Radiology 2000; 215:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/80\">",
"      Potter HG, Nestor BJ, Sofka CM, et al. Magnetic resonance imaging after total hip arthroplasty: evaluation of periprosthetic soft tissue. J Bone Joint Surg Am 2004; 86-A:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/81\">",
"      Fang CS, Harvie P, Gibbons CL, et al. The imaging spectrum of peri-articular inflammatory masses following metal-on-metal hip resurfacing. Skeletal Radiol 2008; 37:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/82\">",
"      Tigges S, Stiles RG, Meli RJ, Roberson JR. Hip aspiration: a cost-effective and accurate method of evaluating the potentially infected hip prosthesis. Radiology 1993; 189:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/83\">",
"      Love C, Tomas MB, Marwin SE, et al. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001; 21:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/84\">",
"      Love C, Marwin SE, Tomas MB, et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med 2004; 45:1864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/85\">",
"      Cyteval C, Hamm V, Sarrab&egrave;re MP, et al. Painful infection at the site of hip prosthesis: CT imaging. Radiology 2002; 224:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/86\">",
"      Durrani Z, Winnie AP. Piriformis muscle syndrome: an underdiagnosed cause of sciatica. J Pain Symptom Manage 1991; 6:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/39/25210/abstract/87\">",
"      Wunderbaldinger P, Bremer C, Matuszewski L, et al. Efficient radiological assessment of the internal snapping hip syndrome. Eur Radiol 2001; 11:1743.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1816 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-194.187.108.93-F5F47B5EFB-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25210=[""].join("\n");
var outline_f24_39_25210=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TYPES OF IMAGING STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Plain film radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Computerized tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Radionuclide bone scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Conventional arthrography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Image-guided injection with anesthetic and/or steroid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Magnetic resonance arthrography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Computerized tomography arthrography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      IMAGING STUDIES FOR SPECIFIC CLINICAL SETTINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Acute hip trauma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14698633\">",
"      - Hip imaging in sports medicine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Acetabular labral tears",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Femoroacetabular impingement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Bone marrow edema syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Avascular necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Arthritides",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Ankylosing spondylitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Calcium pyrophosphate deposition disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Pigmented villonodular synovitis and synovial osteochondromatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Greater trochanteric pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Hip infection and inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Soft tissue infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Septic arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Bone or soft tissue tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Hip arthroplasty",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Aseptic loosening and osteolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12209584\">",
"      Pseudotumors and metal-on-metal resurfacing arthroplasty",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Dislocation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Periprosthetic fracture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Hardware failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Heterotopic calcification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Nerve entrapment syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Snapping hip syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7186765\">",
"      SUMMARY AND RECOMMENDATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/1816\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/1816|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/32/34319\" title=\"diagnostic image 1\">",
"      Acute hip trauma plain film",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/39/14964\" title=\"diagnostic image 2\">",
"      Intertrochanteric fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/57/21398\" title=\"diagnostic image 3\">",
"      Sacral stress fracture MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/17/30993\" title=\"diagnostic image 4\">",
"      Gluteal muscle tear MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/33/10770\" title=\"diagnostic image 5\">",
"      MRI acetabular labral tear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/10/30882\" title=\"diagnostic image 6\">",
"      Osteonecrosis R hip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/48/37635\" title=\"diagnostic image 7\">",
"      Osteonecrosis hip STIR MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/6/7266\" title=\"diagnostic image 8\">",
"      Osteoarthritis of right hip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/58/7072\" title=\"diagnostic image 9\">",
"      Joint space narrowing in RA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/47/7922\" title=\"diagnostic image 10\">",
"      MRI synovial chondromatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/4/44101\" title=\"diagnostic image 11\">",
"      Gluteus medius insert tear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/48/11013\" title=\"diagnostic image 12\">",
"      Trochanteric osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/62/37857\" title=\"diagnostic image 13\">",
"      Benign tumor of femoral neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/53/42847\" title=\"diagnostic image 14\">",
"      Bone scan multiple bone mets",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/58/38817\" title=\"diagnostic image 15\">",
"      Aseptic prosthetic loosening",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/10/42150?source=related_link\">",
"      Antineoplastic therapy for miscellaneous benign diseases affecting soft tissue and bone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12071?source=related_link\">",
"      Approach to imaging modalities in the setting of suspected osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/45/14041?source=related_link\">",
"      Bursitis: An overview of clinical manifestations, diagnosis, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/43/42680?source=related_link\">",
"      Clinical manifestations and diagnosis of prosthetic joint infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1658?source=related_link\">",
"      Complications of total hip arthroplasty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/7/3193?source=related_link\">",
"      Diagnostic imaging of joint pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=related_link\">",
"      Disseminated gonococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=related_link\">",
"      Evaluation of the adult with hip pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/15/4341?source=related_link\">",
"      Gadoteridol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4392?source=related_link\">",
"      Musculoskeletal ultrasonography: Clinical applications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=related_link\">",
"      Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=related_link\">",
"      Osteonecrosis (avascular necrosis of bone)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/21/16729?source=related_link\">",
"      Overview of hip pain in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4649?source=related_link\">",
"      Overview of osteomyelitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25097?source=related_link\">",
"      Radiologic evaluation of the hip in infants, children, and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11049?source=related_link\">",
"      Septic arthritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=related_link\">",
"      Skeletal tuberculosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_39_25211="Differentiation between hibernation and stunning";
var content_f24_39_25211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differentiation between hibernation and stunning",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hibernation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Stunning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Response to inotropes",
"       </td>",
"       <td>",
"        &uarr; then &darr;&darr;",
"       </td>",
"       <td>",
"        &uarr; then &darr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glycosis",
"       </td>",
"       <td>",
"        &darr;&darr;",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blood flow at rest",
"       </td>",
"       <td>",
"        Slight &darr;",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coronary flow reserve",
"       </td>",
"       <td>",
"        &darr;&darr;",
"       </td>",
"       <td>",
"        &darr;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intra/extracellur potassium ([K",
"        <sub>",
"         i",
"        </sub>",
"        ]/[K",
"        <sub>",
"         o",
"        </sub>",
"        ])",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recovery following revascularization",
"       </td>",
"       <td>",
"        &uarr;&uarr;",
"       </td>",
"       <td>",
"        &uarr;&uarr;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Redwood SR, Ferrari R, Marber MS. Heart 1998; 80:218.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25211=[""].join("\n");
var outline_f24_39_25211=null;
var title_f24_39_25212="Pharmacologic cardioversion AF";
var content_f24_39_25212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58616&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58616&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA/ESC guideline summary: Pharmacologic cardioversion of atrial fibrillation (AF)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or general agreement that the following drugs are effective for cardioversion of AF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Flecainide.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Dofetilide.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Propafenone.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Ibutilide.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence",
"or opinion is in favor of the usefulness of the following drugs for",
"cardioversion of AF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Amiodarone, including use as an out-patient when rapid restoration of sinus rhythm does not appear to be necessary.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &bull;&nbsp; A single oral bolus (\"pill-in-the-pocket\") of propafenone or flecainide in the out-patient setting in selected patients in whom the safety and efficacy of this approach has been demonstrated in hospital and who meet the following criteria:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. The absence of sinus and atrioventricular (AV) node dysfunction, bundle branch block, QT interval prolongation, Brugada syndrome, and structural heart disease.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. The presence of AV nodal blockade with a beta blocker or nondihydropyridine calcium channel blocker to prevent rapid AV conduction if atrial flutter occurs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIb - The weight of evidence",
"or opinion is less well established for the usefulness of the following",
"drugs for cardioversion of AF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Quinidine.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Procainamide.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class III - There is evidence and/or",
"general agreement that the following drugs for cardioversion of AF are",
"not useful or may be harmful",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Digoxin.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Sotalol.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; For out-of-hospital cardioversion, quinidine, procainamide, disopyramide, and dofetilide.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 2006; 48:e149.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25212=[""].join("\n");
var outline_f24_39_25212=null;
var title_f24_39_25213="Hormonal changes in nephrosis";
var content_f24_39_25213=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F50596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F50596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Volume regulatory hormones in glomerular disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 225px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Levels of plasma renin activity (ng/L per sec) and atrial natriuretic peptide (fmol/mL) in normal subjects ingesting 20 and 130 meq of sodium per day and in patients with acute glomerulonephritis and nephrotic syndrome excreting 25 meq of sodium per day. Patients with nephrotic syndrome (fourth panel) show signs of renal sodium retention since they have a hormonal profile similar to those in normal subjects excreting 130 meq/day (second panel) despite having a much lower rate of sodium excretion. There is also evidence for a contribution from underfilling as these patients do not have the profile of pure volume expansion (very low renin, very high ANP) seen in acute glomerulonephritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Rodriguez-Iturbe, B, Colic, D, Parra, G, Gutkowska, J, Kidney Int 1990; 38:512.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25213=[""].join("\n");
var outline_f24_39_25213=null;
var title_f24_39_25214="Vitritis in endophthalmitis";
var content_f24_39_25214=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73318&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73318&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Active vitritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Active vitritis in endogenous",
"    <em>",
"     Candida",
"    </em>",
"    endophthalmitis. Several fluff balls typical of",
"    <em>",
"     Candida",
"    </em>",
"    infection can be seen with difficulty; the haziness is due to vitreal inflammation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol Kauffman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25214=[""].join("\n");
var outline_f24_39_25214=null;
var title_f24_39_25215="Frykman IV radius fracture AP view";
var content_f24_39_25215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Frykman IV radius fracture AP view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 311px; height: 430px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This fracture occurred in a 73-year-old osteoporotic woman following a low-energy fall onto her outstretched right hand. Due to the extension of the fracture into the radiocarpal joint and the distal ulnar injury (white arrow), this fracture is categorized as a Frykman IV. Most notable on this image is the displacement of the distal radial fragment (red arrow) and the loss of radial height. Other injuries are present, most notably a scaphoid fracture (black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Erik L Schroeder, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_39_25215=[""].join("\n");
var outline_f24_39_25215=null;
